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Abstract 
 
 
The growth of molecular modelling and free-energy calculations for drug discovery 
and development have provided a platform for the work undertaken in this thesis. The 
known affinity of certain metals for biological targets, such as gold/thiol affinity, has 
guided this research on the characterisation of interactions involved in both protein 
function inhibition and non-canonical DNA sequence stabilisation. The ability to 
calculate microsecond timeframes of our biological targets has allowed for greater 
understanding of these mechanisms at a molecular level. 
 
The research in this thesis is organised into two sections. The first part covers the 
mechanism of permeation and inhibition of AQP3 via a number of molecular dynamic 
techniques, such as umbrella sampling and metadynamics. The effects of a Au(III) 
complex on the protein conformation of AQP3 upon metal binding were investigated 
using steered molecular dynamics. The pH induced gating mechanism of AQP7 and 
its effect on both water and glycerol permeation was studied to understand the protein 
conformational changes involved.  
 
The second part investigates the stabilising effect of Au(I) N-heterocyclic carbenes 
(NHCs) on G-quadruplex DNA structures. The metadynamics calculated free-energy 
results were then compared to FRET melting assay results to determine the mechanism 
of interaction. 
 
Throughout this work we have shown how the use of in silico methods can enhance 
our mechanistic knowledge and understanding of biological systems, helping validate 
and explain experimental results, and vice versa. We have used state of the art 
molecular dynamics techniques, either rarely or not yet used for such complex 
systems, thus, furthering the knowledge of our group, and through published work, 
the wider scientific community 
 
 
 
  
 X 
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Chapter 1 - Introduction 
 
Section 1 
 
1.1 Use of computational tools for the study of biological systems 
 
The continuing increase in computational power, from institution and industry funded 
supercomputers to everyday desktops and laptops, has enabled the development and 
study of biological systems in great detail, more than ever before1. The advancement 
in software packages designed specifically for calculations on biological system, such 
as Gromacs2, Amber3 and Desmond4, have provided new tools to enhance our 
understanding of biological models5. A number of techniques are available whose 
suitability will depend on the system and the reaction/interaction under investigation. 
For small systems with a few atoms, detailed quantum mechanical density functional 
theory (DFT)6 calculations can resolve bond formation and bond breaking processes 
along with optimising geometries of small molecules. For larger more complex 
biological systems with multiple proteins and ligands all-atom molecular mechanics 
can be undertaken. The number of degrees of freedom on further increasing system 
size can be reduced by means of coarse-grained molecular dynamics, which eliminates 
fine interaction details and allow for a significant increase in simulation time and 
length scale (Figure 1.1) to be undertaken.  
Overall, computational chemistry is able to provide insights at levels beyond that of 
conventional biophysical and experimental techniques7. For example, in silico 
experiments can provide missing or hardly accessible experimental information on the 
shortest timescales with atomistic levels of detail. Thus, processes at a range of 
timescales from bond stretching (femtosecond) to protein folding (microsecond) can 
be viewed and analysed using in silico calculations, providing information on subjects 
as diverse as drug screening, through to manufacturing of novel bio-materials for 
renewable energy1.  
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 Figure 1.1 Timescales and associated theory level of biomolecular simulations based on the size of the 
system under investigation, from single atoms to full biological systems (Used with permission from 
Elsevier, License number 4366940859309).1 
 
 
Even with the array of available analytical techniques, such as Nuclear Magnetic 
Resonance (NMR) and Infra-Red (IR) spectroscopies, High Performance Liquid 
Chromatography (HPLC), Electrospray Ionisation Mass Spectrometry (ESI-MS) and 
Fluorescence Resonance Energy Transfer (FRET), details on the dynamic nature of 
biomolecule/biomolecule (e.g. protein/protein) or biomolecule/ligand interactions in 
complex biosystems remain elusive. These techniques mainly provide an averaged 
snapshot of the overall process being investagated7 rather than the intricacies of bond 
formation and electronic interactions. Thus, a combination of experimental and 
computational techniques can bring greater insights into the processes involved at an 
atomic and sub-atomic level. Moreover, whilst X-ray crystallography can identify 
structural conformations of biomolecules under highly specific and non-physiological 
conditions, this technique lacks any dynamic information. The movement of amino 
acid sidechains or protein loops at temperatures and concentrations that are 
biologically relevant cannot be ascertained with this technique, requiring therefore, 
assumptions gleaned from further experimental techniques in order to achieve an 
accurate picture. Nowadays, by using in silico methods in conjunction with 
crystallographic data and other experimental methods of structural assessment, 
detailed knowledge of dynamic processes can be gained, as discussed in the next 
sections. 
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1.1.2 All-atom calculations 
  
System properties can be accessed from atomistic methods by suitable measurements. 
This entails knowing position and velocities of every particle as a function of time, as 
they are affected by interatomic forces. While for small systems quantum mechanics 
(DFT) represents a universal potential, large biological systems are beyond the scope 
of those methods and require therefore approximate model potentials. Therein, the 
potential energy dependency on single atom coordinates, bond stretching, angles and 
dihedrals is parametrically coded into a so-called force field, in which electronic 
degrees of freedom are effectively replaced by a set of interaction potentials. While 
some of the universality of the ab initio approach is lost, this widespread approach 
allows for the calculation of very large systems up to highly complex viruses scaffolds 
constituted by 10’s of millions of atoms1. 
As the main scope of the work carried out in this thesis is based on molecular dynamics 
calculations enhanced by both established and state of the art enhanced sampling 
methods, the remainder of this chapter will briefly review important aspects of this 
area. Firstly, an introduction to biological relevant force fields, followed by an 
introduction to enhanced sampling methods, homology modelling and multiscale 
modelling. 
This will be followed by a more in depth look at the general force field parametrisation 
and molecular dynamics statistical ensembles. Since the processes of interest contain 
activated steps, which poses specific challenges to molecular simulations, an overview 
of the free energy methods used in the subsequent results chapters is given here. 
 
 
1.1.3 Molecular dynamics and the use of force fields 
 
The motion of an object can be fully described by knowing its position as a function 
of time. Motion is affected by velocity changes, velocity changes in turn results from 
forces acting on an object. The acceleration of an object is therefore the second 
derivative of position, which is caused by a force acting on an object of mass m, 
according to Newton’s second law. Molecular dynamics (MD), one widely used 
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atomistic method for biosystems is based on the applicability of classical laws of 
motions to microscopic systems. The process of performing MD simulations relies 
therefore on solving a set of Newton’s equations of motion, one for every particle: 
 
Fi = miai  (Eq.1) 
 
where F is the force operating on a particle i, m is its mass and a the resulting 
acceleration7.  The potential from which forces are calculated roughly defines different 
flavours of molecular dynamics. While ab initio MD is commonly based on DFT, in 
classical MD, relevant for biological system, forces are evaluated based on force 
fields. In MD, forces acting on each atom are calculated iteratively, from which 
positions and velocities are updated and the system propagated7. The system of 
differential equations of motion derived from Eq.1 is solved by means of finite 
difference methods, efficiently implemented into algorithms, among which the most 
popular is the Velocity Verlet method. The latter allows solving the equation of 
motions on a step-by-step basis, based on a timestep, i.e. the shortest time interval in 
a system. A constant timestep and the total number of integration steps are explicitly 
set based on the system under investigation: a commonly used timestep is in the order 
of 1 femtosecond (10-15 s), with the number of steps equating to a range from 
picoseconds (10-12 s) to microseconds (10-6 s), depending on the type of interactions 
under investigation. This motion machinery, the so-called integrator, is independent 
from the portion that evaluate forces, and is therefore transferable among different 
MD calculation types.  
MD allows elucidating dynamic processes which are extremely difficult to observe 
experimentally7 due to too short timescales or lack of spatial resolution. This means 
that MD simulations can be thought of as a computational microscope8. The output of 
such calculations contains the coordinates and momenta of every atom in the system 
as a function of time and is termed a trajectory. The latter can be viewed as a sequence 
of snapshots of the system over the timeframe of the calculation7, spaced by a timestep. 
Some insights can therefore be gained by inspection, like molecular docking, 
hydrogen bonding, p-p stacking, active site size, shape and electrostatic nature of the 
interactions. However, thermodynamic properties require averaging over trajectories. 
Free energy calculations such as molecular binding affinity, membrane permeation 
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events and transport mechanisms entail assessing the importance of certain 
configurations, which cannot be expressed as a function of single snapshots but require 
dedicated configuration weighting schemes. This can be achieved for example using 
methods such as umbrella sampling9 and metadynamics10 (section 1.3), both used in 
this work. 
 
1.1.4 Steered molecular dynamics and enhanced sampling 
 
The occurrence of a certain configuration or event is biased by its probability. The 
presence of energy barriers in a system may nonetheless prevent certain, important 
regions to be visited within a given simulation time. This in turn may bias time-
averaged properties. This situation arises when the effective practical simulation time 
is shorter than the residence time in one particular state, affecting not only the overall 
statistics but also the very chance of observing the event of interest at all. Therefore, 
different approaches beyond standard MD are needed. Their focus is on enhancing the 
occurrence of certain events, in order to achieve a correct weighting of configurations. 
The occurrence of important events can be enhanced by using an external bias to 
increase the probability of the desired event happening within a shorter timeframe11. 
Examples of which include centre of mass (COM) pulling (section 1.3), whereby a 
harmonic restraint is used on the centre of mass of a specified atom or molecule to 
encourage it to sample the configurational space along a defined pathway in relation 
to the rest of the system. Examples of this are the translocation of a molecule through 
a lipid bilayer or a protein, as implemented for example by de Groot in investigating 
the free energies of small uncharged molecules passing through a membrane protein 
pore12. 
An enhanced free energy sampling method is metadynamics, whereby the event under 
investigation can be accelerated along a number of selected reaction coordinates, so 
called collective variables (CV). A CV can be as simple as the distance between two 
groups of atoms or the change in the coordination number of an ion during a reaction, 
or it can result from the combinations of several degrees of freedom. Metadynamics 
attempts to explore the free energy landscape (FES) of a system by depositing 
Gaussian functions biases to fill FES wells, and in doing so, it encourages the system 
to explore the whole FE landscape based on the CV. Metadynamics implements 
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therefore a coarse-grained dynamic in the space of CVs. By moving the system out of 
one FES well, over a saddle point and into an adjacent minimum (Figure 1.2) it allows 
the discovery of either lower minima states or metastable states which could provide 
areas for further exploration or enhancement. In biological systems, these sites can 
correspond to drug target sites or intermediate configurations, which allows to gain 
more insight into a reaction mechanism. As an example, in 2017, Moraca et al 13 
reported on an advanced funnel metadynamics technique proved to be effective when 
used to study the interactions of G-quadruplex DNA with a stabilising organic ligand 
and to determine the binding energies involved. 
 
 
 
Figure 1.2 Free energy surface showing local minima and global minima with saddle point (highest 
point between the two minima). 
 
1.1.5 Homology modelling 
 
Molecular dynamics simulations are started from an initial configuration. For 
biological systems, this is commonly provided by an X-ray crystallography structure 
or homology model of the required protein or nucleic sequence being studied.  
Homology modelling works on the principle of evolutionary conservation7. 
Accordingly, if the structure of one isoform of a protein is known and the amino acid 
sequence of a related isoform can be ascertained, then it is possible to accurately model 
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this protein using the known isoform structure as a template. This can work between 
species. Therefore, if we know the structure of a viral or plant protein, which has a 
mammalian equivalent, the mammalian protein can be modelled. The accuracy is 
dependent on the sequence similarity; if the sequences have >50% similarity the 
homology model should have a high degree of accuracy. A reasonably accurate model 
can be attained with a sequence similarity above 25-30%. The knowledge of the 
structures in question is needed to assess the accuracy of the homology model as a 
small change in the amino acid sequence can alter the hydrogen bond network needed 
to maintain the proteins secondary structure, thus effecting the tertiary structure and 
protein shape.  
Recently, a study by Nikolaev and co-workers14 reported on the accuracy of a number 
of protein structure prediction methods to predict the structure of rhodopsins. In total 
36 rhodopsin sequences were derived using the programs MEDELLER15, I-
TASSER16 and Rosetta17 and compared to the 24 rhodopsin structures available in the 
RCSB database. The quality of each model was assessed using root mean square 
deviation (RMSD) with the results concluding that with a sequence similarity of above 
40% the predicted structures were found to be within 1.4 Å of the crystal structures14. 
It was also shown that with a sequence similarity of between 20-40% the structures 
were accurate to within 4.0 Å of the target. Comparison of the different homology 
methods used concluded that each produced accurate models overall, with the main 
issue being that of the flexible loop regions of rhodopsin. Of note is the need for further 
optimisation of the active sites when using I-TASSER or Rosetta to remove 
occurrences of steric clashes. 
 
 
1.1.6 Multiscale methods – coarse grained (CG) and quantum 
mechanical/molecular mechanics (QM/MM) 
 
Two other techniques have been widely used with biological systems, namely 
quantum mechanical/molecular mechanics (QM/MM) and coarse-grained modelling 
(CG). As with any modelling system, each one has its advantages and disadvantages. 
QM/MM uses a combination of molecular dynamics and quantum chemistry 
calculations, allowing a greater accuracy of chemical processes than classical MD, yet 
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with larger solvated systems than is possible with DFT.  Whilst this method relies on 
the use of a force field to describe the majority of the atoms, for a small number of 
atoms within the system it allows to calculate the formation or breaking of covalent 
bonds. This is not possible with purely force field-based techniques, which are ill-
behaved for configurations deviating from reference structures. This technique can be 
useful for enzymatic systems where the catalytic mechanism is of interest7, for which 
the active site can be treated at DFT level, while the rest of the system and the solvent 
are typically described with molecular mechanics. However, QM/MM calculations are 
limited by the size of the system, the number of atoms needed to be described at the 
quantum mechanical level and, due to this, the time taken for each calculation, 
meaning shorter timescales compared to MM calculations, which could make it less 
practical to use when longer, free energy calculations are required7. The main 
constraint of a QM/MM approach is represented by the separation of the QM from the 
MM region, which poses problems when atoms switch from MM to QM, or vice versa. 
While there are adaptive QM/MM methods, the existence of two Hamiltonians, one 
per region remains the central problem of this approach. 
At the other end of the length scale we find coarse grained modelling (CG). In this 
technique atoms are no longer described explicitly, instead groups of atoms are 
represented as pseudo atoms. In this way an amino acid, carbon chain or a number of 
water molecules can be represented as a single sphere in the model. Therefore, a 
protein containing thousands of individual atoms can be represented by a few hundred 
pseudo atoms. Whilst accuracy is reduced, system size and calculation timescales can 
be increased vastly as the number of degrees of freedom is strongly reduced. For large 
systems containing a number of proteins or to model the assembly of a virus capsids1, 
the need for calculating each individual atom is less urgent,  and so by using CG long 
scale biological processes can be calculated.  
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1.2 Force fields, an introduction 
 
The use of force field offers a handy method to evaluate the potential energy of a 
system, without explicitly performing an electronic energy calculation. Therein, the 
“exact” energy is expressed as a (truncated) expansion of interatomic potential terms18. 
A force field typically contains terms accounting for bonds, angles and can include 
some finer electronic effects in parametric form19. In this way forces can be evaluated 
with enough efficiency to allow for long MD of large systems, which are typical for 
biological problems. Therein, atoms and molecules are mapped onto ‘ball and spring’ 
models with parameters defining atom size, bond length, angle, dihedral angle and 
partial charges18. As individual terms are obtained from quantum chemical 
calculations on small molecules, within the forcefield atom types are used to refer to 
parameter sets for, say, a carbon in different environments such as a methyl or 
carboxylic acid18. Therefore, within the calculation these molecular environments will 
react and interact consistently. This highlights one of the main drawbacks in the use 
of force fields, that is the transferability of parameters. While, to some extent, similar 
molecular fragments can be expected to be described by similar parameters, there are 
no means to decide when and under which conditions a force field will behave less 
reliably18. 
 
The force field energies are calculated as the sum of the energy functions pertaining 
to different terms; 
 
EFF = Estr + Ebend + Etors + Evdw + Eel + Ecross  (Eq.2)18 
 
Each term refers to the energies involved in the distortion of a molecule; Estr describes 
bond stretching, Ebend describes bond angle bending, Etors describes torsional rotation, 
Evdw and Eel describe the non-bonded interactions between atoms and Ecross describes 
the coupling of Estr + Ebend + Etors18. Energy parameters can be obtained from 
experimental techniques and ab initio calculations. Figure 1.3 summarises the force 
field terms and their meaning. 
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By applying these energy parameters to the nuclear coordinates of a model system, 
such as a protein, forces can be evaluated, and the optimised geometry of the system 
can be calculated.  
 
Figure 1.3 Representation of the main energy terms parametrised within a force field (based on Jensen, 
2007, figure 2.1)18 
1.2.1 Bonded parameters 
 
Bond stretching and angle can both be controlled by a simple harmonic potential 
between either two (1,2 stretch), three (1,3 angle) covalently bonded atoms. At the 
reference bond length or angle the energy is at its lowest, by compressing, stretching 
or bending beyond these set parameters results in a rapid increase in energy. The 
individual terms for bond stretch, bond angle and dihedral can be seen below (Eq.3 
and 4). In the case of the dihedrals, the torsional rotation around the bond means the 
function to describe it must be periodic as the energy should return to the same value. 
Therefore, a Fourier series with an appropriate number of periodic terms is used 
(Eq.5). 
 𝐸 = 	∑ 𝐾&(𝑟 − 𝑟*+,-./012  (Eq.3) 
 𝐸 = ∑ 𝐾3(𝜃 − 𝜃*+,-506782  (Eq.4) 
 𝐸 = ∑ 9:- [1 + 	cos(𝑛𝜙 − 	𝛾)]1FG81H572  (Eq.5) 
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1.2.2 Non-bonded parameters 
 
The non-bonded terms described in the force field are split into two main types, van 
der Waals and electrostatic interactions. 
 
Van der Waals interactions model the short range attractive and repulsive forces 
between non-bonded atoms.  As the distance between atoms grows shorter the van der 
Waals energy increases greatly due to the repulsive nature of the atomic orbitals. As 
the distance between atoms increases an induced dipole-dipole interaction creates an 
attractive force between them. This attractive force changes as function of the inverse 
sixth power of the distance between the atoms. Therefore, at longer distances the van 
der Waals energy goes to zero. 
 
The Lennard-Jones potential(L-J)20 is the most common function found in force fields 
to calculate the van der Waals energy due to is relative simplicity in requiring on two 
parameters (e and s);  
 𝑉JK = 4𝜀 NOPHQR- 	−	OS&QTU = 	𝜀 NO&VW:&X QR- 	− 	2 O&VW:&X QTU (Eq.6)18 
 
e is the depth of the potential energy well, 𝑟	is the distance between atoms, s is the 
distance where the interatomic potential energy is zero and 𝑟Z is the distance at which 
the inter atomic distance is at its minimum (Figure 1.4). 
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Figure 1.4 Lennard-Jones plot 
 
The r6 and r12 terms correspond to the attractive and repulsive components of the 
components respectively. The r6 relating to the long term attractive component of the 
L-J potential can be justified theoretically as it relates to the induced dipole moment 
when two atoms are in close proximity, known as the van der Waals dispersion 
interaction, and obeys the scaling law; µ r -6 19. Whereas, r12 relating to the short range 
repulsive component, due to overlapping of electron orbitals, is purely a simplification 
used to increase the efficiency of the computational chemistry calculation for larger 
systems19. Rather than calculating the true repulsion term, such as that used in the 
Buckingham21 or Morse22 potential, the r12 term can be derived by calculating the 
square of the r6 term. In large biomolecular systems containing hundreds of thousands 
of atoms and above the increased calculation speed obtained from the Lennard-Jones 
potential outweighs the need for a more accurate repulsive term. 
 
Electrostatic interactions between pairs of atoms obey Coulomb’s Law: 
 𝐹 = 	𝑘* +W×+^&_   (Eq.7)18 
 
where qi and qj are the magnitude of the charges of each atom, r is the distance between 
the charges and ke is Coulomb’s constant (9 x 109 N m2 C-2), as the distance between 
atoms increase the force between atoms decreases. Calculating the Coulombic 
interaction between each atom pair in a large simulation is computationally expensive, 
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especially so for simulations using periodic boundary conditions. The most common 
solution is to use the Ewald summation to calculate the electrostatic interactions.  
The Ewald summation calculates the short-range and long-range contributions 
separately, the short-range contribution is calculated as a point charge on each atom, 
whereas the long-range contribution is calculated using a Fourier transform.  
 𝒰𝓆 =	𝑘* +W×+^&_  (Eq.8) 
 
The complete equation for the Amber force field can be seen below (Eq.9), combining 
all the above parameters. 
 𝐸b/b57 = 	 c 𝐾&(𝑟 − 𝑟*+,-./012 + c 𝐾3(𝜃 − 𝜃*+,-506782 + c 𝑉d2 [1 + 	cos(𝑛𝜙 − 	𝛾)]1FG81H572 +ce𝐴gh𝑅ghR- − 𝐵gh𝑅ghT +	𝑞g𝑞h𝜖𝑅ghmgnh  
 
 
 
1.2.3 The Verlet Algorithm 
 
The above terms allow us to calculate both bonded and non-bonded interactions and 
the energies involved. Finally, Newton’s equations of motion need to be integrated. 
The simplest numerical integration scheme is a Taylor series expansion (Eq10) for 
solving the equations of motion for any given body (from an atom to a planet the only 
difference is a suitable timestep to describe the motion). 
 𝑓(𝑥) = 	𝑎Z + 𝑎R	(𝑥 − 𝑐) + 𝑎-(𝑥 − 𝑐)- + 𝑎s(𝑥 − 𝑐)s + ⋯𝑎d(𝑥 − 𝑐)d  (Eq.10) 
 
If we apply this to Newtons second law, we get: 
 𝑟g(𝑡 + ∆𝑡) = 𝑟g(𝑡) + ∆𝑡𝑣g(𝑡) + ∆x_-yW 𝐹g(𝑡) (Eq.11)23 
 
(Eq.9) 
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where ri is the position of the given particle, t is time, v is velocity, m is mass and Fi(t) 
is the short form of the Taylor expansion, Fi(r1(t),…..,rN(t)). 
This can also be written for ri(t-Dt) to give a velocity-independent term: 
 𝑟g(𝑡 − ∆𝑡) = 𝑟g(𝑡) − ∆𝑡𝑣g(𝑡) + ∆x_-yW 𝐹g(𝑡) (Eq.12)23 
 
and when equations 11 and 12 are combined and rearranged we get the Verlet 
algorithm (Eq.13) 
 𝑟g(𝑡 + ∆𝑡) = 2𝑟g(𝑡) − 𝑟g(𝑡 − ∆𝑡) + ∆x_yW 𝐹g(𝑡)  (Eq.13)23 
 
The Verlet algorithm allows for the generation of a trajectory based on initial 
coordinates and velocities of a body over a given appropriate timestep, in the case of 
atomistic simulations the timestep is usually in femtoseconds. As the Verlet algorithm 
only calculates position, a second equation (Eq.14) is needed to generate the velocities. 
This can be done from any point in the trajectory. 
 𝑣(𝑡) = 	 z(x{∆x)|z(x|∆x)-∆x  (Eq.14)23 
 
Whilst the Verlet algorithm is computationally simplistic it can be erroneous in its 
velocity approximations with the error increasing with larger timesteps. Two 
adaptations have been devised to reduce this discrepancy; the Leap Frog algorithm 
and the Velocity Verlet algorithm. 
With the Leap Frog algorithm force is calculated first based on the new position, then 
velocity is calculated half step ahead based on position and force before calculating 
the final position and the process starting again for the next time step. This helps 
reduce the error in approximating the velocity. 
In Velocity Verlet the next position is calculated based on velocity and force, then 
velocity is calculated a half step based on the previous force. Force is then calculated 
based on the new position and the velocity is advance a further half step to bring 
position, velocity and fore to the same timestep. In this way the velocity is not 
approximated and is calculated from only known values of position and force. 
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1.3 Statistical ensembles 
 
The “measurement” conditions of any molecular dynamics system can be defined 
using a statistical thermodynamic ensemble24. A statistical ensemble describes the 
probability distribution of the state of a system based on the average of certain 
conserved variables over infinite time. These variable properties, such as pressure, 
energy, volume or temperature will average and therefore provide values for the 
thermodynamic quantity of interest. Each ensemble can be used based on the 
properties of the system under investigation and so are analogues to the reaction 
conditions of a chemical process18 (Figure 1.5). 
The most commonly used ensembles are; 
 
Microcanonical ensemble or NVE ensemble: 
 
In the microcanonical24 ensemble the system is completely isolated with no transfer 
of energy between it and its surroundings. The total number of particles (N), total 
volume (V) and total energy (E) are constant. Temperature cannot be defined as this 
requires an interaction with its surroundings 
 
Canonical ensemble or NVT ensemble: 
 
In the canonical24 ensemble the system energy can be transferred between the system 
and its surroundings. The total number of particles (N), volume (V), and temperature 
(T) remain constant. The system can be thought to be immersed in a large heat bath at 
a set temperature and a high enough heat capacity to remain stable no matter the energy 
transfer from the system to its surroundings. In this way the total energy of the system 
can be calculated. 
 
Grand canonical ensemble or µVT ensemble: 
 
In the grand canonical24 ensemble both energy and particles can be transferred 
between system and its surroundings or a second system. The volume (V) of the system 
remains constant. Again, a heat bath controls the temperature (T) and final 
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thermodynamic variable is chemical potential (µ) can be used to calculate the rate of 
a chemical reaction or phase transition through changes in the particle numbers within 
the system. 
 
Isothermal-isobaric ensemble or NpT ensemble: 
 
In the isothermal-isobaric25 ensemble, like the canonical and grand canonical 
ensembles, energy can be transferred between the system and its surroundings via a 
heat band to control the temperature(T). Also, the volume of the system can change, 
with the pressure (p) of the system being controlled by a barostat, so as to match the 
pressure exerted by its surroundings. The number of particles (N) remain constant 
within the system. As the system maintains a constant temperature and pressure the  
Isothermal-isobaric ensemble or NpT ensemble can be used to for free energy 
calculations of chemical reaction or integration as the Gibbs free energy describes the 
maximum amount of work undertaken within a system under the conditions of 
constant pressure and temperature.  
 
 
Figure 1.5 Graphical representation of statistical thermodynamic ensembles. 
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1.4 Free-energy Methods  
 
Molecular dynamics (MD) propagate positions and velocities of interacting atoms in 
finite timesteps to incrementally build a relevant trajectory, based on a statistical-
mechanical ensemble, for the system under investigation. Ideally, each trajectory 
would be ergodic, visiting all points on the potential energy surface (PES) and thus 
cover every possibility within the system in question. As MD trajectories may fail to 
explore all the relevant regions of configuration space due to the presence large energy 
barriers separating low energy metastable regions11, only a small section of the overall 
configuration space is sampled by unbiased MD methods. 
 
To overcome such barriers and visit important configuration regions, enhanced 
sampling methods have been proposed to help exploring the whole system. Since in 
this way the correct weight of configurations can be obtained, the free energy can be 
evaluated. The free energy of a system can help ascertain the chemical processes 
involved and the probability of a system’s configuration or conformation at a given 
time26. 
By increasing the likelihood of sampling, the rare event under investigation, methods 
such as umbrella sampling and metadynamics can explore relevant areas of 
configuration space, which can provide greater understanding at an atomistic level to 
the processes involved. Umbrella sampling and metadynamics were methods of choice 
in this work. Umbrella sampling is an established method of calculating the free-
energy of a biological system based on trajectory configurations, which are restrained 
by an external harmonic potential. The second method, metadynamics, is a state of the 
art free-energy method which, whilst not yet an established method for use with large 
bio-systems, has proved useful in fragment-based docking studies27. With the potential 
to elucidate the mechanistic nature of our systems, we feel metadynamics is the ideal 
free-energy method to explore further. One advantage of metadynamics is the presence 
of a dynamic trajectory, which is not present in Umbrella sampling.  
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1.4.1 Umbrella Sampling 
 
Umbrella sampling, developed by Torrie and Valleau28, is a method to evaluate the 
free energy barrier between two states. Therein, the reaction coordinated is restrained 
within a narrow set of values with a biasing potential. The measure that differentiates 
the two states, such as a ligand interacting with a protein active site or the folded and 
unfolded states of a protein during activation, defines the reaction coordinate. 
Umbrella sampling uses a bias potential to counter the free energy along the reaction 
coordinate pathway and in effect flatten the free energy surface28. One single bias 
potential is unlikely to provide an accurate picture of the overall energy landscape 
along the reaction coordinate; therefore, it is advantageous to combine the results of a 
number of overlapping trajectory slices, each with individual bias potentials, in order 
to reconstruct an accurate picture of the free energy surface. The reaction coordinate 
can be split into overlapping windows, each accounting for a section of the pathway 
along the reaction coordinate (Figure 1.6).  
 
 
 
Figure 1.6 Schematic of how the reaction coordinate between minimas A and B is split into individual 
windows. 
 
Bias potentials are simple harmonic springs used to restrain the trajectory to reference 
point within the window. The bias potential can either pull the system slowly along 
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the reaction coordinate within the window or maintain it a stationary position, 
allowing for conformational changes without directional progression. In both cases 
the system is allowed to explore the free energy within a set, restricted phase space. 
Due to the trajectory slicing, there is no dynamical information in the sequence of 
configurations that can be collected. 
 
The statistics for each window can then be combined and analysed using an unbiasing 
technique such as weighted histogram analysis method (WHAM) or umbrella 
integration. 
 
 
Weighted histogram analysis method (WHAM) 
 
Weighted histogram analysis method (WHAM) is based on the work of Ferrenberg 
and Swendsen29 on Multiple Histogram equations and further developed by Kumar et 
al30 for use with biomolecule free energy calculations. This involves calculating the 
relative states of interest from a number of individual windows along a reaction 
coordinate, such as those calculated by umbrella sampling. From these states of 
interest histograms of the most probable molecular states can be obtained. The 
histogram probabilities from each umbrella window can then be combined to produce 
a potential of mean force (PMF) of the energies relating to the reaction coordinate 
pathway. 
Chapter 1 
 
 20 
 
Figure 1.7 Histogram of each of 500 windows overplayed, showing the overlap of each. 
 
 
Figure 1.8 Example of a resolved potential of mean force (PMF) from an umbrella sampling calculation 
of H2O2 permeation of AQP3. 
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1.4.2 Metadynamics 
 
Metadynamics is a technique originally developed by Laio and Parrinello10 to 
efficiently explore the free energy surface (FES) of a system based on a number of 
selected reaction coordinates, so-called collective variables (CVs). CVs are able to 
describe the key aspect of the system under investigation, such as how the distance 
between two groups within the simulation changes and the effect such movement has 
on the FES. A single CV can be used or a combination thereof, which is capable of 
describing the dynamics of the system in a way than can then be interpreted by the 
user. A history-dependent potential is included so as to discourage the system from 
revisiting a previously described state. In doing so, metadynamics can push the system 
to explore the whole FES, overcome energy barriers and find more stable 
conformations or metastable conformations, which remains elusive if other methods 
are used (Figure 1.7).  
 
 
Figure 1.7. One-dimensional free energy surface (FES) showing three metastable energy wells and the 
gaussian deposition filling the wells and overcoming the energy barriers. (V(x) equating to the  free 
energy and x dependant on the collective variable (CV used).(Adapted from Fig. 1, Laio and Parrinello, 
200210). 
 
 
Chapter 1 
 
 22 
Metadynamics works by depositing Gaussian functions onto the FES, analogous to 
filling a mould with sand where you can control the size of grain and pour rate. A fast 
deposition rate with a large Gaussian will allow a quick exploration of the FES but 
will fail to differentiate and explore states smaller than the gaussian width. This could 
result in missing possibly crucial states due to its coarse nature, whereas filling with a 
small gaussian may not allow escaping from a single FE well within the simulation 
time. A balance needs to be found based on the system and the reaction/interaction 
under investigation. 
The choice and number of CVs is dependent on the system under investigation. 
Therefore, there are no set rules to state which CV will be best for any given 
calculation. Instead, the CV choice should satisfy three ideal properties31; 
 
• Clearly distinguish between initial state, any intermediates and the final state 
• Describe all the relevant slow events for the process of interest 
• The number of CV’s used should not be too large, so as to be detrimental to 
the time taken to fill the FES 
 
Examples of collective variables are: 
 
• Geometric CV’s – distances between atoms or molecules, angles, torsion 
angles 
• Coordination number 
• Potential energy of the system – changes in entropy and enthalpy 
• Path – such as the pathway between two energy minima of the FES 
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Figure 1.8. Example of a two-dimensional free energy surface with centre of mass (COM distance and 
torsion angle as the collective variables (CVs). 
 
By following these principles and using the simplest CV or collection of CVs possible 
generally affords the best results. A certain degree of trial and error is necessary to 
find the correct combination of CV’s, Gaussian size and deposition rate to fully 
explore the system under investigation and allow an accurate interpretation of the FES. 
As the calculation is run, a history dependent bias potential is constructed based on 
the chosen collective variables, by the deposition of Gaussian functions, the 
summation of which is described as the metadynamics potential V 
 𝑉(𝑠, 𝑡) = ∑ 𝑊(𝑘𝜏)𝑒𝑥𝑝 −∑ (W|W(X)())_-SW	_gR nx   (Eq.15)10 
     
Where t is the deposition rate in MD steps, W is the Gaussian height and s is the 
Gaussian width. As previously stated, the choice of these parameters will affect how 
the system is biased in conjunction with the chosen CV’s, and again a certain element 
of trial and error will be needed to determine the most appropriate values. 
 One issue with metadynamics is achieving convergence and knowing when to 
end the calculation.  By continually depositing Gaussians of equal size the free energy 
can be overestimated and the system may fail to converge fully but fluctuates around 
the final value with an averaged error value proportional to the square root of the bias 
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potential deposition rate32. One way of solving this fluctuating error is to use an 
adaptive bias, i.e. rescaling the Gaussian height ‘on the fly’ based on the previously 
deposited gaussians and temperature known as well-tempered metadynamics.  
 𝒲	=	ω0τGe-	ΔV(θ,t)kBΔT  (Eq.16)11 
 
w0 is the starting height of the gaussian, DT is the term that controls how far away the 
trajectory biasing deviates from the free-energy minima based on a temperature 
different controlled by a biasing factor. Effectively well-tempered metadynamics 
samples the CV at a higher temperature T +DT yet reconstructs the free-energy surface 
corresponding the target temperature. 
 
Whilst exploring the entirety of the system is advantageous and sometimes essential 
to fully understand its dynamics, in some cases this is unnecessary such as when the 
binding site is well established. In this case the history dependent deposition results in 
only exploring the active site briefly before exploring the rest of the system and, due 
to the discouragement of revisiting minima, provides only a single binding/unbinding 
event in a potentially microsecond simulation. For this reason, a development of 
metadynamics specifically to address this issue was devised, Funnel Metadynamics33. 
In Funnel Metadynamics a funnel shaped constraint is applied around the active site 
to dissuade the ligand from exploring outside of the area of interest. The funnel can be 
adapted using simple geometric terms such as Rcyl for the radius of the cylinder 
forming the pathway for the ligand and Zcc and a to determine the width and funnel 
angle to full incorporate the protein active site (Figure 1.9). The size and shape of the 
funnel must be chosen so as not to affect the binding site with an external bias.33 
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Figure 1.9. Schematic showing how the funnel incorporates the active site of the protein. (Adapted 
from Fig.1, Limongelli et al (2013)33). 
 
By effectively reducing the sampling space with the funnel constraint, the 
ligand/protein binding/unbinding mechanism can be calculated multiple times within 
a single simulation allowing for more accurate and faster convergence of the system. 
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Section 2 
 
2.1 Computational methods and drug discovery 
 
With the cost of developing a new therapeutic drug estimated at between $400 million 
and $2 billion34 and a large proportion of this expenditure spent on the synthesis and 
testing of lead analogues35, a method to more efficiently determine and optimise main 
compounds could reduce the time and costs substantially. 
Computer aided drug design (CADD) has, over the past 30 years, evolved into a major 
tool in the development of new therapeutic small molecules. The use of three-
dimensional protein and DNA structures, derived from crystallography and NMR, 
allows for virtual high throughput screening (vHTS) for hit to lead and lead 
optimisation. An example of the potential CADD has for efficiently identifying future 
therapeutics is the case of tyrosine phosphatase-1B inhibitors; virtual screening 
identified 127 compounds showing effective inhibition out of an initial screening of 
365, an approximate hit rate of 35%. Whereas traditional high-throughput screening 
identified 81 compounds out of a library of 400,000, a hit rate of 0.021%35.  
 
In silico methods are usually classified as structure-based or ligand-based. The former 
relies on knowledge of the target structure, such as a protein active site, and the 
interactions within it. The latter is based on the knowledge of the activity of small 
molecules and other chemically similar compounds to construct quantitative structure-
activity relation (QSAR) models and are generally used when little structural 
knowledge of the target is known.  
In both cases the main aim is to develop a compound, which binds tightly within the 
active site and shows a quantifiable reduction in free-energy. Therefore, in silico 
methods that can reliably calculate the free-energy of binding and interaction are 
essential. The methods discussed previously (umbrella sampling and metadynamics) 
are two such computational techniques, which offer advantages in terms of 
computationally efficiency and reliability.   
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Virtual screening libraries are built up of drug-like ligands with certain desirable 
physiochemical properties for the target of interest. A common ‘drug-likeness’ 
evaluation is Lipinski’s rule of five36, which states an orally active drug should not 
violate more than one of the criteria: 1) maximum of five hydrogen bond donors, 2) 
no more than ten oxygen or nitrogen atoms, 3) a molecular mass of less than 500 Da 
and 5) an octanol-water partition coefficient no greater than five. These libraries are 
used in docking studies where molecular docking algorithms are used to rapidly screen 
and score the ligands based on certain criteria relating to the free-energy of each ligand 
within the target site such as; solvent effects, conformational changes, interactions and 
geometry37. Unfortunately, due to the nature of high-throughput virtual screening, in 
docking the target is usually static and based on a crystal structure, which represents 
only a snapshot pose of the active site and does not take into account the flexibility of 
the protein and possible conformational changes induced on activation as well as 
failing to take into account solvent entropy contributions38.  
For the screening of large numbers of compounds docking studies provide the most 
efficient method to identify potential lead compounds but due to the issues previously 
mentioned the development of more accurate active docking where the flexibility of 
the target can be taken into account.  
 
The next stage consists in taking the identified compounds and, through structure 
activity relationship studies, design a highly selective inhibitor for the given target. 
This requires further in silico techniques, based around free-energy calculation 
methods, to further enhance the knowledge base of drug design.  Such methods allow 
for the flexibility of active sites and, with the correct choice of collective variables, 
provide a more complete enumeration of a biological systems conformational states 
than can be obtained by docking alone. 
 
 
2.2 Metals in Medicine 
 
The used of coordination and organometallic metal complexes for therapy is one of 
the emerging areas of drug design. Since the discovery of the Pt(II) complex cisplatin 
(Figure. 2.1) by Rosenberg in 196539 for the treatment of cancer, a number of Pt(II) 
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and Pt(IV) derivatives have been further developed, including the clinically used drugs 
carboplatin40 and oxaliplatin41. The postulated mechanism of action involves direct 
DNA damaging via formation of coordination bonds between the Pt(II) ions and the 
DNA nucleobases. Thus, cisplatin is a pro-drug which, following hydrolysis of the 
chloride ligands inside the cells, can further exchange the water/hydroxide ligands 
with nitrogen atoms in nucleobases, causing DNA structural lesions eventually leading 
to cellular apoptosis (Figure 2.1).  
 
 
Figure 2.1. Cisplatin binding modes with DNA, intrastrand DNA adducts and interstrand crosslinking 
with the frequency of each. (Adapted from Figure 1, Rocha et al (2018)42). 
 
Following the clinical success of cisplatin and analogues, several other experimental 
anticancer metallodrugs have been developed, based on ruthenium, osmium, iridium, 
palladium and gold. Among them, the gold(I)-based compound auranofin43 (Figure. 
2.2) was approved for the treatment of rheumatoid arthritis in 1985 and it is now in 
clinical trials for the treatment of different cancers alone or in combination therapy. 
These different metal-based drugs can exploit novel mechanisms of action with 
respect to cisplatin and other classical organic compounds, and some of them have 
been reported to target proteins instead of nucleic acids targets44. 
 
On the other hand, another key area of drug discovery is the use of small organic 
ligands featuring a metal-binding pharmacophore (MBP) capable of forming strong 
interactions with metals within the catalytic site of metalloenzymes and 
metalloproteins. As an example, matrix metalloproteinases (MMPs)45,46 contain a 
Chapter 1 
 
 29 
catalytically important Zn2+ centre within the active site and coordinating to a 
conserved HExxHxxGxxH binding motif45. Due to their role in a number of 
pathological conditions, MMPs are ideal drug candidates, and several compounds 
have been developed so far with the aim to selectively inhibit their activity also for 
cancer treatment. As an example, ABT-518 (Figure. 2.2) was found to be both a 
potent, orally bioavailable inhibitor with good selectivity for both MMP-2 and MMP-
9 over MMP-147. ABT-518 underwent Phase I clinical trials achieving 48% inhibition 
of B16 melanoma tumour growth in several animal models47.  
 
Similarly, the magnesium dependent HIV integrase (HIV-IN) features an active site 
containing highly conserved catalytic motif coordinating to Mg2+ divalent metal ions48. 
The metal ions are essential for the catalytic activity of HIV integrase, by stabilising 
the negative charge during phosphate hydrolysis, during its role in integrating viral 
DNA into the host DNA. By sequestering these metal ions using organic chelators 
such as Raltegravir48 (Figure. 2.2), it is possible to cause displacement of viral 3’-OH 
of HIV-1 intergrase and prevent integration of the viral DNA. 
 
 
 
Figure 2.2 Example of metallodrugs and metalloenzyme inhibitors. 
 
In this context, computational methods such as docking, and quantum 
mechanical/molecular mechanics (QM/MM) and classical molecular dynamics (MD) 
simulations have played a part in the development of both metallodrugs and 
metalloenzyme inhibitors. Molecular dynamics and QM/MM studies go beyond what 
is possible with classical rigid docking studies by allowing for the dynamics and 
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plasticity of an active site to be explored, allowing for the calculation of 
thermodynamic and kinetic data along with physical pathways of binding/unbinding 
to be obtained, and thus, providing a better overall understanding of the mechanisms 
involved in target/ligand interactions. 
 
Both force field based, and QM/MM studies can be used to estimate ligand-target 
compatibility of libraries of drug like compounds in virtual screening studies. An 
example, the successful identification of broad-spectrum thiol inhibitors of metallo-b-
lactamase via chelation to one or more zinc centres was achieved 49 (Figure 2.3). 
 
 
Figure 2.3 Interactions of D-captopril chelator to two zinc ions (green spheres) of metallo-b-lactamase 
BlaB (pdb ID 1M2X)49. 
 
Some issues arise from such calculations in that force field-based techniques fail to 
take into account the electron density of the metals in either the enzymes catalytic site, 
in the case of metalloenzyme inhibitors or the metal centre with organometallic and 
coordination compounds. The use of QM based methods can overcome some of the 
limitations by allowing step by step changes in the partial charges, and variable 
protonation states to be calculated via ab initio methods rather than the fixed charges 
used in forcefields, allowing for more accurate electrostatic potentials to be 
implemented. However, as previously stated, QM methods come with an increase in 
computational power and a reduction in system size, and so they are not suited to high-
throughput virtual screening and are more appropriate for lead generation and 
optimisation.  
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Therefore, the integration of different computational approaches is often necessary to 
provide a realistic and informative picture of the system under investigation. An 
example of this strategy includes the recent work by Graziani el al50, whereby a multi-
level theoretical approach was used to determine the binding mode of Au(III) 
compound [Au(bipy)Cl2]+ (bipy = bipyridine, Aubipy, Figure. 2.4) with the human 
water/glycerol membrane channel AQP350. The compound was previously shown to 
be a selective and potent inhibitor of this protein isoform51. Initially, the study used 
DFT to determine the free-energy of Aubipy aquation and therefore, the most probable 
gold-based species likely to react with the protein in physiological conditions. 
Classical molecular dynamics simulations were then performed on three systems: A, 
where Aubipy was not present, B, where Aubipy was placed to non-covalently interact 
with the protein extracellular pocket and C, where Aubipy was covalently bound to 
the thiolate sidechain of Cys4050 (the putative Au(III) binding site). To determine the 
effects of Aubipy, the water flux of each system was measured and compared along 
with channel radius to determine if Aubipy induced conformational changes within 
the pore. The results show the pore size of systems B and C were reduced when 
compared to the unbound protein (system), accounting for the inhibition of glycerol 
permeation by Aubipy. Water flux was found to be retarded more in system B (non-
covalently bonded) than in system C (covalently bonded) with figures of 0.151 x 10-
14 cm3s-1 and 1.81 x 10-14 cm3s-1 respectively, both notably lower than the value for 
system A of 4.51 x 10-14 cm3s-1.  
 
Figure 2.4 Structure of the Au(III) compound [Au(bipy)Cl2]+ (Aubipy), inhibitor of human AQP350.  
 
Finally, the geometry of Aubipy in the non-bonded and bonded (systems B and C) 
was calculated using QM/MM (Figure. 2.5). Only the residues and water molecules 
within a c.a. 4 Å of the metal centre were included in the calculations, which equated 
to the compound, 61 amino acid residues and 8-11 water molecules. Geometries were 
compared to the classical MD simulations and found to be in good agreement with 
bond length distances typically within less than 2% and angles within 5%. 
N
N
Au
Cl
Cl
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By using this multi-level approach, a better understanding of how Aubipy inhibits 
AQP3 water flux could be ascertained at a molecular level, with each theory level 
focusing on different yet complementary aspects of the system. 
 
 
Figure 2.5 Position of Aubipy (shown with a yellow surface) in a) the non-covalently bound (system 
B), and b) the covalently bound (system C) models. 2D schematic is shown below with indication of 
the stacking interactions50. 
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Chapter 2 - Aims 
 
This project will cover two topics, the first on the mechanism of aquaporin permeation 
and effects on inhibition of metal compounds (Chapters 3 to 6). The second topic 
covers the development of G-quadruplex stabilisers and their potential as therapeutics 
(Chapters 7 and 8). A combination of both established steered molecular dynamics 
and state of the art metadynamics methods will be used to elucidate the free energies 
and mechanisms of action for the systems. 
 
The first part of this project is split into two aims; 
 
The first aim consists in elucidating the mechanism of aquaporin permeation of 
different substrates (water and glycerol) through the use of molecular dynamics 
approaches. Aquaporin homology models will be used of human AQP3 and AQP7. 
With AQP3, the permeation by H2O and glycerol will be studied to determine the 
exact molecular mechanism of permeation, helping the design of highly specific 
aquaporin inhibitors. With detailed information on the aquaporin permeation, it will 
be possible to design new metal-based inhibitors which would inhibit only one 
aquaporin isoform.  
  
With AQP7, the effect of pH on water and glycerol permeation will be studied via 
both experimental and in silico methods. Changes in pH from neutral to acidic have 
been found to induce a gating mechanism, molecular dynamic methods will be used 
to ascertain the possible mechanism of such gating.  
 
The second aim of the project is to shed light into the detailed mechanisms of AQPs 
inhibition by metal compounds. Thus, the most promising metal-based compound 
(e.g. Au(III)) will be bound to the aquaporin channel to evaluate their inhibitory mode 
of action, using the same techniques described above. A main challenge of this phase 
of the project is the identification of parameters for metal complexes allowing to 
mimic and define the coordination bonds in silico.  
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Overall, both project’s aims converge to help the design of potent and selective AQPs 
inhibitors that could be used as therapeutic agents (e.g. inhibiting the activity of cancer 
related AQPs), but also as chemical probes, to evaluate the role each protein isoform 
in physiology and patho-physiology. 
 
The second part of this project is to help develop highly selective G4 stabilisers using 
a combination of both in silico and experimental techniques. We hope to use state of 
the art computational methods, such as metadynamics, to calculate the free energy of 
binding of organometallic ligands with a number of both promotor and telomeric G-
quadruplex structures, such as hTelo and C-KIT1, allowing the further development 
of potent, highly specific G4 stabilisers. This will also require the development of 
force field parameters for the organometallic ligands.
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Chapter 3 - Aquaporins and molecular dynamics 
 
3.1 Aquaporin structure and function 
 
The controlled movement of water both between and within cells is of great 
physiological importance. A highly specific family of transmembrane spanning 
proteins called aquaporins controls this process1.  The human family of aquaporins 
consists of thirteen isoforms (AQP0 – AQP12), organized into two distinct groups: the 
orthodox aquaporins (AQP0, AQP1, AQP2, AQP4, AQP5, AQP6 and AQP8), which 
are permeated mainly by water; and the aquaglyceroporins (AQP3, AQP7, AQP9, 
AQP10 and AQP11), which are also permeated by glycerol and other small molecules, 
such as urea and H2O21. 
 
Aquaporins are tetrameric protein complexes constructed from four discrete 
monomers, with van der Waals forces maintaining the 3-dimensional structure2. Each 
monomer consists of six helices (H1-H6) joined together by five loops (A-E), as 
shown in Figure 3.1. Two smaller helices (HB and HE), located in loops B and E 
(Figure 3.1 A)3, are close to each other at the centre of the channel to form one of two 
selectivity filters, asparagine-alanine-proline motif (NPA motif), found in all 
aquaporins. The second selectivity filter consists of a conserved arginine residue and 
two (aquaglyceroporins) or three (aquaporins) other amino acid residues named the 
aromatic/arginine (ar/R SF) (Figure 3.1 B), which are always aromatic and may 
include a cysteine residue in some isoforms4. 
 
The ar/R SF constricts the pore size to c.a. 1-2 Å5, creating a steric barrier and 
preventing large molecules passing through the pore (Figure 3.1 B), while the NPA 
motif created by helices HB and HE, in conjunction with the half 
hydrophobic/hydrophilic internal pore surface, creates an electrostatic barrier, 
preventing the passage of charged species through the pore6. 
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Figure 3.1 Aquaporin monomer structure. A. Schematic representation of a generic AQP secondary 
structure and the relative position of each of the elements in the lipid bilayer3. B. AQP3 monomer in 
ribbon representation (left) and surface of the channel (right). Residues Phe63, Tyr212 and Arg218 
(purple) constitute the ar/R S/F with Asn83 and Asn215 (green) form the NPA S/F. 
 
 
3.2 Aquaporins and cancer 
 
The facilitation of water transport is the key aquaporin function. Therefore, AQPs are 
abundantly expressed in tissue types involved in maintaining fluid balance such as the 
kidneys7 and airways7,8  along with the central nervous system9. Due to their 
abundance, aquaporins allow cells to react efficiently to changes in osmotic gradient 
created  by the active transport of ions and other neutral solutes1. A reduction in the 
ability to transport water can have a detrimental effect on these tissues, as it has been 
shown in mice with reduced ability to concentrate urine (AQP1)10, defective secretion 
of saliva (AQP5)11 and reduced skin elasticity (AQP3)12.  
 
Glycerol is a key molecule in physiology and has a role in skin hydration, ATP 
generation and lipid synthesis1. For example, maintaining glycerol levels within the 
stratum corneum helps preventing water evaporation by acting as a humectant12. 
Glycerol can be combined with long chain fatty acids to form triglycerides, for storage 
in adipose tissue, while the triglyceride (TAG) is phosphorylated and incorporated into 
the cell membrane during cell proliferation13,14. Additionally, glycerol is also a 
precursor to Acetyl-CoA, used in the tricarboxylic acid (TCA) cycle to produce 
ATP14,15 (Figure 3.2 A). Thus, aquaglyceroporin expression is particularly high in cell 
types such as adipocytes and liver due to their role in glycerol metabolism. 
A B 
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The overexpression of orthodox aquaporins in tumour cells has been linked to cell 
invasion and metastasis1. Whilst AQP1, AQP4 and AQP5 are  known to be involved 
in cell migration14, overexpression of these isoforms in tumour cell lines has been 
shown to increase their ability to invade adjacent tissues, both in vitro and in vivo16. 
One hypothesis for this observation is that increased levels of aquaporins allow for 
rapid volume changes and rapid water flow, in and out of the cells, thus, allowing for 
rapid cell shape changes resulting in increased cell motility16. 
Recently, immunostaining of suspected malignant thyroid nodules for AQP4 
upregulation has been patented as a method of distinguishing between benign and 
malignant oncocytic lesions, due to the known overexpression of this isoform in 
certain cancerous tissues17. 
 
One aquaporin isoform of particular interest is aquaglyceroporin-3 (AQP3), which has 
been found to be overexpressed in a number of tumour cell types including skin cancer 
and breast cancer18. AQP3 is known to transport both glycerol and H2O2 along with 
water, even though its water permeability is lower than the one of other aquaporin 
isoforms. It is therefore hypothesised that glycerol may play a role in tumour growth 
and proliferation14. As with healthy cells, there are two processes for which cancer 
cells require glycerol uptake; lipid synthesis and the production of ATP. 
Glycerol is initially converted to triacylglycerol (TAG) and stored in adipose tissue19. 
When required, glycerol can be released from the adipose tissue and transported into 
cells to undergo phosphorylation to glycerol-3-phosphate (G-3-P), a precursor capable 
of being converted to both glucose via gluconeogenesis and free fatty acid (FFA) via 
lipogenesis (Figure 3.2). Through the tricarboxylic acid cycle (TCA) glucose can be 
converted into adenosine triphosphate (ATP) the chemical energy source for cellular 
processes. In the case of lipogenesis, the FFA units can convert into phospholipids, 
the building blocks of cell membranes. These processes are required by both healthy 
cells (Figure 3.2A) and tumour cells (Figure 3.2B), with the transport of glycerol 
between cells being facilitated by a number of aquaglyceroporin isoforms such as 
AQP7 in the case of adipocytes19 and AQP9 in liver cells20. Due to the increased rate 
of cancer cell proliferation, these processes are accelerated and therefore, require the 
upregulation of AQPs to aid necessary solute permeation. 
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Figure 3.2 AQP3 glycerol transport function and metabolism. A Glycerol metabolism in liver and 
adipose tissue B Glycerol metabolism in cell proliferation and cancer development (Abbreviations: 
ATP = adenine triphosphate, DHAP = dehydroxy- acetone phosphate, FAD+ = flavine adenine 
dinucleotide, FADH2 = hydroquinone form of flavine adenine dinucleotide, FFA = free fatty acid, G-
3-P = glycerol 3-phosphate, cGPDH and mGDPH = cytosolic and mitochondrial, respectively, glycerol-
3-phosphate dehydrogenase, G1Pa = glucose 1-phosphate-adenyltransferase, MAG = 
monoacylglycerol, NAD+ = oxidized nicotinamide adenine nucleotide, NADH = reduced nicotinamide 
adenine nucleotide, TAG = triacylglycerol, TCA = tricarboxylic acid)14. 
 
 
Hydrogen peroxide, also an AQP3 permeant, is a reactive oxygen species (ROS), 
mostly produced in mitochondria. It can be involved in cellular damage, but it is also 
used as a signalling molecule for different cellular processes21. Extracellular H2O2, 
produced by NADPH oxidase-2 (Nox2), is believed to be taken up via AQP3, and in 
cancer cells it has been shown to induce a signalling cascade that leads to increased 
cell migration and metastasis formation18 (Figure 3.3). 
Whilst ROS are an important part in cell homeostasis, overproduction can lead to DNA 
damage and oxidation of lipids and amino acids and eventually apoptosis22. The 
protein kinase AKT induces cell replication and metastasis. This process is controlled 
by phosphatase and tensin homolog (PTEN), which, can be deactivated via the 
oxidation of specific cystine residues by H2O2. This allows the uncontrolled 
proliferation of cells23. 
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Figure 3.3 Possible pathway for H2O2 induced secondary signaling pathway in cancer cells. 
(Abbreviations: AKT = protein kinase, EGF = epidermal growth factor, EGFR = epidermal growth 
factor receptor, NOX = nicotinamide adenine dinucleotide phosphate oxidases, PTEN = phosphatase 
and tensin homolog). 
 
Overall, both glycerol and H2O2 appear to be important players in cancer development. 
Therefore, by selectively inhibiting their aquaglyceroporin permeation, tumour 
proliferation and migration could be reduced. Thus, the development of selective 
aquaporin inhibitors is of great interest for therapeutic purposes, as well as to 
understand the roles of AQPs in physiological and pathophysiological processes. In 
order to develop highly selective and effective inhibitors, the mechanism of small 
molecule permeation through the pore must be well understood. The use of in silico 
techniques is, therefore, very important to elucidate the molecular mechanism and to 
complement experimental evidences obtained by in vitro and in vivo studies. In the 
next chapter we will provide an overview of the results obtained on metal compounds 
as AQPs inhibitors. 
 
 
3.3 AQP3 inhibition by gold compounds 
 
Inhibition of AQPs’ water permeation by metal-based compounds has been 
investigated for several years. Mercurial compounds such as HgCl2, along with zinc 
and nickel salts, AgNO3 and silver sulfadiazine have shown inhibitory properties24. 
Unfortunately, due to a combination of lack of selectivity and high toxicity, these 
compounds are all unsuitable for therapeutic applications.  At a molecular level, some 
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information on the binding mechanisms of these compounds to AQPs comes from X-
ray structural analysis,25 as well as from site-directed mutagenesis studies26. In the 
case of mercury, it appears that metal binding to Cys residues is responsible for its 
inhibition effects. The affinity of mercury for sulfur donors can be explained by the 
hard and soft (Lewis) acid and base theory (HSAB theory)27, whereby mercury acts as 
the acid and sulfur acts as the base. Whilst mercury has been shown to be an effective 
AQP3 inhibitor, its promiscuity and therefore, toxicity, prevents it from being 
developed into a highly selective inhibitor. 
 
The idea of using HSAB theory of metal ions to selectively target certain available 
residues within a protein structure, such as the sulfur of Cys40 in AQP3, but with 
greater control of the metal compound’s reactivity, has proven viable. Recently, our 
research group discovered gold coordination complexes as selective 
aquaglyceroporins inhibitors24. Specifically, the Au(III) coordination complex 
Auphen [Au(1,10-phenanthroline) Cl2]Cl (Figure 3.4.A) was found to cause highly 
selective and potent inhibition for human AQP328 and AQP729 vs the orthodox channel 
AQP1. Au(III) ions are relatively ‘soft’ Lewis acids and, similarly to mercury, can 
react with sulfur donor. Therefore, it was hypothesized that Auphen could bind to Cys 
residues in the protein channel, such as Cys40 in human AQP3, inducing inhibition of 
substrate permeation by steric hindrance. The Cys40 residue was first identified using 
homology modelling approaches and showed to be accessible for gold binding at the 
extracellular side of the pore (Figure 3.4. B). To further ascertain the accessibility and 
affinity of Auphen and its derivatives for Cys40, QM/MM calculations were 
performed to determine the most stable non-covalent binding modes of the compound 
inside the extracellular pocket30. The calculations showed that Auphen, along with 
similar Au(III) complexes with bidentate N-donor ligands, to have the best binding 
affinity with a DG value of -48 kJ mol-1. In detail, Auphen was shown to interact, via 
p-p stacking, with residues Tyr212 and Phe63 of the ar/R selectivity filter and 
indicated the mechanism of how Au(III) compounds inhibit AQP3. Later on, this 
residue was validated as a binding site for Auphen using mutagenesis studies31.  
This study also showed the link between tumour progression and glycerol uptake and 
the antiproliferative effect of Auphen on A431 skin cancer cells, overexpressing the 
AQP3 isoform.  
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Finally, in 2019 our group, using a combined classical MD and QM/MM approach, 
has reported on the importance of non-coordinative adducts with the protein surface 
in modulating the AQP3 inhibition properties of a series of Au(III) coordination 
compounds32. The study concluded that these interactions, prior to the covalent 
protein/metal complex adduct formation, should be further considered in the future 
design of isoform-selective AQP inhibitors. 
 
 
 
Figure 3.4 A. Au (III) coordination complex Auphen. B. Auphen docking with Cys40 of AQP3 and its 
position relative to the residues of the  ar/R SF24. C. Auphen docked within the NPA region of AQP7, 
showing interactions between Au and Met4729. 
 
 
 Further studies showed that Auphen can also inhibit glycerol permeation via 
AQP729. This isoform, like AQP3, has been found to transport both water and glycerol 
along with other small uncharged solutes. AQP7 is found in abundance in the plasma 
membrane of adipocytes and is the primary glycerol transporter in adipose tissue19. 
Moreover, AQP7 can also be found in thyroid33 and uterus34 tissue and has been found 
to be overexpressed in malignant ovarian cancer cells when compared to heathy 
ovarian tissue35. 
 
Unlike AQP3, AQP7 does not have an exposed cystine residue on the extracellular 
side of the channel, therefore a different mechanism of inhibition was proposed. In 
this case, using a homology modelling of human AQP7 and non-covalent docking 
studies, three methionine residues were identified, below the NPA region on the 
intracellular side of the channel, as the possible gold binding sites (Figure 3.4. C)31. 
Two of the methionine’s, namely Met47 and Met93, were identified as the likely 
+
B C A 
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binding sites for Auphen, resulting in channel blockage. As these residues are found 
on the cytoplasmic side of the protein, Auphen must enter the cell before it can bind 
to the methionine residues. However, this mechanistic hypothesis needs further 
validation. 
 
 
3.4 Molecular dynamics simulations of aquaporins 
 
Molecular dynamics (MD) has been widely used to elucidate the potential energies of 
the ar/R and NPA selectivity filters concerning substrate permeation, mainly focusing 
on water and glycerol 36 along with the free energy calculations for a variety of 
substrates using umbrella sampling37.  
 
The most studied aquaporins using in silico techniques are human AQP1 and bacterial 
glycerol facilitator (GlpF), both with their structures already solved by X-ray 
crystallography38. These simulations provided the first insights into the mechanism of 
water permeation, along with the structural differences between the orthodox 
aquaporins and aquaglyceroporins that exclude or allow the passage of certain 
molecules, such as H2O, glycerol and urea. These studies revealed the highly 
conserved selectivity filters ar/R and NPA and the roles each plays in aquaporins 
selectivity, as well as calculating the free energy of permeation for H2O, glycerol NH3 
and urea37. One study using umbrella sampling to calculate the potential of mean force 
(PMF) of conductance for a number of small solutes via AQP1 and GlpF, showed that 
although they differ in size, both H2O and glycerol were found to have equivalent DG 
values of 13.5 kJ/mol37. In this case the DG value for water was calculated based on 
water density and not by umbrella sampling as was the case for glycerol. 
 
As crystal structure data is available, a number of molecular dynamics studies have 
been carried out on GlpF36,37,39,40, hAQP136,37, and hAQP441,42. In this context, de 
Groot and Grubmüller36  identified the ar/R and NPA selectivity filters and the water 
dipole flip (Figure 3.5). This now established motif can be seen in all the available 
studies on aquaporins, with the interactions within the NPA region helping to maintain 
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the single file water transport mechanism as well as prevent the passage of charged 
species.  
 
 
Figure 3.5 Water dipole moment orientation within AQP1 pore as calculated by de Groot and 
Grubmüller36. Arrows’ head indicates positive end of dipole. (Adapted from de Groot and Grubmüller 
(2001)36. 
 
 
Historically, the lack of structural information on human aquaglyceroporins has 
fostered the use of in silico techniques, such as homology modelling, MD and DFT to 
ascertain the possible binding modes of potential inhibitor/protein adducts as 
described above. However, in 2018 Gotfryd et al resolved the structure of hAQP10 
via X-ray diffraction43, the first time a human aquaglyceroporin has been determined. 
This structure will certainly lead to more accurate modelling in future 
aquaglyceroporin studies. 
 
An earlier study on glycerol permeation via the bacterial glycerol facilitator (GlpF) 
protein by Jensen et al39 used Jarzynski’s identity to calculate the irreversible work 
done by a pull code to encourage glycerol to pass though the GlpF pores to calculate 
the PMF. Whilst this method and umbrella sampling provide two-dimensional energy 
profiles of the pathway of solutes through the aquaporin pores, they fail to provide any 
physiologically relevant trajectory information on the events. Each method uses the 
combination of a number of calculations, whereby the solute is restrained, to provide 
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the free energy plots. As the interactions of solutes with the protein and the transition 
between bulk water and entering the pore are highly complex, trajectory information 
is essential to understand the mechanism of permeation. Although no dynamic 
information is available from these data, they do provide highly relevant information 
on the nature of the pore residue/solute interactions with regards to the two selectivity 
filters. Both show an energy increase and the ar/R SF and NPA region within the 
pore39. 
 
 
Further work by Jensen et al in two papers in 200139 and 2002,40 studied first the 
mechanism of spontaneous conductance of glycerol via GlpF, and secondly the 
energetics involved in the formation of hydrogen bonds between glycerol, water and 
GlpF pore residues during conductance. The results showed how orientation of 
glycerol affects the energy of translocation through the pore, and thus an optimal 
orientation is more energetically favourable (Fig 3.6)39. A third key area within the 
pore was also identified featuring a highly conserved histidine (His66 in the case of 
GlpF) residue below the NPA motif, towards the cytoplasmic pore entrance. Whilst 
not thought to be involved in solute selectivity, this area is involved in hydrogen bond 
network and therefore plays a role in the free energy landscape of solute conductance. 
 
 
Figure 3.6 A, The favourable (left) and unfavourable (right) orientations of glycerol as they pass 
through the ar/R SF of GlpF. B, Position within the pore (along the z-axis vs time for the favourable 
(left) and unfavourable (right) glycerol orientations, showing how in the unfavourable orientation 
glycerol fails pass through the pore.(Adapted from Figure 3, Jensen el al40). 
 
In 2008, Hub and de Groot showed how energy barriers of solute uptake differ 
between orthodox aquaporins (AQP1) and aquaglyceroporins (GlpF)37. This work also 
A B
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provided evidence on the energy expenditure difference of solutes diffusing through a 
lipid bilayer and traversing an aquaporin pore. Steered molecular dynamics (SMD) in 
the form of umbrella sampling with the trajectory of each solute initiated by a pull 
code was used to determine the energy barriers of conductance. The obtained results 
show that it is more efficient for small apolar molecules such as O2 and CO2 to diffuse 
through a lipid bilayer, whilst with more polar and hydrophilic molecules such as 
ammonia, water and glycerol, the energy barrier is far greater and thus discourages 
diffusion37. The free energy barrier for these molecules are greatly reduced when 
passing through the aquaporin pores (Table 3.1). Furthermore, the main finding of the 
paper was the role that water molecules-pore interactions play in pore selectivity and 
free energy of solute uptake, rather than the interactions between solutes and the pore 
itself. The study analysed the hydrogen bond interactions of O2 during permeation of 
hAQP1 and GlpF. O2 was found in reduce water-protein interactions within the ar/R 
region of hAQP1 during permeation and data showed both a reduction in H-bonding 
and thus, a reduction in energy of c.a.60kJ/mol. This was not the case for O2 
permeation of GlpF which showed little to no reduction in water-protein interaction in 
the ar/R region during conductance. The difference in the results is thought to be due 
to the increased diameter and hydrophobic nature of the GlpF pore in comparison to 
hAQP1, thus, reducing the selectivity of GlpF for small polar solutes. 
 
Table3.1 Summary of free energy barriers DGmax in kJ/mol, (values taken from Table 1 Hub and de 
Groot (2008)37. ( * values calculated from water density)  
Solute hAQP1 GlpF hAQP1-HA/RV POPE POPC 
O2 27 12.5 8.5 6 4 
CO2 22 13.5 5 4 1.5 
NH3 18 12.5 9 19 15 
H2O 14* 13.5* 13* 31 27 
Glycerol (24) 13.5 13.5 30 27 
Urea 32.5 29 16 32 34 
 
The pioneering work carried out in these studies has allowed a far greater 
understanding of the role played by each of the selectivity filters during conductance 
events as well as the importance of the single file water chain to the solute uptake. 
With the water mechanism as essential to the selectivity and movement of solutes 
through the pore, it is necessary to understand how solutes transition from bulk water 
to the single file water chain in the various aquaporins. Unfortunately, none of the 
studies above can answer this question due to the nature of the molecular dynamics 
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techniques used, as the classical MD does not allow for an unbiased conductance 
trajectory to be calculated at a physiologically relevant timescale.  
 
Recently, molecular dynamics simulations provided evidence on the mechanism of 
inhibition of Hg2+ of both water and glycerol permeation in human AQP344. This study 
showed that Hg2+ induces conformational changes within the aquaporin pore by 
coordination to the residues within the ar/R SF and a number of water molecules 
present in the pore. Hg2+ shows an affinity for the sulfur of residue Cys40, located 
close to the ar/R SF, forming an octahedral coordination to Cys40 in each of the four 
monomers along with the oxygen of Ile146 and between two and four water molecules 
present in the pore (Figure 3.4).44 By inducing protein conformational changes, and 
not by sterically hindering the AQP3 channel as originally postulated, mercury 
prevents both water and glycerol flux in three of the four pores of the AQP3 tetramer. 
 
 
Figure 3.4. Hg2+ octahedral coordination within the AQP3 pores which is responsible for inhibition of 
glycerol permeation: In all cases, metal ion coordinates to Cys40 and other residues in the protein’s 
pore as well as to water molecules. Adapted from Spinello et al 201644. 
 
 
Overall, based on these promising results, by using state of the art techniques, we hope 
to begin to answer the question of how solutes such as glycerol permeate through 
AQP3 and what the determinants of AQPs selectivity for a certain substrate are. 
Moreover, we aim at elucidating the mechanisms of AQPs inhibition by metal 
complexes by MD methods, to achieve structure-activity relationships and improve 
the design of selective inhibitors.  
Chapter 3 
 
 51 
3.5 References  
 
1 A. S. Verkman, M. O. Anderson and M. C. Papadopoulos, Nat. Rev. Drug 
Discov., 2014, 13, 259–277. 
2 R. M. Cordeiro, Biochim. Biophys. Acta - Gen. Subj., 2015, 1850, 1786–1794. 
3 A. Kirscht, S. S. Kaptan, G. P. Bienert, F. Chaumont, P. Nissen, B. L. de Groot, 
P. Kjellbom, P. Gourdon and U. Johanson, PLoS Biol., 2016, 14, 1–19. 
4 A. Kirscht, Y. Sonntag, P. Kjellbom and U. Johanson, BMC Struct. Biol., 2018, 
18. 
5 L. Yu, R. A. Rodriguez, L. L. Chen, L. Y. Chen, G. Perry, S. F. McHardy and 
C. K. Yeh, Protein Sci., 2016, 25, 433–441. 
6 A. Pelagalli, C. Squillacioti, N. Mirabella and R. Meli, Int. J. Mol. Sci., 2016, 
17. 
7 R. E. Day, P. Kitchen, D. S. Owen, C. Bland, L. Marshall, A. C. Conner, R. M. 
Bill and M. T. Conner, Biochim. Biophys. Acta - Gen. Subj., 2014, 1840, 1492–
1506. 
8 C. Bai, M. A. Matthay, A. S. Verkman and A. S. Verkman, 1999, m, 555–561. 
9 R. Maugeri, G. Schiera, C. M. di Liegro, A. Fricano, D. G. Iacopino and I. Di 
Liegro, Int. J. Mol. Sci., 2016, 17, 1–18. 
10 T. Ma, B. Yang, A. Gillespie, E. J. Carlson, C. J. Epstein and A. S. Verkman, 
J. Biol. Chem., 1998, 273, 4296–4299. 
11 T. Ma, A. Gillespie, E. J. Carlson, Y. Song, A. S. Verkman and C. J. Epstein, 
J. Biol. Chem., 2002, 274, 20071–20074. 
12 M. Tonghui, M. Hara, R. Sougrat, J. M. Verbavatz and A. S. Verkman, J. Biol. 
Chem., 2002, 277, 17147–17153. 
13 C. GM, The Cell: A Molecular Approach, Sinauer Associates, Sunderland 
(MA), 2nd editio., 2000. 
14 B. Aikman, A. De Almeida, S. M. Meier-Menches and A. Casini, Metallomics, 
2018, 10, 696–712. 
15 R. A. Harvey and D. R. Ferrier, Biochemistry, Wolters Kluwer 
Health/Lippincott Williams & Wilkins, Philadelphia, 5th editio., 2011. 
16 J. Hu and A. S. Verkman, FASEB J., 2006, 20, 1892–1894. 
17 WO2013116537, 2013. 
18 H. Satooka and M. Hara-Chikuma, Mol. Cell. Biol., 2016, 36, 1206–1218. 
Chapter 3 
 
 52 
19 N. Maeda, Mol. Aspects Med., 2012, 33, 665–675. 
20 C. Lindskog, A. Asplund, A. Catrina, S. Nielsen and M. Rützler, J. Histochem. 
Cytochem., 2016, 64, 287–300. 
21 G. P. Bienert and F. Chaumont, Biochim. Biophys. Acta - Gen. Subj., 2014, 
1840, 1596–1604. 
22 G. P. Bienert, A. L. B. Møller, K. A. Kristiansen, A. Schulz, I. M. Møller, J. K. 
Schjoerring and T. P. Jahn, J. Biol. Chem., 2007, 282, 1183–1192. 
23 C. Polytarchou, M. Hatziapostolou and E. Papadimitriou, J. Biol. Chem., 2005, 
280, 40428–40435. 
24 A. P. Martins, A. Marrone, A. Ciancetta, A. G. Cobo, M. Echevarría, T. F. 
Moura, N. Re, A. Casini and G. Soveral, PLoS One, 2012, 7. 
25 D. F. Savage and R. M. Stroud, J. Mol. Biol., 2007, 368, 607–617. 
26 M. Zelenina, A. A. Bondar, S. Zelenin and A. Aperia, J. Biol. Chem., 2003, 
278, 30037–30043. 
27 R. G. Pearson, J. Am. Chem. Soc., 1963, 85, 3533–3539. 
28 A. Serna, A. Galán-Cobo, C. Rodrigues, I. Sánchez-Gomar, J. J. Toledo-Aral, 
T. F. Moura, A. Casini, G. Soveral and M. Echevarría, J. Cell. Physiol., 2014, 
229, 1787–1801. 
29 A. Madeira, A. de Almeida, C. de Graaf, M. Camps, A. Zorzano, T. F. Moura, 
A. Casini and G. Soveral, Chembiochem., 2014, 15, 1487–1494. 
30 A. P. Martins, A. Ciancetta, A. de Almeida, A. Marrone, N. Re, G. Soveral and 
A. Casini, ChemMedChem., 2013, 8, 1086–1092. 
31 A. Serna, A. Galán-Cobo, C. Rodrigues, I. Sánchez-Gomar, J. J. Toledo-Aral, 
T. F. Moura, A. Casini, G. Soveral and M. Echevarría, J. Cell. Physiol., 2014, 
229, 1787–1801. 
32 M. N. Wenzel, A. F. Mósca, V. Graziani, B. Aikman, S. R. Thomas, A. de 
Almeida, J. A. Platts, N. Re, C. Coletti, A. Marrone, G. Soveral and A. Casini, 
Inorg. Chem., 2019, 58, 2140–2148. 
33 L. Lacroix, V. Lazar, S. Michiels, H. Ripoche, P. Dessen, M. Talbot, B. Caillou, 
J. P. Levillain, M. Schlumberger and J. M. Bidart, Am. J. Pathol., 2005, 167, 
223–231. 
34 U. Alabalık, G. Türkcü, A. N. Keleş, İ. İbiloğlu, A. Özler, Z. Urakçı and H. 
Büyükbayram, Biotechnol. Biotechnol. Equip., 2017, 31, 148–155. 
35 J. H. Yang, C. X. Yan, X. J. Chen and Y. S. Zhu, J. Int. Med. Res., 2011, 39, 
Chapter 3 
 
 53 
702–711. 
36 B. L. de Groot and H. Grubmuller, Science (80-. )., 2001, 294, 2353–2357. 
37 J. S. Hub and B. L. de Groot, Proc. Natl. Acad. Sci., 2008, 105, 1198–1203. 
38 D. Fu, A. Libson, L. J. W. Miercke, C. Weitzman, P. Nollert, J. Krucinski and 
R. M. Stroud, Science (80-. )., 2000, 290, 481–486. 
39 M. Jensen, E. Tajkhorshid and K. Schulten, Structure, 2001, 9, 1083–1093. 
40 M. O. Jensen, S. Park, E. Tajkhorshid and K. Schulten, Proc. Natl. Acad. Sci., 
2002, 99, 6731–6736. 
41 N. J. English and J. A. Garate, J. Chem. Phys., 2016, 145. 
42 M. Assentoft, S. Kaptan, H.-P. Schneider, J. W. Deitmer, B. L. de Groot and N. 
MacAulay, J. Biol. Chem., 2016, 291, 19184–19195. 
43 K. Gotfryd, A. F. Mósca, J. W. Missel, S. F. Truelsen, K. Wang, M. Spulber, 
S. Krabbe, C. Hélix-Nielsen, U. Laforenza, G. Soveral, P. A. Pedersen and P. 
Gourdon, Nat. Commun., 2018, 9, 4749. 
44 A. Spinello, A. De Almeida, A. Casini and G. Barone, J. Inorg. Biochem., 2016, 
160, 78–84. 
 
 
  
Chapter 3 
 
 54 
 
  
Chapter 4 
 
 55 
 
Chapter 4 - The mechanism of aquaporin inhibition by gold 
compounds elucidated by biophysical and computational 
methods 
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Abstract: The inhibition of glycerol and water conductance via human 
aquaglyceroporin-3 (AQP3) by Au(III) complexes has been studied by stopped-flow 
spectroscopy and, for the first time, its mechanism has been described using molecular 
dynamics (MD) and density functional theory (DFT). The obtained MD results 
showed the most effective gold-based inhibitor, bound to Cys40 in AQP3, is able to 
induce a protein conformational change that closes the pore, thus, preventing glycerol 
and water permeation. Moreover, a good correlation between the affinity of the Au(III) 
complex for binding to sulfur donors in Cys residues and AQP3 inhibition effects was 
highlighted; while no influence of the different oxidative character of the complexes 
was observed. 
 
 
4.1 Introduction 
 
Water movement through cells is a prerequisite for all life forms. The discovery and 
characterization of an abundant protein of the erythrocyte membrane, termed 
Aquaporin-1 (AQP1), 25 years ago, represented a paradigm shift in the understanding 
of molecular and membrane water transport. Since then, several studies have shown 
that AQP1 is a member of a universal family of water and solute-permeable membrane 
proteins – Aquaporins (AQPs) – which have now been shown to be ubiquitous in all 
domains of life.1 
To date, 13 aquaporin isoforms have been identified in mammals (AQP0-12) which 
are expressed in a wide range of tissues, organized as tetramers embedded in 
membranes, and permeating water (orthodox aquaporins), glycerol 
(aquaglyceroporins), and other small solutes.2 
 
Aquaporins have been shown to play important roles in physiology and 
pathophysiology, e.g. maintaining cellular homeostasis and being essential in cellular 
metabolism. Thus, they have been identified as potential targets for drug 
development.3–5 One specific type, aquaglyceroporins, regulate the glycerol content in 
the epidermis and other tissues and appear to be involved in skin hydration, cell 
proliferation, carcinogenesis and fat metabolism.1,6 
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To validate the various roles of AQPs in health and disease, and to develop AQP-
targeted therapies, the use of highly selective inhibitors provides great potential. 
However, so far, no reported small-molecule AQP inhibitors possess sufficient 
isoform selectivity to be candidates for clinical development.7 The first reported  
potent and selective inhibitor of human aquaglyceroporin-3 (AQP3) from our group 
was the water-soluble Au(III) compound, [Au(phen)Cl2]Cl (phen = 1,10-
phenanthroline) (Auphen, Figure 1).8 Auphen inhibited glycerol transport in human 
red blood cells (hRBC) with an IC50 ca. 0.8µM, while having no inhibitory effect on 
AQP1 water conductance. In silico approaches, including homology modeling, were 
used to investigate the non-covalent binding of Auphen with human AQP3 at an 
atomistic level and suggested that the compound could bind to Cys40, with the thiol 
group being a likely candidate for coordinating to Au(III) ions.8 The involvement of 
this residue in the inhibition mechanism was also subsequently confirmed by site-
directed mutagenesis studies.9  
 
 
Figure 4.1 Gold(III) complexes tested as human AQP3 inhibitors. 
 
Further studies on Au(III) compounds with different N^N ligand scaffolds allowed the 
establishment of preliminary structure–activity relationships (SAR).10 Notably, 
Quantum Mechanics/Molecular Mechanics (QM/MM) calculations provided evidence 
that the ligand moiety may play a major role in the compound’s selectivity towards a 
particular AQP isoform,10 favouring the initial non-covalent interactions between the 
inhibitor and the extracellular binding pocket of AQP3. Furthermore, Molecular 
Dynamics (MD) simulations on the adducts of Hg2+ ions (benchmark inhibitors of all 
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AQPs11,12) with AQP3 showed that pore closure may be due to indirect protein 
conformational changes upon metal binding, rather than direct steric blockage of the 
channel by the inhibitor.13 Following up on these results, we describe here the hAQP3 
inhibition properties of four Au(III) complexes (Figure 4.1) assessed in hRBC by 
stopped-flow spectroscopy. The series of compounds included three coordination 
complexes with a dipyridin-2-ylamine (DipyAm) ligand [Au(Dipyam)Cl2]PF6 (1),14 
and with (pyridyl)benzimidazole type ligands – [Au(PbIm)Cl2] (3) (PbIm = 2-
(pyridin-2-yl)-benzimidazole)15 and [Au(PbImMe)Cl2]PF6 (4) (PbImMe = 1-methyl-
2-(pyridin-2-yl)-benzimidazole), respectively. Also, for the first time, an 
organometallic Au(III) compound with a C^N cyclometalated 2-benzylpyridine (pyb-
H) ligand (2)16 was tested as AQP inhibitor. 
 
The mechanism of AQP3 inhibition was studied using MD simulations for the most 
potent inhibitor of the series, allowing the observation of protein conformational 
changes which lead to pore closure upon gold binding to Cys40. The identification of 
structure–activity relationships that may link the electronic/structural properties of 
Au(III) compounds to their biological effects was also carried out. Thus, density 
functional theory (DFT) calculations were performed to further substantiate and 
interpret the observed biological effects. 
 
 
4.2 Results and discussion 
 
Compounds 1–3 were synthesized using previously reported procedures14,17–19. The 
new Au(III) complex 4 was obtained in 82% yield by the reaction between 1-methyl-
2-(pyridin-2-yl)-benzimidazole20 in MeCN with an equimolar aqueous solution of 
NaAuCl4 and an excess of PF6 at room temperature (r.t.) for 3 h, and was then 
characterized by various methods. The gold complexes were tested for their AQP1 
and AQP3 inhibition properties in hRBC via stopped-flow spectroscopy.21  
 
As previously reported for Auphen and related compounds,8,10 some of the new 
complexes act as inhibitors of glycerol permeation via AQP3, whilst not affecting 
water permeation via AQP1. The coordination complex 1 shows moderate inhibition 
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of water and glycerol permeability (IC50  > 20µM), which may be due to its poor 
physiological stability.14 Of note, the neutral organometallic compound [Au(pyb-
H)Cl2] 2 showed limited activity (IC50  > 50µM). It was hypothesized that the lack of 
a positive charge would disfavour the non-covalent interaction of the complex with 
the extracellular surface of AQP3, thus preventing its approach to the pore prior 
binding to Cys40. In line with this observation, while the neutral complex 3 proved a 
weak inhibitor of  glycerol transport (IC50 > 50 M), the novel cationic compound 
[Au(PbImMe)Cl2]PF6 4 is a very potent AQP3 inhibitor (IC50 = 0.6 ± 0.1µM), even 
more effective than Auphen, and ca. 3 orders of magnitude more potent than complex 
3.  
The mechanism of hAQP3 inhibition by complex 4 was analysed using classical 
molecular dynamics (MD). Due to the lack of an available crystal structure, the 
tetrameric protein structure of AQP3 was prepared using homology modelling, 
following an approach previously described by our group13 and reported in the 
methodology section.23 The compound was initially parameterised using DFT and 
QM/MM to generate Au(III) parameters for the applied Amber force field, and then 
directly bound to the thiolate of Cys40, in the form [Au(PbImMe)Cl]2+. Geometry 
optimisation was performed on this fragment (Figure 4.2), which was subsequently 
embedded into monomer A of the AQP3 model. The charge of Au was set to +3 
(Au(III)). 
 
 
Figure 4.2 Geometry of modified Cys40 with complex 4 after energy minimisation.  
 
Five independent MD simulations (0.5 ns) were conducted to determine the effect of 
compound 4 on water and glycerol permeation using both: (i) AQP3 or (ii) gold-bound 
AQP3 (AQP3-Au) models. Figure 4.3 shows the pore size comparison of the structures 
for monomer A obtained from two representative simulations of each model. Binding 
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of complex 4 to Cys40 induces shrinkage of the pore, thus, impeding both glycerol 
and water permeability. 
 
Figure 4.3 (A) Human AQP3 monomer A and (B) AQP3 with modified Cys40 (AQP3-4), showing the 
effect on pore size (based on VDW radii): red = smaller than single H2O, green = single H2O, blue = 
larger than single H2O. Complex 4 and Cys40 are shown in ball and stick representation, with atoms 
coloured by atom type. Generated with HOLE24 and VMD.25 
 
From one simulation of each model, 30 snapshots were taken, and the pore size of 
each monomer was measured using the HOLE24 software package as detailed in Figure 
4.4. In order to validate the observed trend, five snapshots were taken (100, 300, 450, 
600 and 800 frames) from each of the five independent simulations for each model, 
and the pore size was measured. The average pore size of each monomer was 
calculated (Figure 4.5) and allowed the ruling out of spontaneous pore geometry 
fluctuations during the simulation. Surprisingly, the average of the pore size analysis 
shows that binding of complex 4 to monomer A also constricts monomer D, although 
not sufficiently to prevent solute conductance, whilst monomers B and C are 
unaffected (Figure 4.5). 
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Figure 4.4 Pore size taken at the narrowest point of the channel (ar/R SF), from a representative 
simulation (0.5 ns) of AQP3 permeation by glycerol in the absence (A) or presence (C) of the gold 
complex. Each monomer is represented by a trace, and the coloured markers indicate the glycerol 
passage from extracellular to cytoplasmic side. (B) Pockets for glycerol passage, indicated in yellow 
(extracellular pocket), blue (ar/R SF), pink (NPA motif) and green (cytoplasmic pocket). The narrowest 
point of the channel is indicated by a dashed line (approximate localization). In panel D the pore sizes 
of each monomer are shown, with (dashed line) and without (full line) gold complex. The same colour 
code of the point markers was used.  
 
 
Figure 4.5 Pore size taken at the narrowest point of the channel (ar/R SF) from 10 independent 
simulations (0.5 ns) of AQP3 (5 without and 5 with gold complex) for each monomer. In black markers, 
the pore sizes of each monomer are show as an average of 5 independent simulations and with a linear 
trend line (shown in black). In coloured dashed lines with white markers, the results for each of the 5 
individual simulations of AQP3 with the gold complex are shown. In coloured markers is represented 
the average size for each point, for AQP3 with gold complex 4, with an added linear trend line, shown 
in the respective colour.  
 
Chapter 4 
 
 62 
Root mean square displacement (RMSD) shows that the overall protein conformation 
is conserved upon gold binding (Figure 4.6).  
 
 
Figure 4.6 RMSD (Å) of the protein backbone atoms of AQP3 (black) and AQP3-Au (red).  
 
Binding of the complex within the pore induced rearrangement in the side chains of 
the aromatic/arginine selectivity filter residues (ar/R SF) (Figure 4.7). Compound 4 
does not appear to be positioned within the channel in a way that would prevent 
glycerol or water to flux. However, upon Au(III) binding to Cys40, located close to 
the ar/R SF, compound 4 prevents the Arg218 residue from forming an H-bond with 
the protein backbone, as usually observed in AQP3, pushing the side-chain outwards 
into the channel (Figure 4.7).  
 
Figure 4.7 A, Tetrameric view of human AQP3 bound to complex 4. B, Structure of the ar/R SF of 
AQP3 (blue) and upon binding of the gold complex (pink). The gold complex 4 is shown in black with 
thin sticks, gold in yellow-gold colour and chloride in green, both in ball and stick representation. H-
Bonds are shown using orange dashed lines (HB), while H-arene interactions are shown using green 
dashed lines. Figures in panel B were generated with MOE.26 
 
These effects suggest that inhibition of AQP3’s water and glycerol permeability is due 
mainly to conformational changes within the protein induced by binding of the gold 
complex to Cys40, rather than by the complex’s steric hindrance, agreeing with the 
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previous MD study on the binding of Hg2+ to AQP3.13 Similar effects were observed 
when a longer MD simulation was run (8 ns, Figure 4.8). 
 
 
Figure 4.8. MD simulation of AQP3 permeation by glycerol in the presence and absence of the gold 
complex without pull (8 ns). During the time of the simulation, due to the absence of pull, none of the 
glycerol molecules crosses the AQP3 channels. A) RMSD of the backbone of AQP3’s simulation with 
(blue trace) and without (red trace) gold complex. B) Pore size of monomer A measured at the narrowest 
point of the channel. The simulation with gold complex is shown in blue markers and line, while the 
simulation without the complex is depicted in black. C) Structure of the ar/R SF of AQP3 (blue) and 
upon binding of the gold complex (pink). The gold complex 4 is shown in black with thin sticks, gold 
in yellow-gold colour and chloride in green, both in ball and stick representation. H-bonds are shown 
in orange dashed lines, while H-arene interactions are shown in green dashed lines. The figures in panel 
C were generated with MOE.26 
 
The observed structural changes upon gold binding appear to increase the 
hydrophobicity of the pore entrance of monomer A in comparison with monomers B 
to D and the unbound tetrameric model, due to increased exposure of hydrophilic side 
chains (Figure 4.9). Overall, the symmetry of the tetramer is disrupted in the AQP3-
Au model, as can be seen in Figure 4.9, due to the exposure of hydrophilic residues 
(Arg50 and Asp125). These relatively small changes greatly affect the approach of 
glycerol molecules to the channel entrance. 
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Figure 4.9 Top intra and extracellular view of AQP3 (left) and AQP3-Au bound (right) tetramers 
hydrophobic surfaces at the start of the simulation. The gold complex 4 is shown over the surface only 
for indication of its relative position within the tetramer. This does not represent the compound’s 
location across the z-axis. Blue = hydrophobic, red = hydrophilic. Generated with MOE.26  
 
To further investigate why complexes 3 and 4 have different AQP3 inhibitory effects 
and assuming Cys40 as the gold binding site as in the case of Auphen, DFT 
calculations were performed on the adducts between a cysteinate ligand and 
compounds 2–4, as well as Auphen, after the substitution of one of the two chlorido 
ligands (Figure 4.10). The standard Gibbs free energy values of adduct formation are 
reported in Table 4.1 and show a larger formation energy is observed for the positively 
charged Au(III) complexes with respect to neutral complex. These results support the 
hypothesis that the cationic compounds, [Au(phen)Cl2]+ and [Au(PbImMe)Cl2]+ 4, can 
more easily form adducts with cysteinato residues than the neutral complexes 
[Au(pyb)Cl2] 2 and [Au(PbIm)Cl2] 3. Therefore, the corresponding AQP3 inhibition 
effects agree with this trend.  
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Figure 4.10 Structure of the cysteinate complexes [Au(ligand)ClCys]n+ obtained for Auphen, 2, 3 and 
4, whose geometry was optimized by DFT calculations; n = 1, 0, 0, 1, for the adducts of Auphen, 2, 3 
and 4, respectively. 
 
Table 4.1 Standard Gibbs free energy of formation of [Au(ligand)ClCys]n+ adducts in H2O solution (in 
kJ/mol, in terms of the SCF energy, ΔE, and of standard Gibbs free energy, ΔG°) calculated through 
DFT and by Eq. 0 (see Methodology section). 
 
Compound ΔE ΔG° 
[Au(phen)ClCys]+ -53.7 -45.0 
2 [Au(pyb)ClCys] -10.7 -0.2 
3 [Au(PbIm)ClCys] -27.8 -18.9 
4 [Au(PbImMe)ClCys]+ -53.0 -46.6 
 
 
4.3 Conclusions 
 
Due to the broad range of functions of AQPs in physiology and in disease, the 
development of small-molecules selective inhibitors is valuable, as these could be 
used as either chemical probes to detect their function, or as innovative therapeutic 
agents in a variety of diseases. In this work, a new series of Au(III) complexes has 
been studied for their human AQP3 inhibition properties, and the cationic complex 4 
featuring bidentate N-donor ligands was identified as the most effective inhibitor of 
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glycerol conductance. Interestingly, the neutral complex 3, with a similar ligand 
system, was found to be inactive in comparison. DFT studies showed a good 
correlation between the compounds’ calculated affinity for binding to cysteinate 
residues and their AQP3 inhibitory activity.  
 
Of note, MD studies conducted for the first time on the Au(III) complex adduct with 
AQP3 have enabled the observation of protein conformational changes, upon metal 
binding to Cys40, which are mainly responsible for the observed inhibition of glycerol 
and  water conductance. This finding has important implications for the next 
generation of AQP3 inhibitors design, in that other amino acid residues could be a 
potential target, if their coordination to Au(III) ions leads to similar  protein 
conformational changes which result in channel closure. Interestingly, binding of the 
compound in one monomer appeared to affect substrate permeability in the adjacent 
monomers and to also alter the overall extracellular hydrophobic/hydrophilic nature 
of the tetramer surface, which, in turn, affects the approach of the substrates to the 
pore entrance. 
 
 
4.4 Methodology Section 
 
Homology modelling and molecular dynamics:  
The 3D structure of hAQP3 was obtained by homology modelling using the Molecular 
Operating Environment (MOE 2013.08).26 The choice of a template structure was 
based on the sequence identity between hAQP3 and the sequence of the AQPs with 
available resolved structures. The isoform showing the highest sequence similarity 
with hAQP3 is the bacterial isoform GlpF, with 34.68% of sequence identity, which 
was then chosen as a template structure to generate a homology model of hAQP3. The 
template was selected among the structures with the best resolution (2.70 Å) without 
any substrate (pdb 1LDI).28 The tetrameric form was assembled and the structure was 
prepared and protonated at pH 7, with the Amber12EHT force field, as described in 
Spinello et al13, using the Molecular Operating Environment (MOE 2013.08).5. 50 
intermediate models of AQP3 were generated and averaged to obtain the final 
homology model. The model obtained was checked for reliable rotamers involving the 
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side chains in the regions of ar/R SF and NPA, by comparison with the available 
crystal structures of all the other human and microbial AQP isoforms (pdb codes 1H6I, 
3GD8, 3D9S, 1RC2, 1LD1 and 3C02). The structure was protonated at pH 7 and an 
energy minimization refinement was performed, with fixed Cα atoms. 
Afterwards, the effect of binding of Au(III) complex 4 on AQP3 glycerol permeability 
was investigated using classical molecular dynamics (MD). The molecular system 
consisted of the homology model of the hAQP3 tetramer within a double layer of 166 
palmitoyl-oleyl-phosphatidyl-coline (POPC) lipid, prepared using the CHARMM-
GUI online server29,30, using Amber99SB-ILDN in combination with the Slipids 
(Stockholm lipids) force field for lipids.23,31 Four glycerol molecules were placed into 
the system, one above each pore entrance, approximately 30 to 35 Å (to residue 
TRY212 at the pore entrance). The system was solvated with 35379 water molecules 
and used a modified amber99SB-ILDN force field, with the parameters for glycerol 
and 1-methyl-2-(pyridine-2-yl)-benzimidazole generated by the Automated Topology 
Builder and Repository (ATB,version 2.2) website using the B3LYP/6-31G* basis 
set32, using a combination of semi-empirical QM and DFT. Complex 4 was 
parameterised using DFT and QM/MM in order to obtain the parameters for the 
Au(III) ions in the force field. Afterwards, the complex was bound to the thiolate of a 
cysteine residue, to further integrate in the protein complex. The complex’s geometry 
was further optimized (see Figure 4.2) and then incorporated into monomer A of 
AQP3.  
All simulations were run using the GROMACS 5.1.2 simulation software.33 Particle-
mesh Ewald method was used for calculating electrostatic interactions. The Verlet cut-
off scheme with a cut-off distance of 1.4 nm was used for short-range repulsive and 
attractive interactions and Lincs was used to constrain all bond lengths. Nose-Hoover 
temperature coupling was used to maintain the temperature of the system (т = 0.5 ps) 
at 310 K. The Parrinello-Rahman algorithm was used to maintain the pressure of the 
system at 1 bar with a coupling constant of т = 1.0 ps. Simulations were equilibrated 
for 100 ps before production. The four individual glycerol molecules were defined in 
the index and coupled in the pull code (e.g. gly_1 to chain A). A total of 10 MD 
simulations (5 with the Au(III) complex present and 5 without) were run for 0.5 ns 
using the direction COM pull procedure, in each case applying a separate yet equal 
harmonic restraint force to each solute molecule of 600 kJ mol-1 nm2 with a rate of 
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0.02 nm ns-1 along the z-axis. Two 4000000 step runs, or 8 ns were run using the 
same two model systems and parameters. For these runs the pull code was omitted, 
therefore removing any biasing of the system. 
Pore size measurements: Each pore radius was calculated using the Hole 2.0 
program24, which determines the internal surface based on atomic van der Waals radii. 
A snapshot at the beginning of each simulation was taken and coordinates for the 
center of each pore (monomers A to D), at the ar/R SF, were used to generate the pore 
radius along the z-axis. 
In order to assess if the gold complex significantly affects the pore size by inducing 
protein conformational changes, five simulations, with and without gold complex, 
were performed. From these, 5 snapshots were taken (100, 300, 450, 600 and 800 
frames) and the pore size was measured in each. For consistency, the narrowest part 
of the pore was considered to be the distance between the side chains of Tyr212 and 
Arg218 and, for each frame, the distance between the closest N atom of the side chain 
of Arg218 and C of the aromatic ring of Tyr212. The same methodology was used to 
assess the pore size of monomer A for the long (8 ns) simulation. 
 
DFT calculations:  
DFT calculations were performed on the structures of cysteine, HCl, Auphen, 2, 3, 4 
and on the adducts obtained by substituting one chlorido with a cysteinato ligand (see 
Figure 4.10), by using the M06-L34 functional, the Lanl2dz35 basis set for Au, S and 
Cl atoms and the 6-31G(d,p)36,37 basis set for C, N, O and H atoms. Solvent effects 
were evaluated by full geometry optimization within the implicit water solvent, 
reproduced by the polarizable continuum model (PCM).38 Vibrational frequency 
calculations, within the harmonic approximation, were performed to confirm that each 
optimized geometry corresponded to a minimum in the potential energy surface. 
Moreover, vibrational frequency calculations allowed us to estimate the standard 
Gibbs free energy values, at 298.15 K, of each energy minimum structure, both in 
vacuum and in solution. All calculations were performed by the Gaussian 09 program 
package.39 The energy values of formation of the gold complex-Cys adducts, reported 
in Table 4.1 were obtained by the following hypothetical reaction: [Au(Ligand)Cl2]n+ 
+ HCys → [Au(Ligand)ClCys]n+ + HCl, where n is the charge of the metal complex, 
Chapter 4 
 
 69 
and calculated by the Eqn. 0 below, where E can be either the self-consistent field 
(SCF) energy or the standard Gibbs free energy in solution: 
ΔE = E[Au(Ligand)ClCys] + E[HCl] - E[Au(Ligand)Cl2] - E[HCys] (Eq. 0) 
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Abstract: The aquaglyceroporin AQP7, a member of the aquaporin membrane 
channel family, facilitates the conductance of water and glycerol across cell 
membranes and is essential for lipid and energy homeostasis. Regulation of glycerol 
permeability via AQP7 is considered a promising therapeutic target for fat-related 
metabolic complications. Here, we used a combination of in vitro and in silico 
approaches to investigate its regulation by pH. We found that AQP7 moves from fully 
permeable at neutral pH to virtually closed at acidic pH and that Tyr135 and His165 
facing the extracellular environment are crucial residues for channel permeability. 
Furthermore, rather than a reduction in the pore size, protonation of key residues 
changes AQP7’s protein surface electrostatic charges which may result in a decrease 
glycerol’s binding affinity and result in decreasing permeability. It was also found; a 
number of the pH-sensitive residues are located at the monomer-monomer interface 
and the decrease in permeability may be due to cooperativity between AQP7 
monomers. Due to the importance of glycerol permeation via AQP7 in multiple 
pathophysiological conditions, the mechanism of hAQP7 pH-regulation could help in 
the design of highly selective modulators for targeting aquaglyceroporin-related 
disorders. 
 
 
5.1 Introduction 
 
Aquaporins (AQPs) are a family of small membrane proteins expressed in almost 
every organism and tissue type. They are involved in the bidirectional conductance of 
water and small uncharged solutes across cell membranes in response to concentration 
gradients or osmotic and hydrostatic pressure. The thirteen mammalian AQPs (AQP0-
12) are grouped based on their primary structure and permeability. Aquaglyceroporins 
(AQP3, 7, 9, 10) facilitate the permeation of glycerol and other small solutes in 
addition to water1. Due to this selective permeability, aquaglyceroporins play an  
important role in glycerol acquisition and metabolism within skin, fat and liver2–4 
tissues and are thought to be linked to obesity and metabolic-related complications, 
such as metabolic syndrome5,6. 
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As with  many types of channels and transporters, AQPs can be subject to regulation, 
either by transcriptional/translational mechanisms7, protein trafficking8 , or by short-
term channel regulation, known as gating. Gating is usually achieved by mechanisms 
directly affecting the channel’s conformation after it is embedded in the plasma 
membrane, which then impacts on its permeability9. It has been shown that various 
eukaryotic water-selective aquaporins can be gated by phosphorylation10,11, pH11–13, 
divalent cations14,15, or membrane surface tension16–19. In comparison, the regulation 
of aquaglyceroporins and glycerol permeability is less understood. With AQPs 
becoming an  emerging protein target for drug development20, increasing the 
understanding of human aquaglyceroporin regulation could help facilitate the 
identification and development of new modulators with potential therapeutic 
applications21,22. Even with the limited research into aquaglyceroporin regulation, a 
number of  studies have shown gating of AQP3 by pH, copper and nickel23–26.  
 
AQPs have a highly conserved hourglass-shaped internal pore, resulting in a steric 
barrier for solutes. This steric constriction within the pore consists of three (for 
aquaglyceroporins) or four (for aquaporins) amino acid residues, one of which is a 
highly conserved arginine, and at least one other having an aromatic side chain. Thus, 
this constriction site is named aromatic/arginine selectivity filter (ar/R SF). A second 
solute exclusion barrier is found in the centre of the pore, formed where the ends of 
two semi-helices meet and consists of NPA (asparagine-proline-alanine) amino acids 
in each helix. The NPA motif is not always conserved across isoforms, the proline and 
alanine may be substituted, whereas the two asparagine residues are highly conserved. 
The  two asparagines create a positive dipole moment within the pore and  prevent the 
permeation of certain charged species 21. 
 
This study investigated the pH regulation of human AQP7, the main aquaglyceroporin 
expressed in human adipocytes and highly relevant in maintaining efficient glycerol 
fluxes in healthy adipose tissue, as well as involved in obesity and fat-related 
metabolic complications4–6,27.The experimental investigation involved expressing 
hAQP7 in an optimized yeast model developed in the group of Prof. Graça Soveral 
(University of Lisbon)9. Using this cellular model, the function of the hAQP7 channel, 
with respect to water and glycerol permeability, was investigated. Moreover, 
inhibition of glycerol permeation via AQP7 was also confirmed for Auphen - 
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[Au(phen)Cl2]Cl (phen = 1,10-phenanthroline) - a gold(III) compound previously 
reported by our group as a potent inhibitor of human aquaglyceroporins AQP3 and 
AQP7 in their native expression systems28,29.  
Afterwards, the hAQP7 channel regulation by pH was also studied using the same 
yeast model. The experimental data showed that, while at pH 7.4, hAQP7 is fully 
functional, with maximal permeability at pH 6.5 and above, a marked reduction (more 
than 90% decrease) of Pf and PGly was observed at pH 5.0 (Figure 5.1). Interestingly, 
despite this clear reduction, Pf and PGly were still found to be significantly higher than 
in control cells. This indicates that although the permeability is substantially reduced, 
the pore does not completely closed at pH 5.0. Interestingly, the pH-dependence 
profile was found to be similar for both water and glycerol permeation, with pKa 
values estimated as 5.88 ± 0.01 and 5.85 ± 0.01, respectively. Additionally, the 
estimated Ea at three distinct pH values (pH 5.0, 6.5, and 7.5) corroborate the proposed 
channel regulation upon extracellular acidification30. 
 
 
 
Figure 5.1 pH-dependence of hAQP7 permeability. (A) Pf and (B) PGly at pH 5 and pH 7.4. pH-
dependence of hAQP7 was analysed by fitting the experimental data to a Hill equation from where the 
pKa values were estimated. Permeability assays were performed at 23 ºC. Data are mean ± SEM of four 
independent experiments. * P < 0.05, ** P < 0.01, *** P < 0.001. 
 
Based on the experimental results we then used in silico techniques, namely molecular 
modelling and molecular dynamics (MD) approaches, to investigate the mechanisms 
involved in hAQP7-pH regulation at a molecular level and to identify the amino acid 
residues involved in the pH gating. This led to further experimental investigations 
using site-directed mutagenesis combined to help us understand how hAQP7 
regulation can contribute to the roles of this isoform in physiology and                        
A              B 
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patho-physiology, helping the development of aquaglyceroporin-targeted therapies. 
The following chapter covers the computational aspects of this study along with a 
description of the mutagenesis results, which fostered additional computational work.  
 
 
5.2 Results and discussion 
 
5.2.1 WT hAQP7 molecular dynamics calculations  
 
Based on the experimental findings on the pH gating of hAQP7, we initially used a 
molecular modelling approach, previously developed by our group26, to gain 
mechanistic information. Therefore, a homology model of hAQP7’s tetramer was 
obtained using MOE software (MOE 2012.10; CCG 2012)31, and based on the best 
available structure of E. coli‘s glycerol facilitator (GlpF, pdb code 1FX8)32. Homology 
modelling showed that while hAQP7 maintains the highly conserved 
aromatic/arginine selectivity filter (ar/R SF) (consisting of Phe74, Tyr223 and 
Arg229, it does not contain the NPA motif. 
 
The refined homology model of hAQP7 was protonated using the PROPKA 3.1 
package33 at pH 5 and 7. Five independent MD simulations were run for 0.5 ns for 
each pH (pH 5 and 7) with four glycerol molecules, located in the extracellular side of 
the membrane, pulled along the Z-axis towards the intracellular space, mimicking 
imposed glycerol gradients. A total of 10 simulations were run to evaluate glycerol 
permeability. Afterwards, all simulations were analysed, and glycerol molecules 
monitored for successful permeation of hAQP7. To investigate the possible pore 
closure and conformational changes we suspected from the experimental results at low 
pH, the size and shape of the pore were analysed using HOLE34, from snapshots taken 
at five time points in each MD simulation. Figure 5.2 shows a surface representation 
of channel A from both systems, next to the average channel size of all monomers 
throughout the simulations. The results showed no differences were observed in the 
size of the channels at the two pH values for both NPA and ar/R SF, implying that the 
decrease in glycerol and water permeability may not be due to protein conformational 
changes and pore closure. The pore size measurements do show there is an observable 
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difference in the extracellular pocket (EP) (0.5 Å broader), just above the ar/R SF in 
the case of the pH7 system. This small variation may be due to system fluctuations 
during the simulation (as previously observed for other aquaporin isoforms10), as it 
was not detected in all the individual calculations (Figure 5.3A). Yet, a broader 
extracellular binding pocket due to conformational changes at pH 7, could favour 
glycerol passage through the pore, leading to increased permeability. 
 
Figure 5.2 Pore size of hAQP7 monomer A at pH 5 and pH 7. Surface of a representative snapshot of 
monomer A (based on VDW radii): red = smaller than single H2O, green = single H2O, blue = larger 
than single H2O. Pore size represented as an average of all monomers in 5 simulations at each pH value. 
EP – extracellular pocket, ar/R – aromatic/arginine selectivity filter, NPA – NPA motif, CP – 
cytoplasmic pocket. Figure generated by HOLE34 and VMD35. 
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Figure 5.3 A, Pore size of the four AQP7 monomers at pH 5 and pH 7. Each line represents an average 
pore size for each simulation, by using the pore size taken from five snapshots of each simulation. EP 
– extracellular pocket, ar/R – aromatic/arginine selectivity filter, NPA – NPA motif, CP – cytoplasmic 
pocket. B, Pore size average of the four AQP7 monomers for each mutant and WT. Pore size obtained 
with HOLE for each homology model34. 
 
With conformational analysis of the pore indicating that the protein does not alter pore 
size when protonated at pH 5 (Figure 5.2), the next stage was to investigate if glycerol 
and water fluxes were affected within the simulations. 
Figure 5.4A shows glycerol permeation as an average number of glycerol molecules 
able to cross the membrane via the monomer channels. Glycerol permeability is shown 
to be significantly higher at pH 7 than at pH 5 corroborating the obtained experimental 
PGly results (Figure 5.1). 
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To observe water permeation, longer simulations (20 ns) were calculated at both pH 
values, with the glycerol pull code removed. The passage of water molecules through 
the pores was evaluated using a python script to count successful permeation events, 
developed by us and based on previous work36. Only water molecules which 
completely crossed the AQP7 channel were counted, excluding any molecules 
crossing via the lipid bilayer. The molecular dynamics used represents an equilibrium 
simulation, therefore, it is only possible to estimate the diffusion constant (Dw), rather 
than the permeability coefficient. For this purpose, Dw of the single-file water 
molecules was estimated using the Einstein relation37,38, as described by Horner et al39 
: Dw = koz2/2, where z represents the average distance between two water molecules 
in the single-file region and ko represents the transport rate. The transport rate was 
then calculated as the total number of water molecules crossing the channel in the Z-
axis direction, calculated by the script, divided by the length of the simulation (in 
seconds). The final data is represented as the mean ±SEM. As shown in Figure 5.4B, 
Dw evaluated at pH 7 was significantly higher than at pH 5. 
 
Figure 5.4 pH dependence of glycerol and water permeation across the hAQP7 channel (in silico). A, 
Number of glycerol molecules crossing the AQP7 tetramer in MD studies, represented as mean ± SEM 
(n = 5). B, Water diffusion coefficient calculated by MD simulations, represented as mean ± SEM (n = 
3). n = number of simulations. * P < 0.05, *** P < 0.001. 
To conclude, even though the MD and stopped-flow spectroscopy data may not be 
directly comparable, as the in silico studies are not performed under osmotic 
conditions, the in silico and in vitro data are in accordance with each other and 
demonstrate that glycerol and water permeation via hAQP7 are pH-regulated. 
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5.2.2 hAQP7 mutagenesis experimental studies 
 
Previous research on human AQP3 using site-directed mutagenesis24 has shown  that 
only four residues (His53, Tyr124, Ser152 and His154) appear to be responsible for 
AQP3 pH gating. The relevance of these residues on hAQP3 was recently investigated 
using MD and it was proposed that gating occurs in the main due to protonation of 
His154 and its interaction with the neighbouring His12926. From this work, it was 
decided to investigate the mechanism of pH regulation based on sequence alignment 
of hAQP3 and hAQP7. A superposition of the two homology models (preparation of 
the hAQP3 homology model is described in reference26) showed that the 
corresponding residues in hAQP7 are Tyr64, Tyr135, His140, Pro163 and His165. 
The location of the key residues Tyr135, His140 and His165 in the hAQP7 tetramer 
are shown in Figure 5.5A and B.  
 
Detailed analysis of the  protonation sites for each model revealed only four residues 
are protonated at pH 5, which are not at pH 7 (Figure 5.6): these were, on extracellular 
side, His140 (in all monomers), intracellularly, Glu40 (monomers A, C and D), His92 
(monomers B, C and D) and Glu202 (in all monomers). Based on the 
sequence/structural alignment and protonation studies of the homology models, the 
residues facing the extracellular environment were chosen for further site-directed 
mutagenesis studies. These residues were Tyr135, His140 and His165. As previously, 
shown in Figure 5.2, changes in pore size are only observed on the extracellular side 
at pH 7, thus suggesting extracellular amino acids may play a role in pH-dependency. 
As Pro163 does not have a protonatable side chain, and Tyr64 is not protonated at pH 
5, these residues were not investigated further. 
 
Thus, to determine the importance of His165, His140 and Tyr135 experimentally, the 
selected amino acids were substituted by alanine residues (Ala). Due to the proposed 
role of His165 in AQP3 pH gating26, double mutants were also generated. Results 
showed no differences in membrane abundance were observed in cells incubated with 
different pH or osmolarity. Permeability of the AQP7 mutants was then further 
investigated under the same pH range as previously used for WT30. 
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Figure 5.5 Putative residues involved in hAQP7 pH regulation. (A) side and (B) top views of the refined 
homology model of human AQP7 in its tetrameric assembly, in cartoon representation of the tertiary 
structure, with ribbon representation of each monomer. Amino acid residues are shown in stick 
representation and backbone and hydrogens are hidden for clarity. Residues are coloured according to 
the corresponding monomer, as shown in B. Figure generated with MOE31. (C) Water permeability (Pf) 
and (D) glycerol permeability (PGly) measured at pH 5 to 7.5, of control cells and cells expressing 
hAQP7-WT and -mutants. (E) Magnitude of the change in water (Delta Pf) and in (F) glycerol (Delta 
PGly) permeability (from pH 7.4 to pH 5) due to point mutations. All permeability assays were performed 
at 23 ºC. Data (mean ± SEM, n=4 for each data set) were fitted according to the Hill equation. 
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Figure 5.6 A, Top extracellular and B, intracellular views of the homology model of human AQP7 in 
its tetrameric assembly in cartoon representation of the tertiary structure, with ribbon representation (in 
blue) and surface representation of residues lining the channel (grey). Relevant amino acid residues are 
shown in stick representation. In yellow the residues that are protonated at pH 5 in the intracellular side 
are shown. His140 residues in each monomer are protonated at pH 5 and shown in orange, while His165 
and Tyr135 are represented in magenta; all three residues were mutated for further studies. Figure 
generated with MOE.31 
 
Data shows that the water permeability of all mutants remains at least equal, and in 
some cases even slightly higher than WT above pH 7, thus indicating that the hAQP7 
mutants are functional water channels (Figure 5.5C and E). In regard to glycerol 
permeation; while the single H140A mutant displays similar behaviour to WT, all the 
other mutations show a notable reduction in glycerol permeability at pH 7.4 (Figure 
5.5D and F). The mutants H165A and H165A+H140A reduced glycerol maximal 
permeability at pH 7.4 to 44% that of the WT, inducing a shift in the pKa from 5.85 ± 
0.01 to 6.30 ± 0.02. Interestingly, the Y135A and Y135A+H165A mutations rendered 
the protein relatively inactive, reducing the maximal PGly to 10% of that observed for 
WT (Figure 5.5D and F). These data suggest a key involvement of Tyr135 and His165 
residues in the channel pore permeability, whilst His140 alone appears to have no 
contribution to pH-dependency. 
 
 
5.2.3 hAQP7 mutagenesis homology model analysis 
 
Following up on the in vitro results, showing the involvement of Tyr135 and His165 
in hAQP7 permeability, a detailed analysis of the WT MD trajectories was then 
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performed, but a clear role for these residues in pH-gating was not evident. However, 
careful analysis of the H-bond network during permeation at pH 7 shows how glycerol 
preferentially forms hydrogen bonds with residues featuring protonatable side chains 
(e.g. Lys63, Tyr64). Protonation of amino acid residues near the extracellular pore 
entrance (such as His165) at pH 5 may alter the H-bond network, and therefore affect 
the residues responsible for glycerol passage. Based on these considerations, we 
proposed that the contribution of His165 and Tyr135 to AQP7 pore permeability is 
based on a hydrogen bond network which dynamically readapts to variations in 
external acidification. To ascertain if our hypothesis was correct, new homology 
models for all the mutants were prepared. The models were generated based on the 
mutated sequences, refined and protonated at both pH 5 and pH 7, as previously 
performed for the WT model. Each model was then analysed for pore size (Figure 
5.3B).  
 
The largest size difference was found for the Y135A+H165A double mutant (Figure 
5.7A), which showed a decrease in pore size at the ar/R SF of approximately 1 Å in 
comparison to the WT. All the mutants showed a decrease in pore size in the ar/R SF 
region (Figure 5.3B), although not as marked (ca. 0.5 Å) as found in the double mutant. 
None of the mutants showed relevant changes in size around the NPA motif. A 
decrease in the size of the ar/R SF, the first selectivity filter encountered by solutes 
when permeating AQPs from the extracellular side, may contribute to the loss of 
permeability observed for the mutants. However, in the case of His140A, which also 
shows a slight decrease in ar/R SF, whilst having the same permeability of the WT. 
This implies pore size may not be the only factor affecting changes in AQP7 
permeability. In fact, Figure 5.4 and Table 5.1 show the studied mutants also appear 
to alter the pKa of water and glycerol conductance. The effect could be due to 
alterations in the electrostatic surface of the mutants and also induced by different pH 
conditions. The  electric fields within protein pores have previously been identified as 
barriers to solute passage.40 In order to investigate the effects of pH and mutations on 
the electrostatic surface of hAQP7, surfaces for each were generated using the 
Adaptive Poisson-Boltzmann Solver (APBS)41 plugin in Chimera42, and are shown in 
Figure 5.7B and 5.8. 
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The main observable difference we see is that the intracellular electrostatic surface of 
all the models appear to be much more negatively charged (shown in red colour) at 
pH 7 than at pH 5 (Figure 5.7B). At pH 7, the inner channel areas appear more 
positively charged in comparison to pH 5. Interestingly, the H140A mutant appears to 
be very similar to WT, both in surface electrostatic distribution at both pH values and 
in terms of protonation (Figure 5.8), which matches with the experimental findings. 
 
 
Figure 5.7 Pore size and protein surface electrostatic charges. A) – Pore size of human AQP7-WT and 
double mutant Y135A+H165A, analysed using HOLE34. Top channel surface represents the pore size 
of hAQP7 mutant Y135A+H165A (based on VDW radii): red = smaller than single H2O, green = single 
H2O, blue = larger than single H2O. Figure generated by HOLE34 and VMD35. B) Electrostatic surfaces 
of hAQP7-WT and mutant Y135A+H165A, at pH 5 and 7, with the following colour code: positively 
charged = blue, negatively charged = red, neutral = white. Top views of both intra and extracellular 
sides, with the pKa of each protein indicated in the figure. Surfaces were generated using the Adaptive 
Poisson-Boltzmann Solver (APBS)41 plugin in Chimera42. Monomers labelled A-D are shown in grey 
to indicate their position in each view. 
 
The most marked changes were observed for the H165A and Y135A single and double 
mutants, indicating to the crucial role of these two residues in pH gating and glycerol 
permeability. Analysis of protonation at both pH 5 and 7 reveals the mutations do not 
induce protonation changes in the intracellular residues Glu40 and Glu202. At pH 5, 
the protonatable intracellular site His92 is deprotonated in the H165A and 
H140A+H165A mutants, with the H140A mutant partially deprotonated. Protonation 
changes of this residue do not appear to have any affect the permeability at pH 5 for 
Chapter 5 
 
 86 
any of the mutants, implying that deprotonation of His92 is not involved in the 
permeation mechanism. Although none of the mutants shows protonation changes of 
intracellular residues at pH 7, we do see that the intracellular charge distribution is 
altered in Y135A, H165A and double mutants: the electrostatic surface of the channel 
appears to be more negative than WT. This observation supports the idea that changes 
to the extracellular residues may affect the overall electrostatic surface of the protein, 
including the intracellular surface. Therefore, changes in extracellular pH may also 
affect the intracellular charge distribution, possibly by altering the H-bond network of 
the protein and thus, influencing its permeability. 
 
It has also been shown that the pKa differences appear to be due to the alterations of 
electrostatic protein surface, induced by the mutations, which are able to alter the 
protein’s affinity for substrates. Mutating these residues does not appear to render the 
protein pH-insensitive. One possible scenario is that the protein rearranges its H-
bonding network based on the newly inserted residues and redistributes the 
electrostatic potential thus, changing its affinity for substrates, shifting the role of pH-
sensitivity to nearby residues. The effect of electrostatics on the transport modulation 
is quite typical of biological channels and has been previously observed for different 
porins.40 
 
Table 5.1 pH-dependency (pKa values) of water and glycerol permeation of human AQP7 (wild-type 
and mutated). Data presented as mean ± SEM (n=4). *p < 0.05 vs wild-type. 
 
 Water Glycerol 
 pKa pKa 
Wild-Type 5.89 ± 0.02 5.85 ± 0.01 
Y135A 6.06 ± 0.01 6.04 ± 0.01 
H140A 6.11 ± 0.02 5.91 ± 0.01 
H165A 6.65 ± 0.01* 6.30 ± 0.02* 
Y135A+H165A 6.58 ± 0.01* 6.21 ± 0.02* 
H140A+H165A 6.53 ± 0.01* 6.29 ± 0.01* 
Values were compared to AQP7 wild type. *, P<0.05 
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Figure 5.8 Electrostatic surfaces of hAQP7 WT and mutants, at pH 5 and 7. Protonation performed 
using PROPKA 3.1 package33. Surfaces were generated using the Adaptive Poisson-Boltzmann Solver 
(APBS)41 plugin in Chimera42. 
 
 
 
5.3 Conclusions 
Aquaglyceroporins play essential roles in energy metabolism and adipose tissue 
homeostasis which may have implications in obesity and metabolic-related 
complications, such as the metabolic syndrome. The main glycerol channel found to 
be expressed in human adipose tissues is AQP7, which has a fundamental role in 
glycerol release from adipocytes during lipolysis, in which triglycerides are 
hydrolysed to fatty acids. During fasting, intracellularly produced glycerol is 
transported by AQP7 into the bloodstream, where it is then taken up in the liver, via 
AQP9, where it can then be used for gluconeogenesis. Therefore, the fine-tuning of 
AQP7 efficiency for glycerol release from the adipose tissue and its subsequent uptake 
by the liver appears to be the rate-limiting step for the continuation of normal blood 
glucose levels. Previously AQP7 pH-sensitivity has been assessed, yet the molecular 
basis of pH-regulation has never been elucidated.  
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In this study we disclosed the mechanism of pH regulation of hAQP7 activity at a 
molecular level, showing how this channel can change from a fully active to almost 
inactive state when pH drops from 7.50 to 5.00. By using a combination of in vitro 
and in silico approaches we ascertained that residues Tyr135 and His165, which face 
into the extracellular environment, are central to channel permeability. We therefore, 
hypothesize that hAQP7’s lack of glycerol permeability, at pH 5, may be due to 
changes in the overall H-bond network which affects the affinity of the substrates for 
the channel rather than a truly open/closed pore mechanism of gating. Finally, due to 
the positions of key pH sensitive residues within the monomer-monomer interface, it 
is possible that the change in permeability is due to monomer-monomer cooperativity, 
as observed for other aquaporins.43,44  
 
 
5.4 Methodology Section 
 
The 3D structure of hAQP7 was obtained by homology modelling using Molecular 
Operating Environment (MOE 2012.10) (CCG 2012)31. The choice of a template 
structure was based on the sequence identity between hAQP7 and the sequence of the 
AQPs with available resolved structures from human, bacteria and Plasmodium 
falciparum (UniProt 2013 codes O14520, C8TK05 and Q8WPZ6, respectively). The 
isoform that has the highest sequence similarity (67%) with hAQP7 is the bacterial 
isoform Glycerol Facilitator (GlpF), which was then chosen as a template structure. 
Three resolved structures for bGlpF, crystalized both with or without glycerol and 
solved by X-Ray diffraction, were accessed through the Protein Data Bank45. The 
template was selected which had the best resolution (2.2 Å, pdb 1FX8). The biological 
assembly, containing the tetramer structure, was prepared using MOE and protonated 
at pH 7 under forcefield Amber12EHT. Thus, the tetrameric form of the human AQP7 
model was built: 50 intermediate models were generated and averaged to obtain the 
final homology model. 
 
The obtained model was checked for more realistic rotamers of side chains in the 
regions of ar/R SF and NPA, by comparison with the available crystal structures of 
the other available AQP isoforms (pdb codes 1H6I, 36D8, 3D9S, 1RC2, 1LD1 and 
Chapter 5 
 
 89 
3C02). The structure was protonated at pH 7 and an energy minimization refinement 
was performed, also under the Amber12EHT force field, during which the Cα atoms 
were fixed. After identification of the residues of interest for the mechanism of pH 
gating, the same energy minimization procedure was used to further refine them. The 
refined homology model of hAQP7 was protonated using the PROPKA 3.1 package33 
at pH 5.0 and 7.0. Electrostatic surfaces were generated using the Adaptive Poisson-
Boltzmann Solver (APBS)41 plugin in Chimera42. 
 
Two model systems, using the above-described homology model, were built using the 
PDB2PQR Server (version 2.0.0)33, protonated at pH 7 and pH 5. Each molecular 
system consisting of the protonated tetrameric models of the AQP7 embedded in a 
double layer of 175 palmitoyl-oleoyl-phosphatidyl-coline (POPC) lipid. This was 
achieved using the charm-gui online server46. Four glycerol molecules were placed 
into the system, one above each pore entrance on the extracellular side, at an 
approximate distance of 30 to 35 Å. To evaluate glycerol uptake, the system was 
solvated with 33151 (pH 7) and 33098 (pH 5) TIP3P water molecules and used a 
modified amber99sb-ildn forcefield, with the parameters for glycerol generated by the 
Automated Topology Builder and Repository (ATb, version 2.2) website using the 
B3LYP/6-31G* basis set47.  
 
All simulations were run using the GROMACS 5.1.2 simulation software48. Particle-
mesh Ewald method was used for calculating electrostatic interactions. The Verlet cut-
off scheme with a cut-off distance of 1.4 nm was used for short-range repulsive and 
attractive interactions and Lincs was used to constrain all bond lengths. Nose-Hoover 
temperature coupling was used to maintain the temperature of the system (т = 0.5 ps) 
at 310 K. The Parrinello-Rahman algorithm was used to maintain the pressure of the 
system at 1 bar with a coupling constant of т = 1.0 ps. Simulations were equilibrated 
for 100 ps before production. 
 
The four individual glycerol molecules were defined in the index and coupled in the 
pull code (e.g. gly_1 to chain_A). A total of 10 MD simulations (5 for the pH 7 system 
and 5 for the pH 5 system) were run using the direction COM pull procedure, in each 
case applying a separate yet equal harmonic restraint force to each glycerol molecule 
of 100 kJ mol-1nm2 with a rate of 0.02 nm ns-1 along the z-axis in the direction of the 
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intracellular space. Simulations were run for 250 000 steps or 500 ps, with a timestep 
of 2 fs. Each pore radius was calculated using the Hole 2.0 program34, which 
determines the internal surface based on atomic van der Waals radii. Snapshots were 
taken at 5 equal intervals throughout the trajectories, and coordinates for the centre of 
each pore (monomers A to D), at the ar/R SF, were used to generate the pore radius 
along the z-axis, for each simulation.  
 
To test water permeation six MD simulations were performed, three for pH 7 and three 
for pH 5. Simulations were run for 10 000 000 steps or 20 000 ps (20 ns), with a time-
step of 2 fs, using the same two model systems and parameters. In these runs, the pull 
code was omitted, therefore removing any biasing of the system. Water molecules 
were counted using a python script, based on a Tcl script for tracking water molecules 
within a simulation36. The script calculated each water molecule’s position, based on 
the oxygen atom, at each step and tracked its progress over the simulation time, 
registering each completed passage through the tetramer as well as its direction of 
movement. The upper and lower limits on the tetramer height were taken from the 
pore radius data calculated using the HOLE 2.0 program34. Visualization of the 
trajectories and Hole 2.0 pore surfaces and sizes was performed using VMD35. 
 
Glycerol movement across hAQP7 was monitored by analysing its trajectories for the 
whole duration of the simulations. For each simulation, glycerol molecules able to 
completely cross the hAQP7 channels were accounted for and all others excluded. The 
final data is represented as the mean ± SEM of total glycerol molecules crossing the 
aquaporin channels. 
 
The diffusion constant (Dw) data results for the molecular dynamics water flux 
calculations were expressed as mean ± SEM of n individual experiments. Statistical 
analysis between groups was performed by the unpaired Student’s t-test using the 
Prism software (GraphPad Software Inc., San Diego, CA). P values < 0.05 were 
considered statistically significant. 
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Chapter 6 - Unveiling the mechanisms of aquaglyceroporin-3 
glycerol permeation by metadynamics. 
 
Based on the paper:  
 
Darren Wragg, Andreia de Almeida, Angela Casini and Stefano Leoni. Chemistry – 
A European Journal, 2019, 25, 8713–8718. 
DOI: 10.1002/chem.201902121  
 
 
 
AQP7 homology model constructed by Dr Andrea de Almeida. 
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Abstract: Aquaporins are a family of membrane spanning proteins responsible for 
the water flux required by all cells. Aquaporin-3 (AQP3), a member of the sub-family 
aquaglyceroporins, is capable of conducting a number of uncharged solutes glycerol, 
H2O2 and urea, in addition to water. AQP3 has been found to be expressed in a number 
of cancer cell lines including lung, skin and breast cancer; therefore, it has been 
postulated that AQP3, and its substrate glycerol, may play a role in tumour growth and 
metastasis. The mechanisms of water and glycerol conductance via AQP3 are of great 
interest for the development of novel anticancer therapeutics. In this chapter, water 
and glycerol permeation via human AQP3 are described using advanced 
metadynamics approaches, which allow for both the exploration of the free energies 
involved in pore permeation, as well as describing the mechanisms of water and 
glycerol conductance at an atomistic level of detail. 
 
6.1 Introduction 
Biological membranes exquisitely control the uptake and efflux of a number of 
substrates in cells. Water permeation through cell membranes is one of the most 
essential cellular processes for all organisms; yet, little was known about this process 
until the first description of membrane water channels by Peter Agre and co-workers, 
in 19921 and named aquaporins (AQPs). Since then, AQPs have been found 
throughout nature and shown to be involved in numerous physiological processes. 
Furthermore, AQPs have become relevant drug targets for the treatment of a number 
of diseases,2,3 and new roles continue to emerge as the knowledgebase grows and more 
is known about their structure and selectivity towards certain substrates. Increased 
understanding of the underlying mechanisms of permeation via AQPs by water or 
other small molecules can contribute greatly to the understanding of the molecular 
mechanisms of certain diseases, especially those related to AQP over-expression and 
to the development of selective modulators capable of  acting as either chemical 
probes or as possible therapeutics2,3. 
 
AQPs fall into two subfamilies: the orthodox aquaporins which conduct exclusively 
water, and the aquaglyceroporins which conduct glycerol efficiently and generally 
have lower water conductance.4 The latter subfamily can also facilitate the transport 
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of a number of other uncharged solutes including urea and hydrogen peroxide 
(H2O2).5,6,7 In humans, 13 AQP isoforms (AQP0-AQP12) have been characterised, 
among which aquaporin-3 (AQP3) is known to allow the transportation of glycerol8, 
H2O25, ammonia9 and urea8,9. AQP3 is present in a number of tissues, such as kidney8, 
gut10 and in the respiratory tract11, and is also the most abundant aquaporin isoform in 
skin cells12. Additionally, it has been found to be expressed in various cancer types, 
including lung11, skin13 and breast cancer14. Therefore, it has been hypothesised that 
AQP3 and its substrates (glycerol and H2O2) may play a crucial role in tumour growth 
and proliferation3. 
 
Since the discovery of aquaporins, efforts have been made to characterize the 
selectivity mechanisms of the different AQP subfamilies and isoforms. Following the 
elucidation of the first three-dimensional structures of aquaporin-1 (AQP1)15,16, and 
of the bacterial glycerol facilitator GlpF17, a number of valuable computational studies 
have contributed important insights into the mechanistic dynamics and energetics of 
both water and glycerol conduction in AQPs18–20. These studies have confirmed and 
extended our knowledge of the sequence-based “hourglass” model21, which states; an 
AQP monomer features a pore formed by six transmembrane helices (1-6), connected 
by five loops (A through E) and two semi-helices meeting at the centre of the structure. 
Close to the extracellular side, the aromatic/arginine selectivity filter (ar/R SF), the 
narrowest point of the pore, is responsible for size-exclusion of molecules22. 
Underneath, the pore centre is defined by two highly conserved asparagine-proline-
alanine (NPA) motifs contained in the B and E loops and semi-helices responsible for 
exclusion of charged solutes through the formation of an electrostatic barrier.23 In this 
respect, a number of studies have established the important role of this electrostatic 
field generated by the protein matrix in determining AQP selectivity, especially in the 
case of proton exclusion, although dehydration penalty is also assumed to play an 
important role24–28. 
 
Since the first crystal structure15 and molecular dynamics (MD) simulations18 were 
obtained, water transport through AQPs has been understood to be a single-file 
mechanism. MD studies have helped elucidate the role of the selectivity filters and 
their effects on the permeation of water and other small uncharged solutes18,29. Size 
and shape of the pore constrain water orientation and determine the internal water-
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water interactions30. Further work has been undertaken to better understand the free 
energies involved in permeation events of a number of AQP isoforms31, providing 
insight at an atomistic level into the role played by the selectivity filters in water 
transport. Recent studies on carbon nanotubes as bio-mimic channel systems, 
identified an optimal pore size threshold for single-file water transport of 0.8 nm, 
which significantly affects transport rate and molecular translocation direction32. 
Whilst not as complex as AQPs, carbon nanotubes show the efficiency of single file 
water transport over bulk water flux upon molecular confinement. Recent biophysical 
studies suggest that unitary water channel conductance, pf , of AQPs depends 
exponentially on the number (NH) of available hydrogen bond donors and acceptors 
within the pore33. However, different AQPs, despite having the same NH, show 
markedly different pf, which could be explained by the dehydration penalty that water 
molecules face upon entering the single-file region of the pore33. The single file water 
permeability pf and the Gibbs activation energy barrier G‡t for facilitated water 
transport via AQPs are intrinsically linked, and factors other than hydrogen bonding 
may play a role, such as a positive surface charges at the channel mouth. 
 
Minimal information is available concerning glycerol permeation of human AQPs. An 
early equilibrium MD study of glycerol-saturated bacterial glycerol facilitator (GlpF) 
by Schulten and co-workers proposed a mechanism for glycerol conductance34. In 
2002, the same authors reported on steered-MD simulations of glycerol permeation 
through the same aquaporin isoform35, which revealed glycerol-channel hydrogen 
bonding interactions along with the stereoselective nature of the channel. In 2008, Hub 
& de Groot studied AQP1 and GlpF selectivity for O2, CO2, NH3, glycerol, urea, and 
water permeation using classical MD31. The main focus of the study was on the 
description of the key role played by the ar/R site, acting as a filter permeated only by 
small polar solutes31.  
 
In this context, the aim of the following work is to further investigate the mechanisms 
of glycerol permeation by the human AQP3 isoform at an atomistic level, which has, 
so far, never been addressed and to characterize the potential interplay between water 
and glycerol molecules during their conductance through the pore. Thus, the 
homology model of tetrameric hAQP3 was built as previously reported36–38, based on 
the crystal structure of GlpF17 (see methodology section for details).  
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6.2 Results and Discussion 
 
Initially, the work undertaken Hub & de Groot31 was used to establish a baseline for 
our studies on AQP3. Firstly, we calculated the potential of mean force (PMF) for the 
uptake of glycerol by steered-MD and umbrella sampling (see methodology, Figure 
6.1 and Table 6.1).  
 
 
Figure 6.1. A, AQP3 internal pore solvent exclusion surface, indicating the position of the amino acid 
residues that constitute the ar/R SF and NPA, with amino acids shown in black (ar/R SF) or gray (NPA) 
(figure generated using Chimera)3. Extracellular (EP) and cytoplasmic (CP) pockets are also 
highlighted. B, Free-energy of glycerol uptake (solid line) and efflux (dashed line), calculated using 
umbrella sampling. Averaged curve shown in red. 
 
 
Table 6.1. Average DG values for glycerol calculated by umbrella sampling. 
              DG (kJ/mol-1) 
 Glycerol 
Uptake 16 
Efflux 19 
 
 
The results show the same trends in the energy profile of glycerol conductance through 
the AQP3 pore, as those reported by Hub & de Groot31 for GlpF glycerol permeation, 
including similar free-energy DG values (16 kJ/mol-1 for AQP3 and 13.5 kJ/mol-1 for 
GlpF31). This small difference in DG values could be explained by the difference in 
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minimum pore size observed for AQP3 (2.6± 0.3 Å) and GlpF (3.175 ± 0.002 Å) 
(Figure 6.2).  
 
 
Figure 6.2: Pore size of hAQP3 and GlpF monomers. Representative surface of a monomer and 
respective pore diameter (Å) of (A) AQP3 and (B) GlpF. Pore surface based on van der Waals radii: 
Red = smaller than single H2O, green = single of monomer A. Pore size represented as an average of 
all monomers. EP –extracellular pocket, ar/R SF – aromatic/arginine selectivity filter, NPA - NPA 
motif, CP – cytoplasmic pocket. Figure generated by HOLE39 and VMD40.  
 
Whilst classical MD calculations provided the free-energy for glycerol permeation via 
AQP3 by collecting the relevant equilibrium configuration probability distributions, 
they provide no kinetic information of solute conductance, which is required for an 
unbiased mechanistic analysis over a physiologically significant timeframe. To 
achieve this, we used metadynamics to reconstruct the free-energy profile for the 
process of interest from multiple independent runs, each allowing for manifold 
glycerol and water permeation events via the AQP3 pores. Simulation lengths of 200 
ns, and the inclusion of 20 glycerol molecules in a single simulation run, provided 
enough time for conformational changes to be observed within the tetramer during 
water and frequent glycerol permeation through the pores. Metadynamics accelerates 
rare event occurrence along selected reaction coordinates, so-called collective 
variables (CV)41, and it has been recently successfully applied to calculate the free-
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energy surface (FES) for the interactions of organometallic drugs with DNA 
secondary structures42,43. To monitor and encourage both water and glycerol 
molecules to explore the free energy landscape involved in pore permeation, a CV was 
defined as the distance between centre-of-mass (COM) of the glycerol molecules and 
a plane defined by four significant atoms inside the channels (see methodology section 
for details). Therefore, a large variation of the CV corresponded to successful 
translocation events, from a which 2D FES could be obtained (integrated41)for each 
substrate under investigation. The FES highlights the energy expenditure during a 
permeation event, providing a highly detailed energy profile as the molecule crosses 
the pore (Figure 6.3), allowing the matching of local interactions to energy barriers 
involved in solute conductance. As there are no directional constraints on any of the 
solvent molecules and periodic boundary conditions (PBC) are applied in all 
directions, both uptake and efflux permeation can be observed independently.  
 
We obtained free-energy profiles for water and glycerol, for both uptake and efflux 
pathways, through each AQP3 pore. Figure 6.3 shows, despite the ar/R being the 
narrowest section of the pore, our simulations show the electrostatic NPA motif 
provides the highest energy barrier for permeation for both water and glycerol. Whilst 
the ar/R SF constitutes a region of steric hindrance, requiring a molecule to be below 
a certain size and in a particular orientation to be able to pass through, it appears to be 
relatively low in energy demand when compared to the NPA region (Figure 6.3). The 
latter is the area of the pore where the highest DG values are reached for both water 
and glycerol substrates, namely (DGNPA-water ≈ 26 kJ/mol-1 and  DGNPA-glycerol ≈ 40 
kJ/mol-1, respectively (Figure 6.3, Table 6.2). 
 
 
Table 6.2. Free energies DG (kJ/mol-1) for water and glycerol permeation through the NPA filter, for 
both uptake and efflux, calculated by metadynamics. Data shown as mean ± SEM. n = number of 
simulations. Data are calculated from the absolute DG of each successful permeation event and averaged. 
 
 DG (kJ/mol-1) 
 Water Glycerol 
Uptake 26 ± 5 (n = 7) 40 ± 4 (n = 8) 
Efflux 21 ± 5 (n = 14) 35 ± 10 (n = 10) 
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Figure 6.3. A, AQP3 internal pore solvent exclusion surface, indicating the position of the amino acid 
residues that constitute the ar/R SF and NPA, with amino acids shown in black (ar/R SF) or gray (NPA) 
(figure generated using Chimera)44. Extracellular (EP) and cytoplasmic (CP) pockets are also 
highlighted. Free energy of water (B) and glycerol (C) uptake (solid line) and efflux (dashed line). The 
data represents the averaged FES data from multiple successful permeation events calculated by 
metadynamics. 
 
The metadynamics trajectories confirm the established flipping motif of water passing 
though the NPA region of the pore, as observed in other AQPs15,36, and this helped 
validate the CV choice. In a total of 2.4 µs of combined simulation time, 30 water and 
28 glycerol molecules (out of possible 100 water and 140 glycerol molecules selected 
in the simulations) were observed to successfully pass through one of the four pores 
in either direction. However, in the absence of an osmotic gradient, and without 
directional bias, the number of permeation events was imbalanced between uptake and 
efflux, and more significantly so in the case of water: efflux events were 80% more 
successful for water and 60% for glycerol molecules.  
 
Free-energy profiles were obtained for water and glycerol, for both uptake and efflux 
pathways through the AQP3 pores. The mean DG energies for permeation were 
calculated for each solute molecule in each direction, for single crossing events only. 
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To remove any bias from multiple permeation events by the same molecule or where 
alternative paths were taken, the results for these molecules were excluded from the 
data. Table 6.2 summarizes the overall DG values obtained for water and glycerol 
permeation events of AQP3 (Figure 6.4). 
 
 The energy trend for water permeation indicates that the molecule has a lower free-
energy profile than glycerol (Table 6.2). Moreover, the free-energies of glycerol 
permeation in both directions are highly variable, especially efflux (Figure 6.4). This 
higher variability suggests that the water permeation mechanism has a better-defined 
pathway than glycerol and is therefore more dependent on the inner-pore interactions 
during permeation. 
 
 
Figure 6.4. Metadynamics calculated free energy surface data overlay of the 20 successful glycerol 
(left) and 21 successful water (right) uptake and efflux events. ar/R SF, NPA, extracellular (EP) and 
cytoplasmic (CP) pockets are highlighted in grey. The DG of each individual FES was used to calculate 
the average DG value shown in Table 6.2. 
 
In order to understand the molecular pathways, and to identify which amino acid 
interactions are common to both water and glycerol, the H-bond network for each 
successful permeation event calculated by metadynamics was analysed (Figures 6.5 
and 6.6). The H-bond residence time (RT) for each molecule with different amino 
acids within the pores was evaluated to map crucial or preferential sites, in either 
direction of permeation (Figure 6.5). 
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Figure 6.5. Hydrogen bond residence times for each successful permeation event of (A) water and (B) 
glycerol. Hydrogen bonding for GLPF (pdb 1FX8), PfAQP (pdb 3C02) and AQP1 (pdb 1J4N) with 
water or glycerol molecules is shown in purple. Colour coding: graded from white to dark green based 
on residence time in % of time of trajectory spent H-bonding (Simulation time was 200 ns). 
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Figure 6.6. Water (A) and glycerol (B), permeation routes and H-bond patterns and RT (%) from 
metadynamics calculations. Average H-bond RT (%) of glycerol during uptake and efflux (on a scale 
of 0-0.8%) shown in a gradient purple colour, with the strongest colour indicating the highest RT. 
Multiple glycerol and water molecules’ snapshots, taken from one representative simulation, are 
overlaid in one structure to create one single path. Amino acids that form crucial H-bonds are explicitly 
shown. Carbons are colour-mapped (white to purple) according to their corresponding RT (short to 
long). Green boxes represent the positions of water and glycerol molecules within the crystal structures 
of GlpF  (pdb1FX8) and PfAQP (pdb 3C02). Water and glycerol molecules are shown in ball and stick 
representation, with atoms coloured by atom type. Pore colour representation based on hydrophobicity 
of the pore surface, blue = hydrophilic, brown = hydrophobic. Figure generated with Discovery Studio 
Visualiser45. 
 
 
For water permeation; residence times of water molecules ca. 1.4 ns are observed 
inside the ar/R SF, where waters form H-bonds mostly with Tyr212, Ala219 and 
Arg218. Additionally, residence times within the NPA are on average shorter (ca. 0.9 
ns). In this region, water molecules interact with Asn83, Val214 and Asn215. In the 
extracellular pocket (EP), water appears not to bind to any specific residues and has 
an residence time of ca. 1.6, whereas, in the cytoplasmic pocket (CP), water hydrogen 
bonds mainly to three amino acids (Ala80, His81, Glu96) and the residence time can 
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increase up to ca. 2.2 ns (Figure 6.6A). Using the crystallographic structures of GlpF17 
(pdb 1FX8), PfAQP46 (pdb 3CO2) and AQP147 (pdb 1J4N) to pinpoint the positions 
of water molecules, allowed us to identify possible key H-bonding interactions (Figure 
6.6, green highlighted residues) and to match these to the corresponding amino acids 
in hAQP3. GlpF shows a H-bond with the Arg in the ar/R SF (Arg218 in AQP3), while 
PfAQP and AQP1 both show H-bonds to the highly conserved His located in the 
cytoplasmic pocket (His81 in hAQP3). Other H-bonding interactions are more specific 
to each particular isoform, due to the variation in the amino acid composition of the 
pores, therefore, there is no corresponding amino acid available for H-bonding in 
hAQP3.  
 
In the case of glycerol permeation, its size and increased number of available hydrogen 
bonding groups (3 -OH) directly affects its permeation time, thus, increased H-
bonding residence time was observed when compared to water (Figure 6.6). When 
looking at particular residues inside the pore, the longest residence time involving 
specific residues (ca. 2.3 ns) is observed for Asn83 and Asn215 within the NPA 
region, in both directions (Figure 6.6B). A longer residence time after forming H-
bonds with these residues implies a higher free energy barrier in the NPA area, as 
shown in Figure 6.3. Glycerol molecules appear to spend less time in H-bonding with 
the residues in the ar/R SF (ca. 0.9-1.5 ns), especially during uptake. Compared to 
water, there are less H-bond interactions seen for glycerol in the structures of GlpF 
and PfAQP. However, it is possible to identify H-bonds with Arg218, Asn215 and, 
for GlpF, His81 in the cytoplasmic pocket, which are all also observed in our 
simulations. 
 
Further analysis shows that the amino acids involved in both glycerol and water H-
bonding are similar, in particular residues in the ar/R SF (Tyr212, Ala213, Arg218) 
and in the NPA (Asn83, Asn215), along with residues in the cytoplasmic pocket 
(His81, Glu191) (Figure 6.6). For both molecules, the residence time in each H-bond 
is lower for extracellular pocket than for cytoplasmic pocket (cumulative RT for water; 
EP = ca.1.6 ns, CP = ca. 2.2 and cumulative RT for glycerol; EP = ca.2.9 ns, CP = 
ca.4.7 ns), as can be observed in Figure 6.6. The fact that the extracellular pocket is 
funnel-shaped (see Figure 6.2) having highly flexible loops, narrowing as it 
approaches the ar/R SF, leads the substrate molecules to spend more time probing the 
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surface, and thus, spending less time overall interacting with each of the amino acid 
residues. On the other hand, the cytoplasmic pocket is more cylindrically shaped, and 
over the majority of its length showing a diameter of ca. 4.5 Å, starting from the NPA 
region, only broadening in diameter at the very end (Figure 6.2). Confinement below 
the NPA will lead to increased and more specific interactions of the molecules during 
permeation, causing both water and glycerol to spend a considerable amount of time 
in H-bonding with cytoplasmic pocket residues.  
 
As observed in the X-ray structures of GlpF and PfAQP, in our simulations, glycerol 
molecules permeate the pore as part of a single-file water chain, i.e. there is no direct 
glycerol-glycerol contact, which would compete with or replace the water-based 
transport mechanism. This leads to a scenario in which glycerol switches H-bonding 
back and forth between water molecules within the pore and pore surface residues 
during permeation. Figure 6.7 illustrates how glycerol alternates H-bonding between 
the water chain and residues lining the pore surface during both uptake and efflux. 
When the H-bonding evolution is compared to the FES (Figures 6.3 and 6.4), a clear 
correlation can be seen between residence time and character of the H-bonding along 
with characteristic motifs in the free energy surfaces. The longer the glycerol spends 
in H-bonding to the protein and not interacting with water correlates to a higher the 
free energy peak. This result highlights the intrinsic nature of the role of a continuous 
flow of water molecules, into which glycerol is inserted as solute, in both its uptake 
and efflux conductance though the pore. The process explains the variations we 
observe in the FES (Figure 6.4) of glycerol permeation; as they are a result of the 
interplay between solvated glycerol and variable local water configurations and 
glycerol orientation. The latter comprises of molecular rotations and (in selected 
trajectories) competition among glycerol molecules in the vestibule regions, which are 
responsible for sensible deviations in the free energy profiles. 
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Figure 6.7. Hydrogen bond switching of glycerol with pore residues (red) and water (blue) during (A) 
uptake and (B) efflux permeation events 
 
Analysis of the metadynamics simulations show, in the absence of osmotic pressure, 
water is able to traverse the pore in both directions simultaneously, rather than in a 
single direction at a time, by ‘leap-frogging’ over each other in the wider region of the 
pore below the ar/R SF. This means that efflux or uptake results from small 
perturbations in this base mechanism and does not require a complete inversion in the 
direction of water flux. Figure 6.8 shows water molecules inside the pore at the 
beginning of the simulation were free to move in either direction, without file 
disruptions (Figures 6.8A, B). To this end, water implements a “hopping mechanism”, 
in which single water molecules are able to switch with the molecules in either side, 
in either direction, along the single file chain. We propose that this process offers, if 
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not an active regulatory mechanism, at least a structure capable of rapidly responding 
to environmental changes, as both transport directions are active simultaneously.  
 
We observe that this bidirectional water flux is disrupted as a consequence of glycerol 
solute molecules entering the pore, inserting into the water chain in the direction of 
permeation (Figure 6.8C, D). Glycerol insertion prevents water crossing in the 
opposite direction due to its increased size. As soon as glycerol has traversed the pore 
back into bulk water, the leap-frog mechanism within the water chain re-establishes 
itself by filling the pore as the glycerol passes through (Figure 6.8E), i.e. without voids 
or latencies in the basal water transport mechanism.  
 
As previously reported for glycerol conductance of GlpF35, the small reduction in 
energy seen in the FES of glycerol at the extracellular and cytoplasmic vestibules 
(Figure 6.3) aids glycerol conductance via AQP3, increasing the probability of 
glycerol joining the single file water transport mechanism.  
 
 
Figure 6.8. Sequence of snapshots showing how the passage of glycerol through the AQP3 pore 
disrupts the ‘leapfrogging’ water chain. (A) At the start, water molecules are coloured based on 
position: purple – located inside the pore, pink - located in the cytoplasmic pocket (CP), green – located 
in the extracellular pocket (EP). (B) Water molecules start moving from the CP into the channel, 
replacing the purple molecules. (C) A glycerol molecule enters the ar/R region from the EP, yellow – 
waters occupying the pore, originating from both EP and IP. (D) Glycerol passes through the NPA 
region, forcing the waters out of the channel into the CP area, with new water molecules (blue) 
following on and populating the channel area. (E) The chain of water molecules is re-established as 
glycerol leaves the pore and the pore is re-populated by single-file water molecules from EP. 
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6.3 Conclusion 
 
The mechanisms of water and glycerol conductance via human AQP3 was 
investigated using the advanced molecular dynamics approach, metadynamics, where 
each substrate molecule is encouraged to explore the entirety of the simulation model 
and find the appropriate conformation to pass through the tetramer in either direction. 
Over a number of independent simulations, a full mechanistic picture and the 
underlying free energy could be reliably collected for both water and glycerol. Single-
file water permeation via AQP3 appears always to be bi-directional at equilibrium 
conditions, whilst still maintaining a continuous transport flux when compared to bulk 
water. Moreover, glycerol permeation appears to critically depend on this single file 
water flux, with transport resulting from bond switches within a dynamic hydrogen 
bond scaffold created by the interplay of glycerol, water and pore amino acid residues. 
This reveals a novel scenario, in which solute molecules exploit an existing 
bidirectional water conduction mechanism in AQP3. Free energy results also suggest 
a binding affinity between key residues and solute molecules, on the exterior pore 
surface, facilitating solute transport. Further studies will be necessary to optimize the 
metadynamics approach to elucidates the transport mechanisms of glycerol transport 
in non-equilibrium conditions, i.e. mimicking a situation of osmotic imbalance. 
 
 
6.4 Methodology section 
 
Human AQP3 homology model 
The 3D structure of hAQP3 was obtained by homology modelling using the Molecular 
Operating Environment (MOE 2013.08)48. The choice of a template structure was 
based on the sequence identity between hAQP3 and the sequence of the AQPs with 
available resolved structures. The isoform showing the highest sequence similarity 
with hAQP3 is the bacterial isoform GlpF, with 34.68% of sequence identity, which 
was then chosen as a template structure to generate a homology model of hAQP3. The 
template was selected among the structures with the best resolution (2.2 Å, pdb 
1FX8)49 The homology model was prepared and refined as described in36–38. 
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In-silico simulations 
Two different molecular dynamics free-energy methods were chosen to study the 
mechanism of permeation for glycerol and water: umbrella sampling (US), using a 
pull code to provide a trajectory along a given reaction coordinate, and metadynamics. 
The pull code uses a harmonic restraint attached to the centre of mass (COM) of the 
glycerol, on which a directional force is applied, encouraging the molecule to move in 
the desired direction through the aquaporin pores. 
 
Each simulation box contained the AQP3 tetramer homology model inserted into a 
lipid bilayer, made up of 166 POPC lipids (carried out using the charm GUI online 
server50,51). Each system was solvated with TIP3P water molecules, with the number 
added being dependent on the system. For the US, ca. 52000 water molecules were 
added while for the metadynamics simulations the number of water molecules was ca. 
33000. This was due to the difference in box size10x10x20 nm for US and 10x10x15 
nm for metadynamics). A longer box is required for US due to the use of a pull code 
and the starting and end positions of the glycerol molecules. The metadynamics 
simulations do not have this requirement, resulting in a 25% shorter box edge, 
additionally allowing a significant reduction of the simulation calculation time. 
Periodic boundary conditions (PBC) were used for each system.   
 
Four Na+ ions were substituted for corresponding water molecules to neutralise the 
charges of each system. The amber99sb-ildn+slipid force field was used for all the 
simulations, with the parameters for glycerol generated by the Automated Topology 
Builder and Repository (ATb, version 2.2) website using the B3LYP/6-31G* basis set 
11, using a combination of semi-empirical quantum mechanics (QM) and density 
functional theory (DFT). 
 
All simulations were run using the GROMACS 2016.3 software12. Particle-mesh 
Ewald method was used for calculating long-range electrostatic interactions, the 
Verlet cut-off scheme with a cut-off distance of 0.7 nm was used for short range 
repulsive and attractive interactions and Lincs was used to constrain all bond lengths. 
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Nose-Hoover13 temperature coupling was used to maintain the temperature of the 
system (т = 0.5 ps) at 300 K. The Parrinello-Rahman14 algorithm was used to maintain 
the pressure of the system at 1 bar with a coupling constant of т = 1.0 ps. Simulations 
were equilibrated for 100 ps before production. Total energy of the system was 
monitored using gmx_energy program within Gromacs until total energy changes 
were less than 0.4% over 75 ps (figure 6.9).  
 
Figure 6.9. Total energy during 100 ps equilibration step for AQP3 with glycerol. 
 
 
Umbrella sampling 
Four individual glycerol molecules were defined in the index and coupled to a 
monomer in the pull code (e.g. gly_1 to chain_A). Each simulation was run for 0.5 ns, 
using the direction COM pull procedure, in each case applying a separate yet equal 
harmonic restraint force to each solute molecule of 600 kJ mol-1 nm2 with a rate of 
0.02 nm ns-1 along the z-axis. Simulations were carried out with the starting positions 
of the four glycerol molecules either on the extracellular or intracellular sides of the 
aquaporin tetramer, run separately in order to simulate both uptake and efflux. 
 
The pull code provides a quick but not physiologically relevant pathway over a short 
time scale of 500 ps, which is too fast for sidechain movement and therefore provides 
a less accurate mechanism of permeation. Based on this initial trajectory, umbrella 
sampling (US) was run to map the free energy on a physiologically relevant time scale 
(500 windows, 250000 steps, 2 fs time scale: 62.5 ns simulation). Two different US 
runs were performed, based on different efflux and uptake COM pull reaction 
coordinates (RC). 
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From each trajectory, US was carried out on one glycerol molecule in each direction. 
Each trajectory was split into 500 sampling windows with each window undergoing a 
further 500 ps simulation, with the glycerol molecule restrained within each window 
of configurational space. The potential of mean force (PMF) for each was analysed 
using the weighted histogram analysis method (WHAM) (Figure 6.1). 
 
 
Metadynamics simulations. 
Well-tempered metadynamics simulations were run for 200,000,000 steps with a 1 fs 
time-step (200ns) using the Plumed plugin15 for Gromacs. The distance collective 
variable (CV) was used between the COM of glycerol/water molecules and a plane 
formed by the backbone carbons of Asparagine 215 from each of the four monomers. 
This provided a reference plane in the centre of the system, equating to the top of the 
NPA motif. Each of the 20 glycerol/water molecules were given a separate plumed 
control within the same data file, allowing the free-energy for each molecule to be 
calculated within the same simulation.  Gaussians were added every 2000 steps (2ps), 
giving a deposition rate of 0.025 kJ/mol.ps. Gaussian height was 50 TAU (TAU sets 
the height of the Gaussian equal to kBDT x pace x timestep/TAU)  and the Gaussian 
width was 0.025 Å. The bias factor was set to 12, DT was 3600 K. 
 
Free energy surface data (Fig 10) were normalised by setting the baseline to 0 and 
excluding bulk water on either side of the pore to show more clearly the data for each 
permeation event (Fig 4). The individual FES plots for water and glycerol molecules 
are shown in Fig 4 and the average FES shown in Figure 6.3 are taken from the 
trajectories in which a water/glycerol molecule passed through a pore, in either 
direction, once during the simulation. Data for water/glycerol molecules re-crossing 
the pore or passing through the lipid membrane were not included. This resulted into 
21 FES for water (7 for uptake and 14 for efflux) and 20 FES for glycerol (9 for uptake 
and 11 for efflux), which were used for calculating DG values. 
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Figure 6.10. Free energy surface data for glycerol and uptake calculated via metadynamics. 
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Chapter 7 - G-quadruplex DNA and molecular dynamics 
 
7.1 G-quadruplex structure 
 
G-quadruplexes (G4s) are secondary DNA structures containing a high proportion of 
guanine bases. The high stability of G4s has been known since their discovery by 
Gellert, Lipsett and Davis in 19621, and has been attributed to the strong hydrogen 
bond network formed by the assembly of these guanine-rich sequences into planar 
layers consisting of four guanine units, known as G4-tetrads, bound via Hoogsteen 
hydrogen bonds. The G4s are further stabilized by p-p interactions between tetrads 
and by the presence of monovalent cations (e.g. K+ and Na+)2 (Figure 7.1). 
 
In fact, the cavity formed in the centre of each tetrad, first thought to be capable of 
accommodating water molecules1, contains a metal cation, coordinated to the O6 of 
each of the four guanines, which further stabilises the structure. Repeating tetrad 
sequences are then stacked together to form the G4 unit3. The folding of G4s can lead 
to a multitude of different conformations which can be categorized using the 
orientation of the strand folding topologies as antiparallel, parallel and hybrid4 (Figure 
7.2), indicating the strand direction from the 5’ to 3’ end of the sequence. Folding 
conformations can be dependent on the sequence and environment, such as the cation 
type and concentration5. 
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Figure 7.1 Single G-tetrad showing Hoogsteen-type hydrogen bonds and coordinated K+ cation (shown 
in purple). 
 
 
Figure 7.2 Representation of G4-DNA folding topologies from 5’ to 3’. a, Antiparallel. b, Parallel. c, 
Hybrid (taken from Neidle 2017)4. 
 
 
7.2 G-quadruplex DNA and cancer 
 
G-quadruplexes are present in both telomeres and promotor regions of oncogenes6 and 
are known to be involved in a number of biological processes, such as telomere 
maintenance and replication as well as oncogene regulation4,7 and have therefore, 
become an important target for cancer therapy8.  
 
A number of factors account for the variety in G-quadruplex structures observed. Base 
sequence order, solution conditions; such as intracellular concentration of K+ and Na+9 
or whether the G4 stack is formed from a single (intramolecular) or multiple (up to 
four) individual guanine rich strands9 all have an effect on the overall topology. These 
factors in conjunction with parallel, antiparallel or hybrid topologies10 (Figure 7.2) can 
lead to the exposure of multiple tetrad faces. In the case of Tel 2311 (pdb ID 5CCW)  
both the upper and lower tetrads are exposed. Alternately, in the case of hTelo12 (pdb 
ID 2HY9), and C-KIT113 (pdb ID 4WO2) (Figure 7.3), only the upper tetrad is 
exposed. Also, due to the extended loop observed on hTelo access to the upper tetrad 
is hindered. 
 
Telomeric DNA is found at the 3’ end of the chromosome with the final 100-200 bases 
forming a single strand4. With each replication cycle, telomere length is reduced until 
it reaches a finite limit, whereby, senescence and apoptosis are induced14. The main 
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focus of therapeutic telomer G4 stabilisation is indirect targeting of the reverse-
transcriptase enzyme telomerase.  
 
The promoter regions are found at the 5’ end of the DNA sequences, and also within 
the sequence at sites of nuclease hypersensitivity between the gene coding 
sequences15. These areas above the transcription starting point of the gene sequence 
are able to dissociate from the double strand folding and act as binding sites for 
transcription factors such as polymerase, and also give them the flexibility to form G4 
units. As a number of different gene sequences will be present on each chromosome, 
there will be a number of these promoter binding sites along the strand, providing 
many potential sites for G4 folding16 and potentially gene-specific repression through  
the selective targeting of G4 units.15 
 
 
Figure 7.3 Crystal structures of two G-quadruplex models: A, hTelo (pdb ID 2HY9), a telomeric G4. 
B, C-KIT1(pdb ID 4WO2), a proto-oncogene promoter G4. 
 
Most cancer types overexpress the reverse-transcriptase enzyme telomerase4. This 
enzyme is involved in the initiation of tumorigenesis and catalyses the addition to the 
3’ end of the chromosome TTAGGG repeats, thus, maintaining the telomer length and 
preventing apoptosis of the cancer cell. The addition of these guanine-rich repeats 
increases the likelihood of telomers folding into tandem G4 units17 with the addition 
of just four TTAGGG repeats needed to form a stable G4 structure18. Telomeric G4s 
have been shown to inhibit telomerase’s ability to interact with the telomer18 
To allow replication and tumorigenesis to occur, the chromosomes need to be in the 
single strand state. By introducing small molecules with the high binding affinity and 
the ability to stabilise the folding of G4s structures, and stabilise these structures, it is 
A B 
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possible to indirectly inhibit these processes within cancer cells and therefore reduce 
both transcription and telomeric lengthening. Stabilisation is induced through p-p and 
p-alkyl stacking interactions between the aromatic compounds and the guanine 
residues forming the tetrad surface. Through stabilisation of the G4 structure, 
unfolding of the sequence is prevented, therefore replication of the chromosome 
cannot be achieved. The increased occurrence of G4 DNA structures has been shown 
to be a hallmark of cancer8 and thus, provides a highly viable therapeutic target.  
 
 
7.3 G-quadruplex stabilizers 
 
A number of both organic and metal-based compounds have been developed with the 
ability to stabilise G-quadruplex DNA structures and show no affinity for duplex 
DNA. These molecules include key structural features that are essential to their 
binding selectivity: i) a heteroaromatic moiety capable of p-p stacking interactions 
with the planar G4 tetrad; ii) side-chains to increase binding affinity via van der Waals, 
electrostatic and H-bond interactions and cationic charge capable of delocalising the 
p electrons around the  aromatic moiety, this positive charge also has an effect on 
increasing the affinity of the compounds for the negatively charged DNA backbone19 
iii) in the case of metal-based compounds, a central metal ion mimics the cation at the 
centre of each tetrad, helping facilitate interactions via a continuation of the cation 
chain19. 
 
The stabilising effect of new molecules can be quantified by different methods, 
including DNA melting-temperature assays20. This technique calculates the difference 
in melting temperature (DTm) of the G4 structure with and without the ligands to 
estimate the extent of G4’s stabilisation. A greater DTm value obtained indicates that 
the selected compound has greater stabilising effect on the G4 structure. This 
experiment can also be run in the presence of excess duplex DNA to evaluate the 
selectivity of the G4 interactions. 
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Examples of organic G4 stabilisers include RHPS421, BRACO-1922 and berberine14 
(Figure 7.4), all of which have shown anticancer activity. Whilst berberine, originally 
an antibiotic derived from Chinese herbal medicine23, has undergone clinical trials as 
a glucose regulator24, none have yet reached clinical trials as G4 stabilisers.  Of note, 
BRACO-19 has been shown to induce DNA damage, as well as stabilising telomeric 
G4 structures, inducing uncapping of the telomer and breakdown of the telomeric T-
loop strucure25.  
The ability of potential G4 stabilisers to differentiate between G4 and duplex DNA 
and interact exclusively with G4s is essential to avoid side-effects and toxicity. For 
example, the acridinium derivative RHPS4 (Figure 7.4) which, whilst showing 
promising in vivo anticancer activity in a number of animal models, also had off-target 
toxicity with b2 adrenergic and hERG receptors26. 
 
 
 
Figure 7.4 Examples of organic G4 stabilisers. 
 
The majority of G4 inhibitors in development are organic ligands. However, with the 
known pharmacological activity of metal-based compounds such as cisplatin and its 
derivatives carboplatin27 and oxaliplatin28, the development of next generation 
anticancer drugs can take advantage of the chemically diverse scaffolds afforded by 
different families of organometallic and metal coordination complexes29,30. Thus, a 
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number of metal-based compounds have been identified as G4 stabilisers, including 
the Ni(II) tri-ethylpiperidine complex N,N0-bis[4-[[1-(2-
ethyl)piperidine]oxy]salicyli-dene]-4-(2-(piperidin-1-yl)ethoxy)-1,2-
phenylenediamine-Ni(II)31 (Figure 7.5). Using the same ligand scaffold, copper, 
platinum and vanadium compounds were also synthesized to investigate the effects of 
the different metal ions on the G4 stabilization properties31. Whilst the nickel 
derivative proved to have the greater affinity for hTelo G4 with a DTm of 26.8±1.5 
°C31, it was also shown to be less selective than the vanadium complex31in competition 
experiments with circulating tumour DNA (ct-DNA). Whilst the copper and platinum 
derivatives also showed excellent affinity with the hTelo G4, with DTm values of of 
22.9±1.5 °C and 25.4±1.5 °C respectively, the study did not perform the competition 
experiments to ascertain selectivity for these compounds31. 
 
 
Figure 7.5 Examples of Ni(II)-based G4 stabilisers. 
 
The possibility to add functionalities to the ligand system make these coordination 
compounds ideal scaffolds for developing highly specific G4 stabilising ligands. 
Nickel(II) Schiff base complexes have also shown high biding affinity with telomeric 
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G4 structures over duplex DNA in competition experiments30, further demonstrating 
the value of metal based complexes as selective inhibitors. In the case of the Salen-
like derived Ni(II) compound 5-(triethylammoniummethyl)salicylaldehyde chloride 
(Figure 7.5), whilst it showed an selectivity for G-quadruplex DNA over duplex-DNA 
in competition experiments30.  
 
Among the organometallic complexes, featuring a direct metal-carbon bond, the 
gold(I) bis-carbene [Au(9-methylcaffein-8-ylidene)2]+ (AuTMX2, Figure 7.6) has also 
been shown to bind preferentially to G4s vs duplex DNA, as well as to possess 
anticancer properties against human ovarian cancer cell lines32. 
 
Figure 7.6 [Au(9-methylcaffein-8-ylidene)2]+ (AuTMX2), an example of an organometallic G4 
stabiliser. 
 
In this case, the structure of the adduct of AuTMX2 with the Tel 23 G4 has been solved 
by X-ray crystallography (Figure 7.7) 11. The crystal structure shows that three 
individual AuTMX2  are able to interact with the G4 at two distinct sites on both the 
top and bottom exposed tetrad surfaces. Moreover, this leads to the stacking of 
multiple G4 units with AuTMX2 at the interface of both the upper and lower surfaces 
of adjacent G4s molecules. 
 
Figure 7.7 AuTMX2 binding positions with Tel 23 (pdb ID 5CCW). A, 3’-3’ end binding site showing 
the position of a single AuTMX2 adduct (carbons shown in orange). B, Overall crystal structure of Tel 
23 with six AuTMX2 adducts. C, 5’-5’ end binding site showing the positions of two AuTMX2 adducts 
(carbons coloured green and pink). Dashed lines indicate interplanar distance of ca 3.4 A11. 
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7.4 Molecular dynamics simulations of G-quadruplex DNA 
 
G-quadruplex structures make up less than 2% of the DNA structures registered in the 
Protein Data Bank, with the majority of these being registered in the last 8 years 
(145/241 registered since 2010) showing G4s as an up and coming area of research.  
A number of molecular dynamics studies have been carried out with various G4 
models to enhance our knowledge of their dynamic nature. 
 
The majority of MD simulations concentrate on telomeric G4s14,30,33 rather than 
promotor region G4s, providing and insight into the dynamics of G4-ligand 
integrations and lowest energy conformations through the use free energy 
calculations33. These findings indicate an optimal distance and orientation of the 
stabilising ligand with respect to the tetrad surface.  
 
Studies on the affinity of Schiff base complexes with a telomeric G4 model shows the 
potential for metal-based complexes as therapeutics30. Unbiased simulations of Ni(II) 
Schiff base complex (Figure 7.5) show how the complex ‘docks’ with the telomeric 
G4 (hTelo (pdb ID 2HY9) models upper exposed tetrad due to the electrostatic 
attractions between the positively charged ligand and the negativity charged phosphate 
groups of the G4. Further p - p interactions were observed between the complex and 
guanines 6, 10, 14 and 22 of the upper tetrad as the complex positions itself with the 
nickel ion approximately in line with the central potassium ion (Figure 7.8).  
 
 
 
Figure 7.8 Ni(II) Schiff base ‘docking’ with hTelo (pdb ID 2HY9). A, Side view showing the 
complexes optimal distance above the upper tetrad. B, Top view showing alignment of the nickel ion 
centre with the central potassium ion of the tetrad30. 
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Whilst these calculations allow the positioning of the ligand with respect to G-
quadruplexes, they are unable to provide quantitative data on the binding affinities. 
The development and implementation of in silico methods suitable for calculating the 
binding affinities of small molecules with biological systems allows for greater 
comparison with experimental data. 
 
One such method is metadynamics and its variants. The free energy of binding for 
organic ligands using funnel metadynamics14 shows that state of the art in silico 
techniques can provide results matching those of experimental and provide a greater 
insight into the mechanistic details of ligand-G4 interactions. The binding mechanism 
of berberine with the human telomeric G4-DNA model (pdb ID 3R6R) was 
investigated with this method allowing direct comparison with experimental results14. 
 
The use of metadynamics allows the sampling and calculation of the free energy 
landscape of the system. The binding free energy of berberine with the telomeric G4 
model was calculated using variant of metadynamics called funnel- metadynamics. In 
this case a funnel shaped potential is applied to the 3’-end of the G4-DNA complex to 
prevent the berberine ligand visiting areas of the system outside of the funnel (Figure 
7.9). This increases the number of data points associated with the binding and 
unbinding mechanism without affecting the sampling data.  The results show the 
positioning and orientation of the berberine with respect to the outer tetrad surface and 
the favourable p - p interactions between the complex and guanines 4 and 10 of the 
G4-DNA model as well as the stabilising salt bridge between the N+ and the phosphate 
of the DNA backbone.  
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Figure 7.9 The funnel shaped potential restraint used my Moraca et al14. The angle a is 0.75 rad, 
distance zcc is 16Å and Rcyl is 1Å. 
 
These interactions can be seen as energy basins in the calculated free energy surface 
based on the collective variables (CV), in this case the distance between berberine and 
the tetrad and the angle formed between the two were chosen as the CVs. The data 
calculated for the binding affinity and position of berberine with the G4-DNA model 
match those found experimentally from X-ray crystallography and steady state 
fluorescence titration experiments whilst revealing the mechanism at an atomistic 
level and providing validation of the computational techniques used.  
 
Overall, the above-mentioned examples provide trajectories of a relevant timescale for 
the interactions under investigation. Whilst both rely on the accuracy of the force field 
parameters to provide relevant data, by working in parallel with experimental 
techniques this accuracy can be constantly assessed to ensure such accuracy.   
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Abstract: G-quadruplexes (G4s) are four-stranded DNA structures that are over-
represented in gene promoter regions and are viewed as emerging therapeutic targets 
in oncology. The binding modes and free-energy landscape of two Au(I) N-
heterocyclic carbene complexes interacting with G4s, namely a human telomeric 
(hTelo) and a promoter (C-KIT1) sequence, are studied here for the first time using 
metadynamics. The theoretical results are validated by FRET DNA melting assays and 
provide an accurate estimate of the absolute gold complex/DNA binding free energy. 
This advanced in silico approach is valuable to achieve rational drug design of 
selective G4s binders.  
 
 
8.1 Introduction 
 
DNA is able to adopt different structures other than the canonical right-handed double 
helix (B-DNA), and numerous structural studies have shown that guanine-rich DNA 
sequences can form secondary structures termed G-quadruplexes (G4s)1. To form 
G4s, four guanine bases assemble into a pseudoplanar tetrad (G-quartet) which is held 
together by one or more nucleotide strands and stabilized by metal ions. Recent 
bioinformatics studies have shown that there are ca. 716,000 DNA sequences in the 
human genome with the potential to form G4 structures2. These sequences are present 
in telomeres and promoter regions of oncogenes, such as C-MYC and C-KIT1. These 
non-canonical DNA structures have been the subject of intense study over the past 10 
years due to their association with a number of biological processes such as telomere 
maintenance, gene regulation, and replication3,4. 
 
It has been suggested that formation of the quadruplex structure in promoter regions 
can control transcription and, as a consequence, the expression of the corresponding 
oncogenes.5 Furthermore, stabilizing G4s in telomeres results in indirectly inhibiting 
telomerase activity,  affecting cancer mortality.4 
 
In this context, G4s emerge as promising targets for anticancer drug development, 
while their roles in cancer biology have yet to be completely elucidated. A number of 
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studies report on the stabilization of G4s by small molecules with associated 
anticancer effects6. One example is the tri-substituted acridine derivative, BRACO-
19, a telomeric G4 stabilizer, which has shown in vitro anticancer activity in prostate 
cancer.7 Of note are two quinolone molecules, CX-3543 and CX-5461, selectively 
stabilize G4s structures, and have now entered clinical trials8. 
 
In addition to organic molecules, the development of metal-based compounds have 
also shown to be promising experimental G4 stabilizers, including several Schiff-base 
metal complexes (mainly Ni2+9–14, Cu2+11–13, Zn2+9,11,15, Pt2+16, and Pt4+16, as well as 
some metallo-supramolecular DNA-binders17–19. Despite the great advances in the 
development of G4 stabilizers, important challenges still remain. For example, highly 
selective binding of small molecules to specific quadruplex structures over duplex 
DNA and other G4s, is a major issue which needs to be addressed if this approach is 
to make it into the next generation of anticancer drugs.  
 
 
8.2 Results and discussion 
 
Our pioneering work into G4 stabilizers identified small-molecule organometallic 
Au(I) compounds, featuring N-heterocyclic carbenes (NHCs) ligands, as potent, 
selective stabilizers of telomeric G4s.20–22 Thus, we recently reported on a bis-NHC 
gold(I) complex - [Au(9-methylcaffein-8-ylidene)2]+ (AuTMX2, Figure 8.1) - 
containing the natural product caffeine as NHC ligand20. The compound was shown 
to have selective antiproliferative effects on human ovarian cancer cells over non-
tumorigenic ones. X-ray diffraction analysis of the adduct formed by AuTMX2 and 
Tel23, a 23-nucleotide telomere repeat sequence, indicated that the compound binds 
non-covalently between neighbouring G4 units21.  
 
Based on this promising work, our research involves developing new organometallic 
Au(I) NHC complexes capable of targeting specific G4 structures for possible in 
therapeutic and/or imaging applications. In order to rationally achieve the required 
selectivity, in silico methods, including molecular dynamics (MD) approaches, are 
highly valuable as they can elucidate both the structural and energetics underlying the 
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ligand/target recognition process. In fact, a number of classical MD studies on the 
adducts of G4s structures with a number of different stabilizers have been performed 
providing atomistic support for the interpretation of the binding mechanism to G4-
DNA9,11,15,23,24. 
 
Funnel-metadynamics has recently been shown to be successful method for 
calculating the free energy surface of organic ligands and their interactions with G4s25. 
Thus, we applied metadynamics to evaluate the binding of AuTMX2 to two different 
G-quadruplex structures, the human telomeric sequence hTelo (pdb 2HY926) and the 
C-KIT1 oncogene promoter sequence (pdb 4WO227). The results have been compared 
with those calculated for the neutral mono-carbene complex AuTMX-I (Figure 8.1). 
To validate the accuracy of our calculations we also performed gold complexes/G4 
binding assays using FRET (fluorescence resonance energy transfer) DNA melting. 
 
 
Figure 8.1 Chemical structures of the two Au(I) NHCs investigated in this study. 
 
The X-ray structure of Tel23, the telomeric-G4 adduct, with AuTMX2 (pdb 5CCW21) 
was used as reference to run a first set of metadynamics simulations. These initial 
simulations allowed us to calculate the compound’s most thermodynamically stable 
positions and provided a starting point for the free energy calculations with hTelo and 
C-KIT1 (see methodology section for details). This allowed the validation and initial 
positioning of the interaction of AuTMX2 with the selected G4 models to be 
ascertained. The X-ray structure shows seven molecules of AuTMX2, some of which 
are intercalated between the different G4 stacks (Figure 8.2). In our study, the Gibbs-
free energy (at 300 K, DGMD) was determined for all the seven poses (Table 8.1) and 
showed each one has a different binding energy. The starting position for hTelo and 
C-KIT1 corresponds to the AuTMX2 interaction with the topmost tetrad, where 
AuTMX2 interacts exclusively with one G4 stack (pose 1, Figure 8.2), This choice is 
more representative of the situation occurring in solution, where model G4s monomers 
are present. 
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Figure 8.2 X-Ray crystallographic structure of AuTMX2 interaction with Tel23 (pdb 5CCW), showing 
the different poses of the seven complexes with the G4 stack. AuTMX2 positions are numbered from 
1-7 and complexes are colored accordingly. K+ ions are shown as purple spheres. On the right panel a 
top view of the G4 stack, showing pose 1 (colored in green) is shown. This pose chosen as a starting 
position for the further metadynamics simulations. 
 
 
Table 8.1 Gibbs-free energy (DG300) values (kJ/mol) for AuTMX2 interaction with Tel23 (pdb 5CCW). 
For poses, refer to Figure 8.2. 
 
Pose DG (kJ/mol) 
1 -33 ± 9 
2 -53 ± 4 
3 -51 ± 1 
4 -58 ± 9 
5 -51 ± 3 
6 -47 ± 8 
7 -32 ± 13 
 
 
 
 
Moraca et al. used funnel metadynamics to constrain the ligand within a specific 
binding area determined to be the tetrad surface, allowing multiple iterations of 
binding/unbinding within a single large calculation25. However, in our study, the gold 
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complexes were not constrained to one area and were enabled to find the most 
energetically favourable interactions with the entire G4 models, including loops and 
top and bottom tetrads, allowing for possible further interactions to be identified. Thus, 
five 50 ns trajectories were calculated for each combination of compound and G4 
model (providing a total of 4 experimental conditions and a total of 20 simulations). 
The first set of calculations were performed using a simple distance collective variable 
(CV) between the Au+ centre of the complex and the K+ at the centre of the uppermost 
tetrad (see methodology section for details), resulting in a free-energy (DGMD, at 300 
K) profile output, based on the Au+-K+ distance (Figure 8.3, Table 8.2). To closely 
investigate the molecular mechanism of interaction of the gold complexes, further 
multi-CV calculations were run on the same systems. This involved adding a second 
CV for the torsion angle between the complexes and the uppermost tetrads (Figure 4). 
 
Table 8.2 Gibbs-free energy values, experimental (DGexp) and calculated by metadynamics (DGMD), 
for AuTMX2 and AuTMX-I interactions with hTelo and C-KIT1. DG values are expressed in kJ/mol 
and obtained considering T = 300K. [a] Data are obtained from simulations using a simple distance 
collective variable. 
 
 
 
 
 
 
  
 
 
 
 
G4 model 
 hTelo C-KIT1 
 DGMD[a]  DGexp DGMD[a] DGexp 
AuTMX2 (state I) -37 ± 7 -39 ± 2 -45 ± 3 
 
-12 ± 3 
-37.6 ± 0.4 
 
-15 ± 1 
AuTMX2 (state II) -14 ± 3 -12.1 ± 0.4 
AuTMX-I -28 ± 3 -23.2 ± 0.4 -30 ± 5 -29 ± 3 
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Figure 8.3 Graphical overlay of the free energy surface (FES) single collective variable (CV) plots for 
hTelo and C-KIT1 with AuTMX2 (orange) and AuTMX-I (blue). Each overlay consists of the five 
individual FES for each system. 
 
 
 
 
Figure 8.4 Multiple collective variable (CV) plot of free energy surface of AuTMX2 interactions with 
hTelo (centre). CVs correspond to distance (nm) between Au+ in AuTMX2 and K+ in upper tetrad and 
torsion angle (rad). Two states are highlighted (I and II) and two poses for state I are shown as a and 
b. States I-a, b and II are shown in translucent molecular surface, coloured according to lipophilicity 
(green: lipophilic, pink: hydrophilic). G4 structure is shown as sticks and ribbon, with hidden backbone 
for clarity. AuTMX2 is shown in ball and stick, with each caffeine ligand coloured differently (black 
and grey). C2 and C4 highlight the carbon atom positions in AuTMX2 in each of the related poses I-a 
or I-b. 
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As metadynamics allows for the exploration of the whole free energy surface of an 
interaction, rather than just one minimum, it is possible for further meta-stable 
positions to also be observed. In fact, this was the case for hTelo’s trajectories with 
AuTMX2 which shows two possible binding sites (state I and II) with the first one 
(state I) having the lowest energy (ca. -37 KJ/mol, Table 8.2). Figure 8.4 shows the 
multiple collective variable (CV) plot of the free energy surface for AuTMX2 
interactions with hTelo. Interestingly, state I shows two minima (a and b), 
corresponding to the same Au+-K+ distance (ca. 0.8 nm) but with two different torsion 
angles. The latter are related to AuTMX2 being in virtually the same position above 
the tetrad but with the gold complex rotating around its centre, thus, resulting in the 
same pose with two different torsion angles (see position of the caffeine ligands in 
Figure 8.4). 
 
In state I, AuTMX2 is interacting with both an adenine (A13) in the loop b region, and 
two of the guanine bases in the upper tetrad (G4 and G22), with strong p-stacking 
interactions between the NHCs of the gold complex and the aromatic rings of G22 
(Figure 8.4). Instead, the higher energy state II (ca. -14 KJ/mol, Table 8.2) corresponds 
to a position whereby the gold complex does not interact with any of the guanine bases 
in the upper tetrad, but exclusively with the loop thymine (T11) (Figure 8.4). In this 
second state, the loop covers the top of the G4-tetrad, hindering any possible 
interactions between the gold complex and the G-tetrad.  
 
Interestingly, a similar behaviour was observed for AuTMX2 binding to C-KIT1, with 
two states I and II (Figure 8.5, Table 8.2). C-KIT1 structure and surface are very 
different to that of hTelo: while hTelo has a prominent flanking loop capable of 
covering the top of the tetrad, C-KIT1 top surface is virtually flat. This structural 
feature leads the gold complex to interact with the top of the tetrad and the rings of 
flanking bases (A1) (Figure 8.5) with no obstruction. Thus, state I corresponds to 
AuTMX2 stabilized by p-stacking with the guanine rings (lowest energy), while in 
state II, it interacts with both A1 and G6 via p-stacking (Figure 8.5).  
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Figure 8.5 Multiple collective variable (CV) plot of free energy surface of AuTMX2 interactions with 
C-KIT1 (center). CVs correspond to distance (nm) between Au in AuTMX2 and K+ in upper tetrad and 
torsion angle (rad). Two states are highlighted (I and II), which correspond to AuTMX2 interaction 
with the top of the tetrad (I) or with both the top of the tetrad and flanking base A1 (II). In state I, one 
representative pose (a) is highlighted, where the complex is interacting with the top of the tetrad. States 
I and II are shown in translucent molecular surface, colored according to lipophilicity (green: lipophilic, 
pink: hydrophilic). AuTMX2 is shown in ball and stick. 
 
  
Multi-CV calculations were also run for the neutral mono-NHC complex AuTMX-I 
with both hTelo and CKIT1. The compound was shown to interact via  p-p and p-alkyl 
interactions with the guanine tetrad (G22) and the loop (A13) in hTelo (Figure 8.6), 
as observed for AuTMX2 (state I). However, as expected, the calculated DGMD was 
lower with respect to that of AuTMX2, due to the lack of the second caffeine ligand 
(Table 8.2). 
 
 
Figure 8.6 Multiple collective variable (CV) plot of free energy surface of AuTMX-I interactions with 
hTelo (center). CVs correspond to distance (nm) between Au in AuTMX-I and K+ in upper tetrad and 
torsion angle (rad). Two states are highlighted (I and II), which correspond to AuTMX-I interaction 
with the top of the tetrad (I) or the groove in loop c (II). In state I, one representative pose (a) is 
highlighted, where the complex is interacting the top of the tetrad and A13 in loop b. States I and II are 
shown in translucent molecular surface, colored according to lipophilicity (green: lipophilic, pink: 
hydrophilic). AuTMX-I is shown in ball and stick. 
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The enhanced efficiency provided by multiple collective variable simulations proved 
extremely valuable in identifying a second, unexpected binding mode of AuTMX-I 
(state II), with a similar energy to state I. In this second case the complex interacts 
within a groove in loop c (Figure 8.6) by p-p stacking the caffeine moiety with T18. 
This interaction was only observed when using the multiple collective variable for the 
calculations.  
 
In the case pof C-KIT1, AuTMX-I shows a single binding mode with the compound 
p-stacking with G6 of the uppermost tetrad (Figure 8.7). Moreover, the iodido ligand 
tends to position itself outside the G4 structure, in both hTelo and C-KIT1 adducts. 
 
The interesting observations of multiple binding modes of AuTMX2 led us to further 
investigate the stabilization properties of the two gold-based complexes. This was 
achieved through the determination of the Gibbs-free energy (DGexp) from the DNA 
FRET melting profiles. Thus, AuTMX2 and AuTMX-I were synthesized by adapting 
published protocols20,28. starting from their methylated precursors and fully 
characterized. The difference in DNA melting temperature (ΔTm, in °C) of hTelo and 
C-KIT1 induced by the binding of the two Au(I) NHC complexes was readily 
monitored through the modification of the FRET phenomenon and enabled an easy 
quantification of the compounds’ stabilization properties of G4-DNA.  
 
 
Figure 8.7 Multiple collective variable (CV) plot of free energy surface of AuTMX-I interactions with 
C-KIT1 (center). CVs correspond to distance (nm) between Au in AuTMX-I and K+ in upper tetrad 
and torsion angle (rad). Only one state is observed (I), which corresponds to AuTMX-I interaction with 
the top of the tetrad. One representative pose (a) is highlighted, where the complex is interacting with 
G6, on the top of the tetrad. Pose a is shown in translucent molecular surface, colored according to 
lipophilicity (green: lipophilic, pink: hydrophilic). AuTMX-I is shown in ball and stick. 
 
Chapter 8 
 
 143 
 
Figure 8.8 Representative FRET melting profiles of a 0.2 μM hTelo (A) and C-KIT1 (B) G-quadruplex 
DNA solutions in 60 mM potassium cacodylate buffer in absence (black solid lines), and in presence 
of 1 μM of AuTMX2 (red lines) and AuTMX-I (blue lines). C) ΔTm of hTelo and C-KIT1 G4s in the 
presence of AuTMX2 (red) and AuTMX-I (blue). Data is shown as mean ± SEM of three independent 
experiments; ** p<0.005, *** p<0.001. Results for AuTMX-I hTelo vs C-KIT1 are significantly 
different (significance not shown in the plot), * p<0.05. 
  
 
The compounds were then incubated with fixed amounts of each G4 for 10 min and 
the DNA melting profile recorded. As shown in Figure 8.8, both NHC complexes 
stabilize the hTelo and C-KIT1 structures, with the strongest effects being observed 
for AuTMX2. As previously reported22, AuTMX2 shows a characteristic melting 
profile for hTelo, featuring a two-step melting pattern, where a small increase in 
fluorescence is initially observed before the steep increase after ca. 65 ºC (Figure 8.8A, 
red trace). Alternatively, AuTMX2 with C-KIT1, investigated here for the first time, 
shows a gradually incrementing curve, rather than an initial steep ramp or two-step 
curve. In the case of the mono-caffeine derivative, AuTMX-I, the ΔTm of both G4s is 
approximately 2-fold lower than the one found for AuTMX2 (Figure 8.8, blue trace). 
(6.5 ± 0.2 ºC for hTelo and 11.0 ± 1.8 ºC for C-KIT1, respectively). Interestingly, 
AuTMX-I does not have an effect on the shape of the melting profiles of either DNA 
sequence, which is similar to the control DNA (Figure 8.8A-B, black and blue traces). 
 
In order to calculate the energy of binding (DGexp) of the gold compounds to each G4, 
the experimental data were normalized to folded fraction (q) of G4-DNA and fitted 
according to Eq. 1 and 229, where the enthalpy (∆H) for the process was derived from 
the resulting fit30. In order to fit a two-step melting profile of AuTMX2 with hTelo, a 
second equation (Eq. 4) was used, allowing us to take into account the upper and lower 
limits of the sigmoid curve used for fitting. This allowed us to treat the data fits as two 
independent melting curves. Thus, DGexp was calculated for both compounds vs each 
G4 structure, and also for hTelo’s two-step melting curve (Table 8.2). The resulting 
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fitting curves are shown in Figure 8.9. From the reported results, as expected, a trend 
could be identified in which the greater the stabilization of the G4 structure by the 
compound and lower is the energy of binding (when considering the most stable mode, 
state I for hTelo). 
 
Eq. 1: 𝜃(𝑇) = 𝜑(𝑥) = *R{*, where 
Eq. 2: 𝑥 = 	O∆ Q OR − RVQ 
Eq. 3: ∆𝐺sZZ = ∆𝐻. O¡¢V − 1Q 
Eq. 4: 𝜑(𝑥) = *R{*£¤WV¥¦¦§¨ + 𝐿𝑖𝑚¬­®*& 
 
 
Figure 8.9 Folded fraction (q) of hTelo and C-KIT1 with either AuTMX2 (red traces) or AuTMX-I 
(blue traces). Corresponding fits are shown as black or grey traces, and calculated Gibbs-free energy 
(DG300) is shown in each plot. The most representative poses for each combination of G4-gold complex 
are shown as hydrophobic (green)/ hydrophilic (magenta) surfaces, with the gold complex and the DNA 
bases shown in stick representation. Gold atoms, iodido ligand and K+ are shown in ball-and-stick 
representation, with phosphate backbone in black ribbon. Bellow each pose the interactions observed 
between the complexes and the G4s, corresponding to arene-arene or arene-H interactions are shown, 
where A – adenine, T – thymine, G – guanine. 
 
Most importantly, the DGexp are in perfect accordance with the DGMD values obtained 
from the metadynamics calculations (Table 8.2). Analysis of the melting curves and 
DGexp values of AuTMX2 with the two G4 models clearly suggest the existence of two 
distinct binding modes, in line with the computational results. Thus, considering 
hTelo, the first binding mode corresponds to the lower energy state I (Figures 8.4 and 
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8.9), exclusively featuring compound’s interaction with the guanines in the tetrad. The 
second binding mode corresponds to the higher energy (state II) involving 
loop/flanking base interactions and/or interactions with part of the tetrad (Figures 8.4 
and 8.9). As previously observed, the flatness of the top tetrad of C-KIT1 allows the 
compound to probe the entire top-surface of the G4 without hindrance. Since the 
stacking of the complex with the guanines is more favourable (state I), it would be 
expected that this is the interaction most likely to occur in vitro.  
Notably, our metadynamics results also point towards the existence of a second 
binding site for AuTMX-I with hTelo, involving the loop C. This interaction may be 
exploited in the future for further optimization of selective hTelo stabilizers.  
 
 
8.3 Conclusions 
 
Overall, the obtained computational results fully support the experimental data 
revealing two ligand binding modes of AuTMX2 on the two G4s structures. Moreover, 
they are providing further structural and energetics information on the ligand binding 
mechanism, including a free-energy landscape quantification. The validation of the 
binding energy of gold(I) complexes-G4s adducts calculated by FRET DNA melting 
assays was also achieved by metadynamics methods. This investigational approach 
can be extended to other types of molecules as G4 stabilizers, including organic 
compounds, highlighting selectivity features essential to orient the drug design. 
Considering that putative G4-forming sequences have been found in other mammalian 
genomes, yeasts, protozoa31, bacteria and viruses, the present integrated approach is 
certainly of value in other research disease areas. 
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8.4 Methodology Section 
 
To validate the method, free energy calculations were first carried out using the crystal 
structure for Tel23 (pdb ID 5CCW) containing four identical G4 units stacked with 
seven AuTMX2 (Figure 8.2). A single entire stack was taken from the crystal structure 
and used for the MD simulation. 
 
Further free energy calculations were carried out on the adducts of [Au(9-
methylcaffein-8-ylidene)2]+ (AuTMX2) and Au(9-methylcaffein-8-ylidene) Iodide 
(AuTMX-I) with G-quadruplex models hTelo (pdb ID 2HY9) and C-KIT1 (pdb ID 
4WO2) were run with both [Au(9-methylcaffein-8-ylidene)2]+ (AuTMX2). The 
parameters for both the complexes were defined using Gaussian 932 using PBE0 hybrid 
functional and the LanL2DZ basis set. The information taken from the DFT 
calculations were used to define the bonded parameters for each complex, this 
included all the bond lengths, angles, dihedrals and charges. 
 
Each system was set-up in a 10x10x10 nm box with periodic boundary conditions 
(PBC). The systems were solvated with approximately 32000 TIP3P water molecules 
dependent on G4 model used. Ions were added to each system to neutralize the charge 
and add a salt concertation of 0.15M using KCl to mimic physiological conditions. 
All simulations were run using the GROMACS 2016.3 software33 and the Amber99sb-
ILDN-slipid forcefield. Particle-mesh Ewald method was used for calculating 
electrostatic interactions. The Verlet cut-off scheme with a cut-off distance of 0.84 nm 
was used for short range repulsive and attractive interactions and Lincs was used to 
constrain all bond lengths. Nose-Hoover34 temperature coupling was used to maintain 
the temperature of the system (т = 0.5 ps) at 300 K. The Parrinello-Rahman35 
algorithm was used to maintain the pressure of the system at 1 bar with a coupling 
constant of т = 1.0 ps. Simulations were equilibrated for 100 ps before production. 
Total energy of the system was monitored using gmx_energy program within 
Gromacs. In the equilibrated system fluctuations remained within less than 0.5 % of 
the average value as shown in Figure 8.10. 
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Well-tempered metadynamics simulations were run for 50000000 steps with a 1fs time 
step (50ns) using the Plumed plugin36 for Gromacs. The distance collective variable 
(CV) was used between the Au of the TMX complex and the K of the top tetrad of 
each G4 model. In the case of the Tel23 stack, each of the seven AuTMX2 adducts 
were given a separate plumed control within the same data file, allowing us to 
calculate the free energy for each within the same simulation. The computational 
parameters were set with a Gaussian height of 0.05 kJ/mol and a Gaussian width of 
0.025 Å. Gaussians were added every 2000 steps (2 ps) giving a deposition rate of 
0.025 kJ/mol.ps. The bias factor was set to 12 thus, the DT was 3600K. Eight further 
well-tempered metadynamics simulations were run for 150000000 steps with a 1 fs 
time step (150 ns) using the Plumed plugin36 for Gromacs with and additional CV for 
torsion angle on each of the four systems(two for each system).The torsion angle was 
defined by either the two carbons either side of the gold centre for AuTMX2 (C2 and 
C4) or the carbon and iodine either side of the gold centre for AuTMX-I (C2 and I) 
and the N7 of G10 and N1 of G4 of hTelo and N1 of G2 and N1 of G10 for C-KIT1. 
The computational parameters were set with a Gaussian height of 0.05 kJ/mol, a 
Gaussian width of 0.025 Å and a torsion angle of 0.08 rad (p). Gaussians were added 
every 2000 steps (2 ps) giving a deposition rate of 0.025 kJ/mol.ps. The bias factor 
was set to 12 thus the DT was 3600K. The evolution of the free energy as a function 
of time for a representative simulation is shown in Figures 8.11 and 8.12. 
 
Figure 8.10: Total energy of system during 100 ps equilibration step for hTelo with AuTMX2. 
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Figure 8.11: Evolution of the energy minimum of the first peak (see Figure 8.3, C-KIT1-AuTMX2) as 
function of time. Its value does not change anymore after 15 ns. 
 
 
Figure 8.12: Overlays of the last 5 ns of the simulations. The 5 free energy curves are calculated with 
a 1 ns delay. No changes are observed in the distance range 0 < d < 3.0 nm. 
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Chapter 9 - Conclusions and future work 
 
9.1 Conclusions and Perspectives 
 
The growth of molecular modelling and free-energy calculations for drug discovery 
and development have provided a platform for the work undertaken here. The known 
affinity of certain metals for binding biological targets, such as the propensity of gold 
ions to coordinate to sulfur donors in amino acid residues, has guided our research 
towards the characterisation of the interactions between metal-based compounds and 
proteins or non-canonical DNA structures. Such interactions result in either protein 
inhibition or DNA stabilization, respectively, which are essential to achieve the 
desired metallodrugs’ pharmacological effects. Thus, the ability of MD and 
metadynamics approaches to calculate microsecond timeframes of our biological 
targets has allowed for greater understanding of these mechanisms at a molecular 
level. 
 
This thesis work is organized into two main sections. In the first one, we have studied 
the mechanism of permeation and inhibition of human aquaglyceroporins (AQPs) via 
a number of molecular dynamic techniques, such as umbrella sampling and 
metadynamics. AQPs are essential membrane proteins involved in cell homeostasis as 
well as in different pathologies, including cancer. Thus, the effects of one of the most 
potent AQP3 inhibitors, an Au(III) compound, on the protein conformation upon metal 
binding to Cys40 were investigated using steered molecular dynamics. Furthermore, 
with the aim of identifying key amino acids involved in the physiological transport 
and regulation mechanisms of aquaglyceroporins, two additional computational 
studies have been conducted: i) on the pH induced gating mechanism of human AQP7 
and its effect on both water and glycerol permeation; ii) the mechanisms of glycerol 
and water permeation via human AQP3. 
 
In the second part of the project, we have focused our research on the understanding 
of the mechanisms of interactions between organometallic Au(I) complexes and non-
canonical G4 DNA structures with pharmacological relevance. Thus, the stabilising 
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effect of Au(I) N-heterocyclic carbenes (NHCs) towards different G4s were evaluated 
using metadynamics and compared to FRET DNA melting measurements to 
determine the free-energy of binding and the mechanism of interaction. 
 
Based on this overall structure, the thesis is organized into different chapters, including 
an introductory one (chapter 1) and one including the main aims of the work (chapter 
2).  
 
While chapter 3 provides a specific introduction on the topic of AQPs and their 
relevance to physiology and disease mechanisms, as well as information on the state-
of-the-art in terms of AQPs inhibition by gold complexes and molecular dynamics 
studies, in chapter 4 we have evaluated the effect of the Au(III) complex 
Au(PbImMe)Cl2]PF6 on the permeation of glycerol via AQP3.  
A centre of mass (COM) pull code was used to encourage four glycerol molecules to 
pass through the AQP3 tetramer pores. Two models were used, and the results 
compared. The first model, constituted by the ‘native’ human AQP3 tetramer, was 
used as the control and the parameters set to consistently calculate the passage of all 
four glycerol molecules through the tetramer (one glycerol per pore). The second 
model contained the [Au(PbImMe)Cl2]PF6 directly bound, after detachment of a 
chloride ligand, to the sulfur of the Cys40 residue of one monomer of AQP3. The same 
pull parameters were used in both cases and the effects of the compound binding on 
the protein structure and permeation were observed. The calculation showed 
interesting distortions of the protein conformation, most notably Arg218 was 
prevented from H-bonding with the protein backbone and pushed outward into the 
channel, narrowing the pore and preventing both water and glycerol conductance. 
Further analysis showed changes to the extracellular surface of protein channel upon 
binding of the Au(III) compound, increasing the exposure of hydrophobic side-chains 
which are likely to affect how glycerol approached the pore entrance. Overall the MD 
calculations within this study showed that the binding of [Au(PbImMe)Cl2]PF6 did 
not cause direct steric hindrance of the pore, preventing glycerol and water 
conductance, but actually induced protein conformational changes which indirectly 
affected the substrate’s approach and passage through AQP3.    
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In chapter 5 we investigated the effect of pH change on human AQP7. Experimental 
results showed AQP7 ‘gating’ from fully permeable at physiological pH or higher to 
virtually closed at acidic pH, suggesting that changes in the extracellular environment 
can have a dramatic change on solute permeability. The calculations were performed 
on two AQP7 model systems. The first system contained an AQP7 tetramer protonated 
at pH 7, the second system contained an AQP7 tetramer protonated at pH 5. Analysis 
of the models showed a difference of just four residues protonated at pH 5 which are 
not at pH 7 (residues Glu40, His92, His140 and Glu202). As before, a centre of mass 
(COM) pull code was used to encourage four glycerol molecules to permeate through 
the aquaporin tetramer of both the pH 5 and pH7 models. A number of longer 
simulations were also performed to determine changes in water conductance between 
the two systems. The result showed a significant reduction of both glycerol and water 
permeation between the pH 7 and pH 5 model, in agreement with the experimental 
results. 
Further analysis of the models showed no significant reduction in average pore size 
between the two models, ruling out any conformational changes between the proteins 
in the channel region. The main differences were highlighted in the electrostatic 
surface of the tetramer, with an overall increase in positive charge intensity of the 
extracellular surface and a reversal of charge, from negative to positive, on the 
intracellular surface at pH 5. As the surface interactions are an important factor in the 
conductance rate of solutes through the pore, the observed pH changes may affect the 
hydrogen bond network between glycerol and the protein, causing the reduction of 
glycerol permeation at pH 5, rather than an open/closed gating mechanism. 
 
In chapter 6, we focused on the investigation of the mechanism of AQP3 permeation 
by water and glycerol using both an established potential of mean force technique in 
umbrella sampling and a state-of-the-art free energy method, metadynamics. The main 
focus of the chapter is the use of metadynamics to calculate the free energy for the 
conductance of water and glycerol over a physiologically relevant timeframe in which 
the solute molecules can explore the entirety of the model. Results show the 
interactions between the protein residues lining the pore surface, water and glycerol 
during both uptake and efflux. Hydrogen bond residence time was used to ascertain 
these interactions, showing the pathway taken by glycerol and water as they pass 
through the protein pore and highlighted the importance of the ar/R and NPA 
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selectivity filters and the role they play. Free energy surface results show the NPA 
electrostatic barrier to be the more energetically costly rather than the steric ar/R 
selectivity filter, as previously discussed. It should be noted that the NPA motif is 
responsible for the established flipping mechanism observed within the water chain.  
Therefore, it is not surprising that this region is the one with the highest energy barrier. 
A third area of interest was observed within the pore around His81, located just below 
the NPA motif. Both the free energy and hydrogen bond data show both solutes to 
have a strong interaction with His81 and the surrounding residues. The simulations 
also show the bi-directional behaviour of water through the pore at equilibrium 
conditions and the importance of water in glycerol transportation.  
 
 
Ongoing work 
 
Further ongoing work on AQPs concerns elucidating the transport mechanism of H2O2 
via human AQP3. In this case, a combination of both biased and unbiased in silico 
techniques was used to study the permeation of H2O2 through the pore. H2O2, a 
reactive oxygen species (ROS) known for causing cellular damage when 
overproduced, is thought to induce a signalling cascade leading to cell migration and 
metastasis in certain cancer cell lines, with AQP3 knockout studies in breast cancer 
cell lines showing reduced H2O2 uptake1. By knowing the permeation pathway of 
H2O2 along with the energies involved in this substrate’s conductance, we hope to be 
able to identify key residues for this substrate transport which may support the design 
of highly selective inhibitors. 
 
Initial studies involved using the established umbrella sampling technique to 
investigate H2O2 permeation via an homology model of AQP3, based on the structure 
of GlpF (pdb 1FX8). The potential of mean force (PMF) results is shown in figure 9.1 
for both uptake and efflux pathways. An average DG value of 7.5 kJ mol can be 
calculated for a permeation event.  
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Figure 9.1. Free-energy of H2O2 uptake (solid line) and efflux (dashed line), calculated using umbrella 
sampling. Averaged curve shown in red. 
 
Whilst umbrella sampling provides an insight into the energies involved, as previously 
discussed, this method does not relevant mechanistic data. Therefore, we have applied 
two further approaches to explore the system at a more physiological timeframe. The 
methods chosen were transition path sampling (TPS), to provide unbiased trajectory 
information, and metadynamics to provide both free energy and mechanistic 
trajectories of conductance events.  
TPS calculations are currently ongoing with the model built using a single AQP3 
monomer and one H2O2 molecule in a solvated system. As we are focusing the 
calculations on the pathway, having a smaller system allows for greater efficiency of 
the calculation. 
 
The metadynamics calculations consist of a full AQP3 tetramer embedded in a POPC 
lipid bilayer, as was also used for the umbrella sampling. Multiple 200 ns simulations 
have been run to capture as many permeation events as possible. In all 15 uptake and 
14 efflux events were successfully observed from a total of 1.2 µs of combined 
simulation time. The averaged free-energy results for both uptake and efflux can be 
seen in figure 9.2. Whilst the free-energy curve calculated by umbrella sampling and 
metadynamics do not match energetically, they do contain similar motifs in the 
calculated averages with the NPA region shown to be the highest energy barrier during 
H2O2 conductance. The calculated absolute DG values for H2O2 match the trend seen 
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with glycerol and water permeation in chapter 6, with H2O2 values between those of 
glycerol and water (Table 9.1). 
 
 
 
 
Figure 9.2. Average free-energy surface of H2O2 uptake (solid line) and efflux (dashed line), calculated 
using metadynamics sampling. Averaged curve shown in red. 
 
Analysis of the H-bond network for H2O2 permeation shows similar interactions 
within the ar/R and NPA regions as seen with both water and glycerol. Again, the 
previously seen long residence times (ca. 1.1 ns for water and ca. 2.1 ns for glycerol) 
with the highly conserved His81 of ca. 2.0 ns, located below the NPA motif, are also 
observed. The main differences are evidenced in the extracellular pocket, where less 
defined interactions are observed for hydrogen peroxide in comparison to glycerol, 
and a different approach pathway is also noticed. This could be due to the similarity 
between H2O2 and water, meaning hydrogen peroxide is able to insert into the water 
 
Table 9.1. Free energies DG (kJ/mol-1) for water, glycerol and H2O2 permeation through the NPA filter, 
for both uptake and efflux, calculated by metadynamics. Data shown as mean ± SEM. n = number of 
simulations. Data are calculated from the absolute DG of each successful permeation event and averaged. 
 
 DG (kJ/mol-1) 
 Water Glycerol H2O2 
Uptake 26 ± 5 (n = 7) 40 ± 4 (n = 8) 29±10 (n=15) 
Efflux 21 ± 5 (n = 14) 35 ± 10 (n = 10) 37±9 (n=12) 
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chain more easily than glycerol and have less of a detrimental effect on the 
bidirectional water flux.  
Preliminary results of this study provide an insight into H2O2 conductance and are 
consistent with our previous on glycerol and water. The TPS analysis will, we hope, 
increase our understanding of the conductance pathway. 
 
 
Figure 9.3. H2O2 permeation routes and H-bond patterns and RT (%) from metadynamics calculations. 
Average H-bond RT (%) of glycerol during uptake and efflux (on a scale of 0-0.8%) shown in a gradient 
purple colour, with the strongest colour indicating the highest RT. Multiple H2O2 molecules snapshots, 
taken from one representative simulation, are overlaid in one structure to create one single path. Amino 
acids that form crucial H-bonds are explicitly shown. Carbons are colour-mapped (white to purple) 
according to their corresponding RT (short to long). Pore colour representation based on hydrophobicity 
of the pore surface, blue = hydrophilic, brown = hydrophobic. 
 
 
Concerning the second part of the thesis, chapter 7 provides a concise introduction on 
the structure and function of G4 DNA structures, as well as on the most representative 
families of G4s stabilizers, including metal coordination complexes. In chapter 8, we 
used metadynamics to calculate the binding affinities of two Au(I) N-heterocyclic 
carbene (NHC) complexes with two G-quadruplex model sequences, namely hTelo, a 
human telomeric sequence, and C-KIT1, a promoter sequence.  
By calculating the binding affinities of the Au(I) NHC complexes with the G4 models 
we could ascertain which compound had the greater effect on G4 stabilisation by 
combining the in silico work with experimental FRET DNA melting assays. Through 
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mathematical modelling we were able to calculate the experimental DG value from the 
FRET data and have a direct comparison to the metadynamics calculations. 
Remarkably, the calculated binding free-energy values perfectly matched the 
experimental ones. As metadynamics allows the calculation of further metastable 
states, and not only the main free energy minima, we observed how the binding mode 
of the bis-carbene Au(I) complex with hTelo is a two stage process, as also 
hypothesized based on the FRET data. In addition, we were able to associate different 
binding modes of the two compounds with the G4s structures in correspondence to the 
different energy minima. Further studies will require the validation of these binding 
modes via different experimental techniques, such as NMR and CD spectroscopies. 
 
 
Overall, throughout this work we have shown how the use of in silico methods can 
enhance the knowledge and understanding of biological systems, helping validate and 
explain experimental results, and vice versa. We have used state of the art techniques, 
either rarely or not yet used for such complex systems, furthering the knowledge of 
our group, and through published work, the wider scientific community. 
 
 
9.2 Future work 
 
The work carried out here has provided a proof of concept for a number of biological 
systems and computational methods. In particular the use of metadynamics with large, 
complex transmembrane proteins and the elucidation of their mechanism of 
permeation. To further validate our approach, this work should be expanded to cover 
other aquaporin isoforms such as AQP8 and AQP10, to ascertain if the permeation 
mechanism we have observed in AQP3 is true for these isoforms.  
Previous work by Wambo et al (2017)1 have shown the osmotic driving force of 
aquaporin solute conductance. In this work a large system consisting of four GlpF 
tetramers embedded into a POPE lipid bilayer was constructed. A hybrid periodic 
boundry conditions (PBC) was used whereby a ridged boundary was implemented   
parallel to the membrane to prevent solvent mixture along the z-axis unless transported 
via one of the 16 pores. A different salinity was modelled in each of the solvated sites 
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by adding an additional salt concentration to the extracellular side, thus creating an 
osmotic gradient. Previous studies involved  simulating an osmotic gradient by 
applying hydraulic pressure to the system2. The method employed by Wambo et al 
(2017) is a more elegant solution as it does not bias the system and therefore allows 
for more reliable free energy results. Taking this work as inspiration, we proposed an 
alternative model to study the effect of osmotic gradients created by solutes such as 
glycerol and H2O2 concentration on the extracellular and intracellular sides of an 
aquaporin. In this case a large stacked double membrane/AQP system providing 
distinct solvated regions capable of mixing only via pore permeation could be built 
whilst still maintaining PBC. This would allow us to simulate the intra and 
extracellular regions, and the osmotic effects, more accurately based on biological 
conditions used experimentally. Depending on where the solute molecules are placed 
in the system it would be possible to model osmotic shocks on aquaporins and help to 
better understand their bidirectional nature. This system would allow us to calculate 
competition experiments between permeable solutes such as glycerol, H2O2 and urea. 
Whilst still being a simplified, and therefore, a manageable system, it would allow for 
a greater insight into the role played by aquaporins in the redistribution of solutes due 
to osmotic pressures. 
 
The further parametrisation of metals for use with force fields and the refining of Au(I) 
and Au(III) would allow the evolution of the growing catalogue of organometallic and 
coordination complexes to be evaluated in silico. Taking the work with these 
compounds to a higher theory level, such as density function tight binding DFTB3. 
Whilst being more established for materials chemistry calculations, this method has 
proved successful at calculating the conformational properties of a number of 
biomolecules such as peptides and DNA bases4. Work undertaken on this method 
within our group has led us to believe DFTB could allow us to further incorporate and 
understand the complex electronic interactions between organometallic compounds 
and their biological targets and thus, enhance our calculations and knowledgebase.  
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2. Symposium on interdisciplinary collaborations. Life Sciences Hub Wales.  
Oral contribution: MD studies of Hydrogen peroxide and glycerol permeation of 
AQP3. (24/11/16) 
 
3. Conference on Atomistic Simulations of Biomolecules: towards a Quantitative 
Understanding of Life Machinery. the Abdus Salam International Centre for 
Theoretical Physics (ICTP) Trieste, Italy. 
Oral and poster contributions: Molecular dynamic studies of H202 permeation via 
Aquaporin-3. (06/03/17 – 10/03/17) 
 
4. 16th Annual Cardiff Chemistry Conference. Cardiff University. Cardiff, UK. 
Poster Contribution: The Mechanism of Aquaporin Inhibition by Gold Compounds 
Elucidated by MD Simulations. (15/05/17) 
 
5. Southwest Structural Biology Meeting, Cardiff University. 
Poster Contribution: The Mechanism of Aquaporin Inhibition by Gold Compounds 
Elucidated by MD Simulations. (14/09/17) 
 
6. TUM-IAS workshop “Inorganic Chemistry meets Medicine. Die Technische 
Universität München (TUM), Munich, Germany.  
Oral contribution: Advanced molecular dynamics approaches for drug discovery. 
(24/10/17 – 26/10/17) 
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7. Structure Activity relationships. UK QSAR/MGMS meeting, Cardiff 
University, Cardiff, UK.  
Poster contribution: On the mechanisms of DNA G-quadruplexes targeting by 
gold(I) N-heterocyclic compounds: new insights by combined meta-dynamics and 
biophysical methods. (11/04/18 – 12/04/18) 
 
8. 17th Annual Cardiff Chemistry Conference. Cardiff University. Cardiff, UK. 
Oral contribution: On the use of advanced molecular dynamics methods to design 
drugs targeted to non-canonical DNA structures. (15/05/18) 
 
9. EuroBIC 14, University of Birmingham, Birmingham, UK.  
Poster contribution: On the mechanisms of DNA G-quadruplexes targeting by 
gold(I) N-heterocyclic compounds: new insights by combined meta-dynamics and 
biophysical methods. (26/08/18 – 30/08/18) 
 
10. Milestones in Molecular Simulations, Imperial College London, London, UK 
Poster contribution: On the mechanisms of DNA G-quadruplexes targeting by 
gold(I) N-heterocyclic compounds: new insights by combined meta-dynamics and 
biophysical methods. (21/06/19) 
 
 
